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ABSTRACT
Comparative Transcriptomic Analysis of Developmental Stages
in Isolated Mammary Epithelial Cells
Nicole Kristen Einfalt

The mammary gland is an organ common to all mammals; it is of value for neonatal
nourishment, human nutrition through dairy consumption, and is a source of pathology in
humans through the development of breast cancer. While transcriptomic analyses have
been applied to cultured mammary epithelial cells (MEC) and to whole gland samples,
few have studied purified MEC isolated directly from the gland in vivo. To identify the
differentially expressed genes influencing MEC development during pregnancy and the
differences between the nulliparous and primiparous quiescent states, primary MEC were
isolated from virgin, pregnant, and primiparous quiescent sibling mice. Computational
analysis was attempted using two differing platforms for the analysis of RNA sequencing
data, the commercially-available CLC Genomics Workbench and the recently-launched,
publicly-available Green Line Analysis. In the virgin-to-pregnant and virgin-to-postlactational quiescent developmental comparisons, 31.02% and 26.97% of differentially
detected genes, respectively, were dually detected by both platforms (p-value<0.05), with
the remaining genes being detected in one platform but not the other. Expression was
likewise compared for the dually differentially expressed genes detected with high (>500
RPKM), medium (10-500 RPKM), and low (0.02-9.99 RPKM) expression between the
two developmental comparisons. In the virgin-to-pregnant and virgin-to-post-lactational
quiescent developmental comparisons, 30.00% and 1.04% of differentially detected genes
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with high expression, respectively, were dually detected by both platforms (pvalue<0.05); 30.51% and 7.60% of differentially detected genes with medium expression,
respectively, were dually detected by both platforms (p-value<0.05); and 26.68% and
11.33% of differentially detected genes with high expression, respectively, were dually
detected by both platforms (p-value<0.05). Although a small portion of differentially
detected genes were dually detected between the two platforms, functional analysis for
biological meaning revealed similar depictions of the underlying biological themes. The
developmental comparison between the virgin and pregnant states suggests through
enhanced mitochondrial processes, amino acid availability, cellular communication, and
immune responses the lactational capacity is being established during the first half of
pregnancy, when MEC are devoted to growth and proliferation and formation of the
alveolus is not yet occurring. The developmental comparison between the virgin and
primiparous quiescent states indicates an overall decrease in oncogenic pathways yet
increase in ribosomal integrity may be associated with the parity-induced protection
against breast cancer. Last, parallel analysis of the transcriptome and proteome from the
same sample source allowed for the comparison of two differing means of analyzing the
molecular phenotype and showed regulation of mRNA abundance may not necessarily
reflect the expression pattern of the corresponding protein. A mathematical phenomenon
was noted in the percent of dually detected transcripts relative to proteins, suggesting
perhaps twenty percent of MEC genes are actively expressed at a given time.
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CHAPTER 1 – Literature Review
1.1 Introduction
Common to all female mammals is the milk-producing mammary gland that
functions to nourish the neonate. Development of the mammary gland occurs in distinct
ductal and secretory phases in response to endocrine signals; yet intriguingly, the
majority of this development occurs postnatally. Upon the consummation of puberty and
pregnancy, the mammary gland is fully differentiated and distinguished structurally by
functional alveoli capable of synthesizing and secreting milk (Robinson et al., 1999).
Lactation persists until weaning, at which time the gland involutes and is remodeled to
the pre-pregnant state (Watson, 2006). Following involution, mammary epithelial cells
(MEC) enter a state of reversible cell cycle arrest, remaining functionally quiescent until
proliferative hormonal cues promote differentiation to reestablish the lactogenic alveoli in
preparation for subsequent pregnancies (Harmes and DiRenzo, 2009).
While the hormonal regulation of mammary gland morphology is well
understood, much remains to be learned about the molecular mechanisms governing
development and differentiation. A combination of targeted disruption (gene knock-out)
and tissue transplantation experiments has been utilized to explain the role of these
molecular signals; however, further investigations to better understand these mechanisms
may guide improvements not only in milk production but also in the prevention and
treatment of breast cancer. This review describes the hormonal regulation of the
developmental events and stages specific to mammary gland morphology and introduces
the bioinformatics approach that was utilized for a whole system analysis. The following

1

thesis addresses the comparisons between key developmental stages of isolated MEC to
provide potential insights in lactation and cancer.

1.2 Mammary Gland Development and Functional Stages
Development of the mammary gland occurs in distinct phases in response to
endocrine signals. Although anlage is established during fetal development, the majority
of mammary gland morphogenesis is postnatal. Ductal elongation and branching are
observed only after the onset of puberty, while functional differentiation is obtained only
after pregnancy and parturition (Hennighausen and Robinson, 1998). To facilitate a more
complete comprehension of the mechanisms cardinal to lactation and tumorigeneis, this
section describes the anatomy and physiology of the mammary gland throughout a
female’s sexually reproductive lifespan.

1.2.1 Fetal Development
In all prenatal mammals the mammary gland originates from a localized
thickening of the abdominal ectoderm, the outermost layer of embryonic epithelial cells
(Hovey et al., 2002). As the epithelial cells constituting the thickening ectoderm
proliferate, becoming columnar and multilayered, they thereby establish a protuberance
that extends above and below the plane of the ectoderm (Hens and Wysolmerski, 2005).
These protuberances form the mammary placodes, or designated pre-organ regions that
eventually give rise to the mammary gland. In the mouse, five pairs of placodes form
between embryonic days ten and eleven (Hens and Wysolmerski, 2005), while in
humans, a single pair of placodes form between the seventh and eighth week of gestation
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(Russo and Russo, 1987). A similar development takes place in ruminants, where the
four placodes that develop into the four glands of the bovine udder form around
embryonic day thirty-seven (Akers et al., 2000; Hovey et al., 2002). Moreover, it is well
established that initial embryonic mammary gland development is dependent on intrinsic
as opposed to systemic factors, as mammary placodes explanted in vitro follow the same
proliferation and differentiation as their in vivo counterparts, even when cultured without
supplemental hormones or growth factors (Levine and Stockdale, 1985; Robinson et al.,
1999).
Little cell proliferation is observed by the embryonic MEC following placode
formation; however, the migration and accretion of cells from the adjoining epidermis
results in the formation of the rudimentary mammary epithelial bud. A study originally
performed by Propper and Gomot (1973) demonstrated that embryonic mammary
epithelium can induce non-mammary epithelium to form mammary buds when cultured
in vitro. This study was later confirmed in vivo (Cunha et al., 1995) and complimented
by tissue recombinant studies demonstrating how embryonic salivary epithelium, when
combined with mammary epithelium, develops a ductal branching network resembling
the salivary gland, yet when subsequently grafted into lactating hosts synthesizes milk
proteins (Sakakura et al., 1976).
The morphology of the mammary placodes and buds is identical in males and
females; however, the ensuing sexual dimorphism in mice introduces the importance of
hormonal exposure during fetal development. Beginning on embryonic day twelve,
transcription of the androgen, estrogen (E), and parathyroid hormone-related protein
(PTHrP) receptors increases (Heuberger et al, 1982). By this stage of fetal development
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the mammary bud is surrounded by a primary layer of mesenchyme, the embryonic
stroma with multipotent abilities to differentiate into supportive and connective tissues
(Mele et al., 2013). Androgens produced by the fetal testes act on mesenchymal
receptors to evoke condensation of the embryonic stroma around the male mammary bud,
resulting in destruction of this rudimentary structure by embryonic day sixteen (Pamar
and Cunha, 2004). In contrast, testes-lacking female mice to do not experience androgeninduced destruction of the mammary bud. Studies on the effects of exogenously-applied
testosterone found that embryonic female mammary buds do regress when exposed to the
androgen from embryonic days thirteen to sixteen, however testosterone exposure after
embryonic day sixteen failed to result in the destruction of the female mammary bud.
Thus, there is a window of embryonic endocrine sensitivity, after which androgens
cannot evoke destruction of the female mammary gland (Kratochwil, 1977). Curiously,
removal of endogenously-produced estrogens by X-irradiation of the ovaries at
embryonic day thirteen does not result in mammary gland developmental effects until
puberty, suggesting that the female morphology is the default state (Hovey et al., 2002;
Raynaud, 1950). Sexual dimorphism of the mammary gland is not apparent in ruminants
and humans until just prior to puberty and with the onset of puberty, respectively (Akers
et al., 2000; Russo and Russo, 1987)
Upon the formation of the mammary bud, epithelial-stromal interactions play
fundamental roles in mammary gland morphogenesis. This is not only apparent in the
growth and preliminary branching observed during the remainder of gestation but also in
the continued growth and development following parturition. In the final stages of fetal
development, the MEC of the mammary bud proliferate, promoting not only the

4

sprouting of the bud out through the dense mesenchyme and into the lower dermis in
preparation for ductal branching, but also the concurrent differentiation of the overlying
epidermal cells into the tissue of the nipple (Hens and Wysolmerski, 2005). As the
mammary bud sprouts, its epithelial cells express PTHrP, the receptor for which is
located in the mesenchyme. In both PTHrP and PTHrP-receptor knock-out mice, ductal
outgrowth of the mammary bud, sexual dimorphisms, and nipple formation fail, thereby
indicating PTHrP is necessary for the mesenchyme to support prenatal mammary
development and to differentiate accordingly (Wysolmerski et al., 1998).
Prior to parturition, the mammary gland is characterized by primitive ducts that
form a rudimentary branching network. The distal portion of these ducts resemble a
bilayered structure and are composed of an outer layer of undifferentiated cap cells
surrounding an inner layer of luminal epithelial cells (Hinck and Silberstein, 2005).
Estrogen and growth hormone (GH) promote cell division and embryonic expansion of
the primitive ducts through mesenchymal-derived growth factors, as opposed to exerting
their effects directly on the ducts themselves (Silberstein, 2001). Separate knock-out
(Cunha et al., 1997) and hypophysectomized (Wadden et al., 1998) studies in mice have
shown that mesenchymal intermediaries, namely E-mediated epidermal growth factor
(EGF) and GH-mediated insulin-like growth factor-1 (IGF-1), are necessary for ductal
elongation. In contrast, progesterone (P) and prolactin (PRL) exert their effects on the
mammary epithelium. Specific to the prenatal development of the mammary gland, PRL
is essential for establishing the rudimentary branching network from the primitive ducts
(Lamote et al., 2004). Knock-out experiments involving PRL and its receptor, PRLR,
have demonstrated that mice deficient in the PRL gene possess a basic, immature
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branching network compared to their extensively-branched control group. Thus, PRL is
inferred to be an obligate regulator of mammary gland development (Horseman, 1999).
At parturition, minor differences exist across species in the architectural
arrangement of the mammary gland. In humans, a small group of lobules emerge from a
terminal duct, giving them the appearance of a grape cluster found at the end of a stem.
In mice, lobules appear more club-like; however, the stroma into which they invaginate is
considerably higher adipose with only minor amounts of fibrous connective tissue
(Parmar and Cunha, 2004). In the newborn calf, although the teats are discernable, the
mammary fat pad and epithelium are barely palpable, existing in a negligible amount
extending dorsally above each teat (Rowson et al., 2012).

1.2.2 Postnatal Development
From parturition to puberty, growth of the mammary gland is minimal and
isometric, remaining proportional to that of the entire body (Lamote et al., 2004).
Isometric growth persists until approximately age eight-to-twelve years in humans, four
weeks in mice, and three months in cows, at which time the onset of puberty commences
the allometric growth and functional differentiation that establishes the specialized
lobulo-alveolar system prior to pregnancy (Hovey et al., 2002).

1.2.3 Pubertal Development
During isometric growth, an inhibition is maintained by the central nervous
system, keeping the gonadotropin-releasing hormone (GnRH) neurons of the
hypothalamus functionally quiescent. Upon removal of this inhibition, GnRH stimulates
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the onset of puberty through the production of reproductive hormones via the
hypothalamic-pituitary-gonadal axis (Porterfield and White, 2007). Together,
reproductive and metabolic hormones direct the cell proliferation, differentiation, and
apoptosis that promote the further expansion and branching of the mammary ductal
network into the surrounding stroma. Accordingly, while prenatal development of the
mammary gland was influenced by interactions with the mammary mesenchyme, the
development associated with puberty and pregnancy is dependent upon the stroma and its
constituents (Hovey et al., 1999).
The club-like bulbs of the mouse mammary gland are collectively known as the
terminal end buds (TEB) and represent the active site of ductal expansion and branching.
Although the corresponding active sites of the human and ruminant mammary gland
differ histologically and lack a bulb-like appearance, they can be considered a TEB-like
structure as they undergo comparable proliferation and differentiation (Hovey et al.,
2002). Similar to the primitive ductal establishment of the prenatal mammary gland, the
TEB of the pubertal gland are a multilayered structure, composed of an inner layer of
luminal epithelial cells surrounded by an outer layer of cap cells at the tip and
myoepithelial cells along the neck and length of the duct. The concurrent apoptosis of
the luminal epithelial cells with mitotically-proliferating cap cells extend the ducts
through the stroma, which in turn is encompassed by the adipose cells of the mammary
fat pad (MFP) (Klinowska et al., 1999). Lateral buds develop along the mature ducts,
resulting in the open architecture of the post-pubertal branching network and ultimately
decreasing the ratio of stroma to parenchyma (Hovey et al., 1999).
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Estrogen is accepted as the primary ovarian hormone directing ductal expansion
and branching during puberty. The E receptor (ER) exists in two subtypes, ER-a and
ER-b. While ER-b knock-out mice display no developmental defects, ER-a knock-out
mice are infertile and fail to develop as expected during the pubertal stage of mammary
gland growth and differentiation (Couse and Korach, 1999). However, if the ER-a is
knocked-out after puberty, alveolar differentiation is still able to occur, indicating the ERa is necessary for and specific to pubertal mammary gland development (Briskin and
Rajaram, 2006). Although the ER-a is solely restricted to the epithelial compartment in
humans and ruminants, in mice it is located in both the stroma and the epithelium, the
latter of which functions in a paracrine manner through the influential effects of growth
factors (Lamote et al., 2004). Amphiregulin, another example of a stromally-derived, Emediated growth factor, acts upon the epithelial cells of the TEB to direct ductal
development. Accordingly, amphiregulin mRNA is most highly expressed during the
pubertal growth phase, and its inactivation results in the failure to undergo ductal
outgrowth and branching (Howlin et al., 2006).
Similarly, GH, mediating its effects through IGF-1, is also necessary for the TEB
formation and ductal proliferation of pubertal development. Impaired pubertal ductal
outgrowth is observed in both IGF-1 knock-out (IGF-1KO) and GH receptor knock-out
(GHRKO) mouse models; however, the pubertal phenotype can be rescued in IGF-1KO
mice upon the dual administration of IGF-1 and E. Growth hormone and IGF-1,
therefore, function synergistically with E, as administration of IGF-1 alone is unable to
promote ductal outgrowth (Howlin et al., 2006). This synergism has also been
demonstrated in ruminants, where administration of both GH and E stimulates mammary
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gland development in peripubertal heifers; however, such a response is not observed
upon the administration of GH alone (Hovey et al., 2002).
Although required for the alveolar development associated with pregnancy, the
precise influence of P and its epithelial receptor, PR, specific to pubertal development of
the mammary gland in vivo has yet to be determined (Howlin et al., 2006). Ductal
branching is impaired in PR knock-out (PRKO); mice, however, the post-pubertal
phenotype is not abolished, indicating P is not essential for ductal elongation by or in
itself (Hovey et al., 2002).
Interestingly, the biologically active form of vitamin D3, 1,25-(OH)2D3, is a
systemically-circulating hormone recently proposed to have a suppressive effect on
mammary ductal development, potentially through the antagonism of proliferative signals
(Howlin et al., 2006). The vitamin D3 receptor (VDR) is a nuclear steroid hormone
receptor and is expressed in the epithelial cells of the TEB. In mice, mammary glands
from VDR knock-outs are significantly heavier compared to wild-type glands and are
characterized by a greater number and degree of TEB, branching, and ductal expansion.
These findings indicate that the vitamin D3 signaling pathway participates in negative
growth regulation of the pubertal mammary gland (Zinser et al., 2002).
The pubertal morphology of the mammary gland is not limited to influence by
those hormones and locally-produced growth factors mentioned thus far. Mitogens such
as epidermal growth factor (EGF), transforming growth factor (TGF), and hepatocyte
growth factor (HGF) direct the mitotic cell division observable in ductal outgrowth.
Stromally-derived matrix metalloproteases (MMP) are enzymes responsible for
remodeling the extracellular matrix (ECM), and have been suggested as necessary in the
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invasion of the MFP by the ductal epithelium (Fata et al., 2004). Still other influential
regulators may include transcription factors, cell cycle regulators, cytokines, and migrant
cell types such as macrophages and eosinophils (Howlin et al., 2006; Gouon-Evans, et al.,
2000). However, the focus of this review is limited to the hormonal regulation of
mammary development. Consequently, while E and GH are recognized as the key
regulators of pubertal development, it is crucial to understand proper morphology and
function of the developing mammary gland are dependent upon the extensive interplay of
numerous regulators.

1.2.4 The Virgin Adult
Upon the completion of puberty, ductal elongation and branching morphogenesis
have established a mammary network extending throughout the stroma in the virgin
adult, and the motile TEBs are no longer discernible. Alveolar buds, which develop into
the functional terminal ductal lobular units in humans and ruminants and lobuloalveolar
units in mice, remain rudimentary until dictated to differentiate further by the endocrine
signals associated with pregnancy (Parmar and Cunha, 2004).
The mammary gland of the virgin adult is comprised of a heterogeneous mixture
of cell types (Shackleton et al., 2006). The luminal and myoepithelial cells form a basal
parenchymal layer that is separated from the stroma by the basement membrane. The
stroma, in turn, consists of fibroblasts, adipocytes, inflammatory cells, vascular and
lymphatic components, and the ECM. Cross-species differences exist in the cellular
composition of the mammary stroma, most notable of which is the adipocyte-rich mouse
stroma compared to the fibrous connective tissue-rich human and ruminant stroma.
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Although postulated to affect the lactational composition and capacity of each species,
the exact physiological significance of these histological abundance differences remains
unclear (Parmar and Cunha, 2004; Hovey et al., 1999).
While the mammary gland of the virgin adult is relatively quiescent compared to
the morphological changes associated with the previous developmental phases, minute
morphological changes do occur in response to the estrous cycle. This cyclical
remodeling is the result of hormonally-regulated cell proliferation, differentiation, and
apoptosis that collectively promote rudimentary lateral branching and alveolar budding
(Chua et al., 2010). The estrous cycles of the mouse and bovine last four-to-five days
and twenty-one days, respectively, and are divided into proestrus, estrus, metestrus, and
diestrus. In humans, the cycle lasts between twenty-five-to-thirty days and consists of
follicular and luteal phases (Hovey et al., 2002). The greatest extent of alveolar budding
is observed in diestrus in the mouse and in the luteal phase in humans. The
morphological changes of the estrous cycle in ruminants, however, remain unexplored.
Within all species, the transitory estrous cycle-associated appearance of alveolar buds is
thought to indicate a developmentally prepared-for-pregnancy mammary gland (Chua et
al., 2010; Hovey et al., 2002).

1.2.5 Development during Pregnancy
The hormonal influence of mammary gland development during pregnancy is
impressive. Pregnancy begins with the implantation of the blastocyst into the uterus
following conception, and the ensuing hormonal cues direct extensive proliferation and
secretory differentiation to produce functional alveolar units capable of milk secretion.
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The tissue remodeling associated with alveolar morphogenesis is dependent not only
upon an initial synergy between P and PRL, but also on the influence of E, placental
lactogen (PL), and GH. Still other potentially influential hormones include but are not
limited to thyroid hormones, corticosteroids, insulin, leptin, and PYHrP. However,
further investigations are needed to distinguish the developmental function of these
hormones during pregnancy from the function they serve during lactation (Brisken and
Rajaram, 2006; Neville et al., 2002; Tucker 1981).
Specific to the development of the mammary gland during pregnancy, MEC of
the ductal network reorganize into polarized cells, forming a spherical layer of MEC that
face an open lumen connected to the ductal network and are surrounded by contractile
myoepithelial cells. Myoepithelial cells, in turn, are in direct contact with the basement
membrane, a specialized structure of ECM that underlies the mammary epithelium. The
cells of the ductal epithelium contain sparse cytoplasmic organelles and, remaining nonsecretory, primarily function as a channel for conveying milk upon the initiation of
lactation (Barcellos-Hoff et al., 1989). The luminal alveolar cells accomplish the
synthesis of milk while the myoepithelial cells, in response to oxytocin, contract to expel
milk out of the alveolus and into the ducts to nourish the young (Richert et al., 2000).
However, while differentiation of the MEC into alveolar structures has been heavily
investigated, little is currently known regarding the function and significance of
coordinated changes required for alveolar formation within the stroma (Brisken and
Rajaram, 2006).
Together, P and PRL promote the initial MEC cell proliferation associated with
early pregnancy and are required for the polarization of the luminal alveolar cells.
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Characteristic to humans and ruminants, PRL levels remain elevated throughout
pregnancy (Anderson et al., 2007; Tucker, 1981). Characteristic to the mouse, however,
this synergy is expunged in the later stages of pregnancy. While P supports the
continuation of gestation, increased signaling by PRL is required for the initiation of
lactation and the expression of most milk protein genes (Neville et al., 2002).
Molecular modulators and their mechanisms within MEC are of pivotal
importance for understanding the signaling pathways by which hormonal regulation is
able to induce morphological changes. The PR, a steroid hormone nuclear receptor, is
not found in all MEC, so the proliferation of these cells in response to P is partly
mediated by paracrine factors (Oakes et al., 2006). Similar to that mentioned in previous
developmental stages, transplantation studies have demonstrated how wild-type
mammary epithelium can promote alveolar differentiation in adjacent PRKO epithelium
(Brisken et al., 1998). Studies by Conneely and colleagues have identified two different
isoforms of the MEC PR, PR-A and PR-B. Their analysis on mammary glands of PRAKO and PR-BKO mice has shown that alveolar morphogenesis is drastically diminished
in mice lacking the PR-B isoform, while ablation of the PR-A does not affect the ability
of PR-B to elicit normal alveolar development (Conneely et al., 2003; Mulac-Jericevic et
al., 2000).
The wingless-related NMTV integration site 4 (Wnt4) and receptor activator of
nuclear factor (NF)-kB ligand (RankL) are two proposed mediators of the P signaling
pathway. When P binds to PR-B, it is speculated to achieve its developmental effects
through one of these downstream signaling mediators (Brisken et al., 2000; Oakes et al.,
2006). Wnt4 is the only Wnt gene directly induced by P, and within murine MEC in the
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early stages of pregnancy, P has been shown to induce Wnt4 expression. Wnt4 is thus
thought to mediate the maturation of the ductal side branching leading to alveolar
morphogenesis, as transplantation of mammary epithelia from Wnt4-knock out
(Wnt4KO) mice has demonstrated that Wnt4 is key to this process. However, ductal
side-branching and alveolar morphogenesis do develop later in pregnancy in Wnt4KO
mice, indicating other P-induced factors might play a role in mediating proliferation and
alveolar morphogenesis (Brisken et al., 2000). The other candidate, RankL, is likewise
speculated as a P-signaling mediator. When RankL binds to its receptor, Rank, the
ensuing IkB kinase-a (IKK-a) signaling pathway activates the downstream NF-kB
transcription factor, the phosphatidylinsoitol 3-kinase (PI3K) Akt pathway, and the
CAAT/enhancer binding protein-b (C/EBP-b) signaling pathway (Fernandez-Valdivia
and Lydon, 2012), all of which are known to be influential in alveolar morphogenesis
during pregnancy in mice (Oakes et al., 2006). Remarkably, in wild-type mouse hosts
transplanted with PRKO mammary epithelium, ductal side branching and alveolar
budding is observed upon the administration of exogenous RankL, supporting the notion
that this paracrine mediator is fundamental to the P-signaling pathway (FernandezValdivia and Lydon, 2012). Whether RankL has the same functional role in humans
remains to be determined. Considering the profound proliferation that is triggered by
Wnt4 and RankL in P-promoted mammary gland development, these mediators and their
inhibitors are of clinical interest in future applications specific to the prevention and
treatment of breast cancer (Tanos et al., 2013).
Another essential molecular modulator associated with pregnancy is the signal
transducer and activator of transcription protein 5a (STAT5A). In response to PRL
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binding to PRLR, the receptor dimerizes, inducing the phosphorylation and activation of
Janus kinase 2 (JAK2). The activated kinase consequentially phosphorylates STAT5A,
which in turn translocates to the nucleus of MEC and serves as a mandatory transcription
factor in the expression of specific genes related to alveolar morphogenesis (Liu et al.,
1996). Examples of those genes induced by STAT5A include claudins and connexins,
which are necessary for cell-cell interactions, collagens and laminins, which are
necessary for stromal-epithelial interactions, the suppressor of cytokine signaling 2
(Socs2) protein, which functions as a negative regulator of the PRL-signaling pathway,
and the E74-like factor 5 (Elf5) transcription factor, which is necessary for the structural
and functional development of mammary alveoli (Oakes et al., 2006). Socs2 and Elf5
function as the most influential molecular mediators of the PRL-induced development of
the mammary gland, and Harris and colleagues have used PRLKO mice to demonstrate
that alveoli are capable of milk production following either the additional genetic ablation
of Socs2 or the retrovial re-expression of Elf5 (Harris et al., 2006). While Socs2 knockout mice exhibit an overall loss of growth control and disproportionately large organs,
further analysis of the physiological significance of Elf5 is unfortunately hindered by the
early embryonic lethality of Elf5-knock out mice (Zhou et al., 2005).
The precise significance of E on mammary gland development after ductal
morphogenesis remains to be fully investigated. While P is directly essential for alveolar
morphology during pregnancy, E, interacting with ER-a, is presumed not only to be
influential in ductal growth but also to indirectly stimulate alveolar development through
its subsequent induction of PR and PRLR in the mammary epithelium (Neville et al.,
2002).
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Likewise, the role of GH in MEC differentiation is unclear. While GH appears to
signal through its stromal receptor, GHR, it is not necessary for alveolar development.
Although ductal outgrowth and branching are diminished in GHRKO mice, lactation is
still able to occur following parturition (Kelly et al., 2002). Furthermore, and specific to
humans, female dwarves lacking GH are capable of lactating, maintaining the supportive
yet non-essential role of GH in alveolar development (Neville et al., 2002).
The syncytiotrophoblast cells of the placenta, a transient organ that develops only
during gestation, are able to secrete several hormones that function either to maintain the
pregnant state of the maternal uterus or to promote alveolar formation within the
mammary gland (Porterfield and White, 2007). Placental lactogen is a polypeptide
hormone secreted by the placenta of humans, rodents, and ruminants, and is structurally
similar to GH and PRL. Accordingly, while there currently is no known specific PL
receptor (Neville et al., 2002), studies by Herman and colleagues have shown that
isolated ovine PL is able to bind to bovine GHR and PRLR (Herman et al., 2000).
Whether similar binding occurs in humans and mice has yet to be determined (Neville et
al., 2002). However, considering PL is far more abundant in maternal circulation
compared to fetal circulation, its functional role remains pivitol to the former through the
support of GH- and PRL-mediated alveolar formation (Porterfield and White, 2007).
Equally interesting to note are the equally dramatic changes in other tissue types
in accordance with pregnancy. For example, to function metabolically under the
increased energy requirements of pregnancy and lactation, the intestines and liver
enlarge. To provide the mammary gland with the increased quantities of energy, sugars,
and amino acids required for milk production, there is a parallel increase in the
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vasculature of the stroma (Oakes et al., 2006). Maternal behavior is stimulated by PRL at
the end of pregnancy and maintained by oxytocin following parturition (Uvnas-Moberg
and Eriksson, 1996).
Proper morphogenesis of the functional mammary gland is thus dependent upon
the coordination of endocrine induction, signaling pathways, and their corresponding
molecular mediators to direct the formation of alveolar units from the ductal epithelium.
The following sections will reference these developmental pathways as many of the same
processes necessary for proper morphogenesis are reflected in lactation and manifest in
metastatic tumorogenesis (Colletta et al., 2004). Consequently, the regulation of MEC
proliferation and differentiation is significant in the application to milk production within
the dairy industry and in the prevention and treatment of breast cancer.

1.2.6 Lactation
Milk production, which is blocked by P during pregnancy, is stimulated by PRL
and the increased transcription of milk protein genes around parturition (Anderson et al.,
2007). While the physical process of milk ejection is similar among species, differences
do exist in the coordination of increased PRL signaling and P withdrawal. Although PRL
levels remain elevated throughout pregnancy in humans, P does not fall until the placenta
is removed following parturition. In contrast, in mice and ruminants, PRL rapidly spikes
as P decreases just prior to parturition. Thus, while full lactation is slightly delayed in
humans, milk is readily available for the newborn pups and calves in mice and ruminants
(Neville at al., 2002).
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Various changes are observed within the mammary gland upon the transition from
pregnancy to lactation. Histologically, at the onset of lactation, the rudimentary alveolar
buds have fully developed into functional terminal ductal lobular units in humans and
ruminants and lobuloalveolar units in mice. Additionally, the ductal network has
branched extensively throughout the MFP, and tight junctions between the alveolar cells
have closed (Anderson et al., 2007). The most prominent histological change is the
increase in size and abundance of lipid droplets and casein micelles within the alveolar
cells, and the movement of these particles into the alveolar luminal space (Neville et al.,
2002). Typical of any cell specialized for secretion, the endoplasmic reticulum (ER) of
the lactating MEC is extensive and in contact with numerous mitochondria (Boisgard et
al., 2001). On a more systemic level, the onset of lactation is also accompanied by
increases in blood volume and cardiac output. The resulting increase in blood flow to
and from the mammary gland is correlated to milk yield and provides the mammary
gland with the nutrients required for synthesis of the various milk components
(Svennersten-Sjaunja and Olsson, 2005).
Milk ejection from the alveoli is stimulated by suckling, regulated by a
neuroendocrine reflex, and required for the continuation of lactation (Anderson et al.,
2007). Specifically, the suckling stimulus depolarizes the somatosensory afferent
neurons at the tip of the nipple, triggering the magnocellular and parvicellular neurons of
the hypothalamus to promote the respective release of oxytocin and PRL from the
pituitary gland (Porterfield and White, 2007). While oxcytocin binds to its receptors on
the myoepithelial cells of the ductal network, thereby causing them to contract and
transport milk through the ducts to nourish the young, PRL binds to its receptors on the
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secretory MEC of the alveolus, thereby promoting their continued production of milk
components (Neville el at., 2002; Uvnas-Moberg and Eriksson, 1996).
Although PRL is required for the continuation of lactation, other metabolic
hormones such as insulin, glucocorticoids, thyroid hormones, and GH have also been
proposed to be potentially influential in milk production and yield. Insulin levels during
lactation are relatively low, and a decreased responsiveness of adipose and skeletal
tissues to insulin serves to increase the availability of glucose for the mammary gland
(Svennersten-Sjaunja and Olsson, 2005). Adrenal steroids, such as glucocorticoids, are
known to maintain blood glucose levels during periods of starvation, and are thus
pertinent in the negative energy balance that exists in ruminants and mice during early
lactation. Humans rarely enter a negative energy balance during lactation, and thus
glucocorticoid levels remain relatively lower (Neville et al., 2002). Thyroid hormones
are known to increase membrane Na+-K+ adenosine triphosphate (ATPase) concentration
and activity, consequently increasing the metabolic pathways and overall energy
expenditure of a cell (Porterfield and White, 2007). Triiodothyronine (T3) is a tyrosinebased thyroid hormone that is formed from the enzymatic 5’-deiodination of thyroxine
(T4) within the thyroid and peripheral tissues such as the mammary gland. Interestingly,
despite the decreased amount of deiodination in the liver and kidneys during lactation,
there is an increased amount in the mammary gland, and the resulting hypothyroidism of
the peripheral tissues decreases their metabolism yet enhances that of the mammary gland
(Neville et al., 2002; Tucker 1981). The precise role of GH during lactation remains
debatable. Exogenously administered GH is known to mobilize energy reserves and has
been shown to enhance the blood flow, uptake of nutrients, milk synthesis, and activity of
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secretory cells (Bauman, 1999). The resulting increase milk yield has thus led to its
commercial application in the dairy industry. However, it is unclear whether the effects
of GH are restricted to the luminal alveolar cells of the mammary gland or are more
relevant to the overall nutrient availability of the lactating female (Svennersten-Sjauja
and Olsson, 2005).
Fascinatingly, in addition to the various nutritional components synthesized and
secreted into the milk, the mammary gland has recently been shown capable of
synthesizing several hormones and growth factors including PRL, leptin, PTHrP, and GH
(Neville et al., 2002). Hence, the lactating mammary gland is not only functioning as
directed by specific systemic cues but is also itself a site of hormone production.
Prolactin serves as the primary reproductive hormone governing lactation, while other
metabolic hormones have been speculated to be indirectly influential. These metabolic
hormones are not essential to the alveolar functioning of the mammary gland, but rather
may affect the synthesis of the various milk components by altering the nutrient
availability of the lactating gland (Neville at al., 2002). Milk secreted by the mammary
gland consists of water, proteins, lipids, carbohydrates, vitamins, and minerals. Specific
synthesis of the protein, lactose, and lipid components will be discussed in the following
subsections.

1.2.6.1 Protein Synthesis
The synthesis of proteins is important not only for the generation of those secreted
in the milk but also for the generation of those necessary and responsible for proper cell
function and survival. Protein synthesis is an energetically expensive process, yet the
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increase in efficiency of milk protein synthesis remains a profitable aspiration for the
dairy industry (Bionaz and Loor, 2011). When stimulated by a PRL-mediated lactogenic
environment, MEC selectively regulate the production of milk proteins. Caseins and
whey are the main proteins produced by the mammary gland and comprise 95.6% of the
total proteins secreted in milk, with the remaining 4.4% of total secreted proteins
originating in the blood as immunoglobulins and lactoferrins (Maas et al., 1997). Protein
synthesis is accomplished through the coordinated steps of selective transcription of
deoxyribonucleic acid (DNA) to ribonucleic acid (RNA) by RNA polymerase II within
the nucleus, exportation of the RNA through nuclear pore complexes, translation of the
RNA to a sequence of amino acids within a ribosome, and finally post-translational
modifications such as removal of the signal peptide, phosphorylation, and glycosylation
of the protein just prior to secretion (Alberts et al., 2008). The availability of amino acids
for the translational process within MEC is generally regarded as the limiting factor in the
synthesis and secretion of milk proteins (Boisgard et al., 2001).
Significant to this process is the function of the ribosome, a catalytic complex that
uses the genetic information carried by RNA molecules to guide the synthesis of proteins.
Eukaryotic ribosomes are assembled from a small 40S subunit and a 60S large subunit
each consisting of thirty-three and forty-nine unique proteins, respectively. While the
small ribosomal subunit provides a framework on which transfer RNA (tRNA) molecules
match the RNA nucleotide sequences to specific amino acids, the large ribosomal
subunit, links the peptide bonds between individual amino acids within the sequence of
the protein (Alberts et al., 2008). Interestingly, individual ribosomal proteins have
recently been highlighted as having extra-ribosomal functions such as DNA repair,
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regulation of apoptosis, and autoregulation of ribosomal protein synthesis. Furthermore,
ribosomopathies, disorders resulting from impaired ribosome biogenesis and function,
have recently been shown to be oncogenic and consequently detrimental to cellular
homeostais (Shenoy et al., 2012; Warner and McIntosh, 2009).
The newly synthesized proteins found in milk are aqueous solutes and secreted
through an exocytotic pathway, meaning they are packaged into secretory vesicles within
the Golgi apparatus and transported to the apical region of MEC. The membrane of the
transport vesicles fuse with the plasma membrane, ultimately resulting in the discharge of
the synthesized protein contents into the luminal alveolar space (McManaman and
Neville, 2003). The regulation of this exocytotic secretory pathway remains to be
explored. While PRL and the resulting JAK-STAT signaling pathway are generally
regarded as essential regulators of protein expression in non-ruminant mammary glands,
recent studies in mice and ruminants have highlighted a role of the mammalian target of
rapamycin (mTOR) signaling pathway in milk protein synthesis (Bionaz and Loor, 2011).

1.2.6.2 Lactose Synthesis
Lactose is the main carbohydrate found in milk, serving as a vital source of
energy for the newborn offspring. Both ruminant and nonruminant offspring are able to
digest this disaccharide, breaking it down into glucose and galactose. Synthesis of
lactose is unique to mammary alveolar cells and occurs within the lumen of the Golgi
apparatus by the enzyme lactose synthase (Anderson et al., 2007; Shennan and Peaker,
2000). Lactose synthase is composed of two protein units, a-lactalbumin and
galactotransferase. While P represses the expression of a-lactalbumin within the
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mammary gland throughout pregnancy, PRL induces the expression of both of these
protein components. Lactose synthase catalyzes the formation of lactose and uridine
diphosphate- (UDP-) galactose from glucose and UDP-galactose (Turkington and Hill,
1969). Beginning with suckling by the offspring, the dam experiences a gradual increase
in milk and lactose production, and the volume of milk secreted is closely related to the
rate of lactose synthesis (Shennan and Peaker, 2000; Uvnas-Moberg and Eriksson, 1996)
Alveolar cells of the lactating mammary gland are characteristically high in
cytoplasmic glucose concentration, a phenomenon that results from the presence of the
non-insulin dependent glucose transporter, GLUT1, on the basolateral membrane
(Shennan and Peaker, 2000). The GLUT1 transporter is also located on the membrane of
the Golgi apparatus, allowing for the uptake of glucose into the Golgi apparatus and its
subsequent interaction with UDP-galactose and lactose synthase (Anderson et al., 2007).
However, while the membranes of the Golgi apparatus and apical alveolar cell are freely
permeable to water, neither are permeable to lactose. As a result, the newly synthesized
lactose osmotically draws water into the Golgi apparatus, thereby significantly
contributing to the overall milk volume yield (Shennan and Peaker, 2000). Similar to
protein secretion, lactose is packaged into vesicles within the Golgi apparatus and
secreted into the luminal alveolar space through an exocytotic pathway (McManaman
and Neville, 2003).
Significant to note are the other fates of glucose utilization by the alveolar cells of
the lactating mammary gland. While glucose is required for the synthesis of lactose, it
can also be converted into glucose-6-phosphate (G-6-PO4) for adenosine triphosphate
(ATP) production within the mitochondria, for glycerol production in the synthesis of
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triacylglycerol (TAG), or for nicotinamide adenine dinucleotide phosphate (NADPH)
production through the pentose phosphate pathway (Anderson et al., 2007).

1.2.6.3 Lipid Synthesis
In addition to lactose, lipids also serve as a vital source of energy for the newborn
offspring. The amount of fat in milk can range from less than 1% to greater than 50%,
depending not only on the species but also on the breed within that species (Shennan and
Peaker, 2000). While the percentage of fat is typically around 4% in humans and
ruminants and 20% in mice, the exact percentage is highly influenced by diet intake and
stage of lactation (Neville and Picciano, 1997; Gors et al., 2009). TAG, formed from
three fatty acid tails connected to a glycerol backbone through an ester linkage, is the
major component of milk fat, typically accounting for 98% of the fat found in milk
(Anderson et al., 2007). Fatty acids, in turn, can either be taken up from the circulating
blood or synthesized through liopogenesis by the lactating MEC (Shennan and Peaker,
2000).
Fatty acids within the blood are considered an exogenous lipid source and are
derived either from the diet or adipose tissue. Transport to the mammary gland is
facilitated through the formation of chylomicrons or through the binding to transport
proteins such as albumin or very low-density lipoprotein (VLDL) (Anderson et al., 2007;
Shennan and Peaker, 2000). TAG itself cannot enter mammary tissue; upon reaching the
mammary gland, lipoprotein lipase breaks TAG down into its constituents. Whether fatty
acids cross the MEC plasma membrane via diffusion or a transport system is currently
unknown (Neville and Piacciano, 1997). Glycerol and fatty acids are then taken up from
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the blood and into the alveolar cells where they are subsequently used for TAG synthesis
(Anderson et al., 2007).
In addition to hepatic and adipose tissues, lipogenesis can also occur in mammary
tissue. Depending on the species, these tissues utilize different precursor molecules to
convert acetyl-coenzyme A (acetyl CoA) into fatty acids for TAG synthesis and
secretion. In non-ruminants such as humans and mice, glucose serves as the precursor for
fatty acid synthesis, undergoing glycolysis within the cytosol for conversion to pyruvate,
transport into the mitochondria for conversion to citrate via the tricarboxylic acid (TCA)
cycle, and lastly transport out of the mitochondria for conversion into acetyl CoA by the
enzyme ATP citrate lyase (Neville and Picciano, 1997). In ruminants, however, volatile
fatty acids (VFA) such as acetate and butryate, not glucose, are the primary energy
source, resulting from the ruminal fermentation of ingested carbohydrates. Specific to
ruminant lipogenesis, acetate, as well as b-hydroxybutyrate, serve as the precursors for
acetyl CoA synthesis, the conversion of which is performed by the enzyme acetyl CoA
synthetase (Bernard et al., 2008).
Once generated in the ruminant or non-ruminant, acetyl CoA in the cytoplasm is
converted into malonyl CoA by acetyl CoA carboxylase, after which fatty acid synthase
catalyzes the formation of the growing fatty acid chain, a process that requires NADPH
as an electron-donating reducing agent (Porterfield and White, 2007; Neville and
Picciano, 1997). The production of this reducing agent varies between species. While
ruminant MEC primarily produce NADPH from the conversion of isocitrate to aketoglutarate using the enzyme isocitrate dehydrogenase, non-ruminant MEC can
produce NADPH from the pentose phosphate cycle and from the conversion of malate to
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pyruvate using the enzyme malate dehydrogenase, in addition to also utilizing isocitrate
dehydrogenase (Anderson et al., 2007; Bernard et al., 2008; Neville and Picciano, 1997).
Ultimately, the newly formed fatty acid chains are esterified to a glycerol-3-phosphate
backbone by the actions of glycerol-3-phosphate acyl transferase and diacylglycerol
acyltransferase enzymes located on the endoplasmic reticulum, thus completing the
synthesis of the TAG molecule (Bernard et al., 2008)
The secretion of TAG into the milk is unique to MEC. Individual TAG molecules
combine and incorporate themselves into cytoplasmic lipid droplets that are transported
to the apical plasma membrane. Upon reaching the plasma membrane, the lipid droplets
fuse with it, become embedded within it, and eventually are pitched off from it in a
unique budding secretory process. Together, the membrane-enveloped lipid particle
secreted into the alveolar luminal space is known as the milk fat globule (MFG)
(McManaman and Neville, 2003; Neville and Picciano, 1997).

1.2.7 Involution
Upon the completion of lactation, involution is an essential process that returns
the mammary gland to its pre-pregnant state in preparation for subsequent pregnancies.
Accordingly, the cessation of suckling and milk removal by the young deems the
lactating MEC redundant and initiates their removal. The resulting morphology of the
post-involutional mammary gland is similar to that of the virgin mammary gland,
characterized by a rudimentary ductal branching network. Of all the phases specific to
mammary gland development discussed thus far, the process of involution is the least
well understood (Pai and Horseman, 2011). Yet considering that the inability of
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mammary tissue to regress is associated with increased tumorogenesis, involution of the
mammary gland is an essential developmental activity (Strange et al., 1992). The process
can be divided into two main events, a reversible apoptotic phase followed by an
irreversible remodeling phase (Watson, 2006).
The apoptotic phase of involution is reversible, meaning milk production and
secretion can be rescued. In mice this phase is known to last for the first two days
following forced weaning with pup removal. Provided the pups are returned and allowed
to nurse within that time frame, apoptosis is halted and lactation resumes (Watson, 2006).
The initial accumulation of milk within the alveolar luminal space results in a volumeand pressure-induced swelling that flattens the surrounding epithelial cells. This
accumulation initiates distinct alterations that collectively promote apoptosis and
shedding of the secretory epithelium (Richert et al., 2000). Apoptosis is distinct from
necrosis. While the former is a programmed event involving coordinated cellular
condensation of a tissue structure, the latter progresses from a stressed cellular
environment, resulting in the loss of structure and the random destruction of protein and
nucleic acids (Strange et al., 1992). Thus, and in accordance with the programming of
cell death, the alterations induced by milk accumulation include the increased expression
of leukemia inhibitory factor (LIF) and transforming growth factor b3 (TGF-b3). The
binding of these factors to their receptors on the MEC luminal membrane promotes
receptor dimerization, inducing the phosphorylation and activation of JAK2, which
subsequently phosphorylates and activates signal transducer and activator of transcription
protein 3 (STAT3). While activation of STAT5A was previously described as necessary
in the development of the alveolar structures during pregnancy, STAT3 is likewise
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necessary for the initiation of involution following the cessation of milk removal.
Accordingly, STAT3 translocates to the nucleus of MEC where it serves as a mandatory
transcription factor in the expression of specific genes related to apoptosis (Watson,
2006; Liu et al., 1996). These include the genes for insulin-like growth factor binding
protein 5 (IGFBP-5) and CCAAT-enhancer binding protein d (C/EBPd), as well as the
genes for the negative regulatory subunits of the phosphatidylinsolitol-4,5-bisphosphate
3-kinase (PI3K) Akt signaling pathway (Watson, 2006). Akt, also known as protein
kinase B (PKB), is a general mediator of cell survival that, when activated through
phosphorylation, can itself phosphorylate and consequently deactivate pro-apoptotic
proteins such as B-cell lymphoma-extra large (BCL-X), BCL-2-associated death
promoter (BAD), BCL-2-like protein 4 (BAX), and BCL-2 homologous antagonist killer
(BAK) (Alberts et al., 2008; Datta et al., 1997). Thus, the inhibition of Akt activation is
key to the apoptosis associated with involution. Perturbation of this coordinated kinase
signaling cascade can result either in excessive cell death or unnecessary survival,
manifesting in tissue necrosis or cancer, respectively (Datta et al., 1997).
Following the apoptotic phase, the irreversible remodeling phase is characterized
by decreased milk protein gene expression, disruption of the basement membrane,
collapse of the ECM surrounding the alveolar structures, adipose and vascular
remodeling, and clearance of cellular debris (Li et al., 1996; Pai and Horseman, 2011). In
a study using casein hydrolysates that disturb the integrity of tight junctions between
MEC in dairy cattle, Shamay and colleagues have proposed that leakage of milk
components into the surrounding interstitial space, caused by disruption of the MEC tight
junctions, triggers the remodeling phase of involution (Shamay et al., 2003).
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Components of the basement membrane, such as laminin, collagen, and fibronectin,
normally serve to engage integrins located on the basal MEC membranes, thereby
biochemically-anchoring MEC to the ECM (Pai and Horseman, 2011). During
involution, however, stromally-derived MMP break down the ECM surrounding each
alveolus, disrupting the integrin signaling and thereby resulting in MEC detachment and
collapse. While the epithelium becomes increasingly more disorganized as the alveolar
structures collapse, the stroma increases in density (Richert et al., 2000). Concomitant
with alveolar collapse is collapse of the vasculature enveloping each secretory unit.
Invading macrophages phagocytize the accumulating cellular debris, a unique immune
response that curiously lacks a vigorous inflammatory reaction. Activation of this
involution-associated immune response is crucial, as failure to clear away cellular debris
can result in ductal ectasia, mastitis, and inflammation (Pai and Horseman, 2011).
Cellular quiescence is a physiological state distinct from senescence, as the
proliferative arrest is reversible in the former yet irreversible in the latter (Harmes and
DiRenzo, 2009). Upon the finalization of involution the mammary gland is considered
functionally quiescent, remaining dormant until hormonal cues promote differentiation to
reestablish the lactogenic alveoli in preparation for subsequent pregnancies (Harmes and
DiRenzo, 2009). Involution is complete within ten to fifteen days in mice (Lascelles and
Lee, 1978). In ruminants, involution is complete within thirty to sixty days; however,
this process does not include significant tissue remodeling or regression (Capuco and
Akers, 1999; Pai and Horseman, 2011). Morphologically, although milk stasis does
initiate apoptosis of ruminant MEC, detachment of the basement membrane and total
alveolar collapse are less pronounced during the remodeling phase of involution than they
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are in mice (Capuco and Akers, 1999). Unfortunately, although the governing
mechanisms of involution are similar between differing species, the general scarcity of
human mammary tissue samples during involution limits the precise characterization of
this post-lactational developmental phase (Faupel-Badger et al., 2012).

1.3 Lactational Capacity
Lactational capacity, defined here as the efficiency of milk production, is of
specific interest to the dairy industry considering the application of novel management
approaches may increase the profitability of milk production. In a basic fundamental
sense, milk production is not only a function of the number of secretory MEC but also of
the secretory activity per cell (Capuco and Akers, 1999). Various techniques have been
adopted in an attempt to maximize the function of and production by the mammary
gland. For example, the frequent milking of ruminants earlier in lactation and the use of
bovine GH (somatotropin) each result in a tenacious increase of milk yield (Wall et al.,
2006; Akers 2006). Similarly, the length of the dry period, the non-lactating state in
between parturitions, can be managed and affects milk production and persistency in
subsequent lactations just as much as does the nutritional status of the female (Capuco
and Akers, 1999). However, the underlying mechanisms to milk production, that is the
hormonally-mediated genetic expression of receptors, signaling proteins, transcription
factors, and cell death/survival signals, also stand as a guideline for selection or
intervention strategies that best support the lactational capacity. A complete
understanding of these intracellular signaling mechanisms and their economical

30

significance to the dairy industry for enhanced MEC form and function are innovative
implementations of agriculturally-applied molecular biology (Akers, 2006).

1.4 Incidence of Breast Cancer
As discussed in prior sections of this review, the hormonal milieu that promotes
mammary gland differentiation is the result of an intricate interplay of ovarian, pituitary,
and placental hormones acting upon not only the mammary epithelium but also the
surrounding stroma. The processes through which these hormones promote secretory
differentiation are of critical interest to further advances in breast cancer prevention,
diagnosis, and management. While there are an estimated 1.38 million new cases of
breast cancer each year, of which greater than ninety percent are ductal in origin, those
factors and mechanisms that initiate cancer progression remain largely ambiguous (Russo
et al., 2001; Hinck and Silberstein, 2005; Eccles et al., 2013). An estimated 458,000
women die each year from breast cancer, making it not only the most frequently
diagnosed cancer in the female population, but also the most common cause of cancer
death (Eccles et al., 2013). Curiously, there does exist a parity-induced protection or risk
dependent on the age of a female at first parity. An early full-term pregnancy is
associated with a reduced risk of breast cancer development, whereas either nulliparity or
late parity is associated with a greater risk of breast cancer development (Russo et al.,
2001). Specific to women, a full-term pregnancy completed before age twenty-four is
protective against breast cancer development yet, a full-term pregnancy completed after
age thirty is precarious (Neville et al., 2002; Russo et al., 2001). Inarguably, there exists
an urgency to improve the current body of knowledge relating to this parity-associated
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mechanism which may provide insight to guide further efforts in prevention and
treatment. Significant to these efforts is an understanding the fundamental hallmarks of
cancer as well as the current limitations in breast cancer research. These topics will be
discussed in the following subsections.

1.4.1 Hallmarks of Cancer
Cancer may be thought of as a disease involving dynamic changes in the genome,
where the signaling processes that once supported normal cell proliferation and
homeostais become defective, consequently facilitating cancer cell proliferation and
tissue invasion (Hanahan and Weinberg, 2000; Radisky and Hartmenn, 2009). These
genomic changes are not limited solely to the parenchyma since alterations in the stroma
likewise influence mammary tumorogenesis. Regulatory defects in cell growth,
differentiation, and migration therefore impact not only cell-cell or cell-matrix
interactions, but also epithelial-stromal interactions (Imagawa et al., 2002).
The progressive transformation of a normal cell or tissue into a defective
derivative can be classified according to any one or combination of cancerous
characteristics. These hallmarks of cancer are acquired capabilities, including but not
limited to self-sufficiency in growth signals, insensitivity to anti-proliferative signals,
avoidance of apoptosis, sustained angiogenesis, and tissue invasion and metastasis
(Hanahan and Weinberg, 2000).
Growth signaling, primarily through extracellular mitogenic growth factors,
stimulates a cell to grow and proliferate. While cells other than the targeted cell produce
these extracellular signaling molecules, cancer cells are capable of synthesizing and
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responding to their own growth factors (Alberts et al, 2008; Hanahan and Weinberg,
2000). Under normal conditions, growth factors bind to receptors on the cell surface and
initiate intracellular growth-promoting cascades. Interestingly, the receptors for insulin,
EGF, and vascular endothelial growth factor (VEGF) all require integrin association for
optimal activation. In turn, integrins bind to ECM proteins such as laminins, collagens,
and fibronectins. Cells unable to maintain proper integrin-mediated adhesion to the ECM
experience impaired proloferation and survival since many of the kinases activated for
progression through the cell cycle are likewise regulated by integrin (Giancotti and
Ruslahti, 1999). Yet cancer cells are able to adjust which integrins they express, thereby
selectively promoting their continued survival (Hanahan and Weinberg, 2000).
Conversely, cancer cells can also acquire an insensitivity to anti-proliferative
signals. Crucial to the cell cycle are those regulatory components governing progression
through G1, G2/M, and metaphase-to-anaphase, the checkpoints immediately prior to
chromosomal duplication, division of the nucleus during mitosis, and division of the
cytoplasm during cytokinesis, respectively. The activation through phosphorylation of
numerous cyclins by cyclin-dependent kinase (CDK) guides the progression through the
G1 and G2/M checkpoints, while both protein phosphorylation and protein destruction
guide progression through the metaphase-to-anaphase checkpoint (Alberts et al., 2008).
Specifically, regulatory factors known as E2F proteins promote the transcription of genes
required for chromosomal duplication. The E2F factors are typically bound to a
retinoblastoma (Rb) protein, thus rendering them inactive. However, if Rb is
phosphorylated (pRb), E2F is released for the expression of genes necessary for cell cycle
progression and proliferation (Giacinti and Giordano, 2006). Disruption of this

33

regulatory mechanism often liberates E2F, leaving cells insensitive to anti-proliferative
signals that normally prevent progression through the cell cycle (Hanahan and Weinberg,
2000). Protein degradation likewise guides cell cycle progression, operating through
ubiquitinating ligases that mark targets for destruction by proteasomes. These ligases,
such as the anaphase-promoting complex (APC) and the Skp1/Cullin/F-box complex
(SCF), allow for the completion of mitosis and the destruction of inhibitory CDK,
respectively (Alberts et al., 2008). Disruption of these mechanisms is likewise associated
with proliferation abnormalities. Thus, while normal cells monitor their external and
internal environments during growth and proliferation, cancer cells circumvent the
corresponding checkpoints, proliferating uncontrollably with an infinite potential to
replicate (Nakayama and Nakayama, 2006).
Apoptosis is a control mechanism that eliminates abnormal, nonfunctional,
unnecessary, or potentially dangerous cells. An acquired avoidance of apoptosis, in
conjunction with abnormal proliferation, is typical of perhaps all types of cancer
(Hanahan and Weinberg, 2000). Damages and cellular stress are managed by the
regulatory transcription factor p53. When activated through phosphorylation, p53
translocates from the cytoplasm into the nucleus and stimulates the transcription of
components for CDK inhibitors, thereby halting progression through the cell cycle. If the
sensed damage cannot be repaired during cell cycle arrest, apoptosis can also be initiated
through a p53-mediated pathway. This pathway includes both the increased expression
of pro-apoptotic BAX proteins and the decreased expression of anti-apoptocic BCL-2
proteins. An apoptosome complex is then formed from the combination of chytochrome
c proteins that were released from the mitochondria and the activation of the cytosolic
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apoptotic protease activity factor 1 (APAF-1) (Alberts et al., 2008). In turn, the
apoptosome complex initiates a caspase cascade that ultimately leads to the coordinated
cellular condensation, cytoskeletal collapse, and nuclear envelope disassembly associated
with apoptosis (Strange et al., 1992). Thus, p53 is a key suppressor of tumor formation
and has come to be referred to as the “guardian of the genome” (Alberts et al., 2008;
Bose and Ghosh, 2007). Under normal conditions, the levels of p53 are kept low by
mouse double minute 2 homolog (MDM2) proteins, which function as yet another
ubiquitinating ligase that target p53 for destruction by proteasomes. p53 is mutated in
approximately fifty percent of all cancers, while over expression of MDM2 contributes to
the remaining prevalence (Bose and Ghosh, 2007). Consequentially, cancerous cells are
able to avoid apoptosis, aiding their survival and proliferation despite the genetic
abnormalities.
All cells require contact with the circulatory system for delivery of oxygen and
nutrients, removal of waste products, and hormonal signaling. This obligates any cell to
reside within 100 µm from a capillary (Hanahan and Weinberg, 2000). Sustained
angiogenesis, the formation of new blood vessels, is yet another acquired capability that
supports the ever-increasing metabolic needs of cancerous cells. As these cells
proliferate, promoting tumor expansion, they become hypoxic and initiate an angiogenic
switch favoring vascular development. The primary regulator of this hypoxia-induced
angiogenesis is hypoxia inducible factor 1a (HIF-1a), a protein whose increased
expression promotes the transcription of pro-angiogenic factors such as vascular
endothelial growth factor (VEGF). These growth factors interact with their tyrosine
kinase receptors on the surface of endothelial cells to promote new blood vessel
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formation and growth (Alberts et al., 2008; Liao and Johnson, 2007; Hanahan and
Weinberg, 2000). Vascular endothelial growth actor is an obligate regulator of
angiogenesis because knock-out experiments in mice possessing only one allele of VEGF
result in embryonic fatality (Liao and Johnson, 2007). Normally adult blood vessels are
relatively quiescent, with angiogenesis being tightly regulated unless activated during
tissue renewal and wound healing. Its enhanced activation in cancer not only promotes
tumor expansion but also provides a route through which cancerous cells may metastasize
(Alberts et al., 2008; Hanahan and Weinberg, 2000).
Tissue invasion and metastasis, the translocation of cancerous cells by the
circulatory system to distant and foreign environments for the establishment of new
colonies, are the cause of ninety percent of all cancer-associated deaths (Alberts et al.,
2008; Hanahan and Weinberg, 2000). Normally cells are tethered to the ECM and to
other cells by integrins and cell-cell adhesion molecules (CAMs), respectively. However,
when cancer cells alter these interactions, they may acquire invasive and metastatic
capabilities. Additionally, cancerous cells often exhibit an increased transcription of
extracellular protease genes concomitant with a decreased transcription of protease
inhibitor genes. These proteases degrade the surrounding matrix, thereby facilitating the
invasion of cancerous cells into the stroma or blood supply (Hanahan and Weinberg,
2000). Unfortunately, the mechanism by which cells acquire invasive and metastatic
capabilities is the least understood of all the hallmarks of cancer (Alberts et al., 2008;
Hanahan and Weinberg, 2000).
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1.4.2 Current Limitations of Breast Cancer Research
The signaling pathways of cancer development are complex, yet these pathways
remain a common focus of breast cancer research. Any cancer-promoting gene
processing a tumorogenic phenotype may be termed an “oncogene,” the identification of
which helps guide numerous aspects associated with cancer prevention and treatment.
For example, knock-out experiments in mice pertaining solely to post-lactational
involution have identified over fifty different regulatory oncogenes (Radisky and
Hartmann, 2009). Additionally, more than ninety different human breast cancer cell lines
have been established, each representing unique characteristic of the malignancies
described earlier (Ronnov-Jessen et al., 1996). These numerous identifications and
establishments emphasize how easily defective signaling pathways influence cancer
development and progression (Radisky and Hartmann, 2009).
While many limitations exist in cancer research as a whole, several specific
limitations currently affect that which pertains to breast cancer. For example, it is not
known if lactational differentiation of the mammary gland as a whole induces the parityassociated protection against breast cancer or if the protection is a result of a unique
temporal hormonal combination. Here, time point studies involving specific hormonal
isolations and applications are necessary to determine whether a parity-induced hormonal
protection profile exists (Britt et al., 2007). Although multiple oncogenes such as
BRCA1, BRCA2, CHEK2, ATM, PALB2, BRIP1, TP53, PTEN, CDH1, and STK11
have been identified as genetically predisposing a female to the development of breast
cancer, there still lacks a detailed understanding of the associated epigenetic factors, point
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mutations, and psychosocial considerations (Britt et al., 2007; Thompson et al., 2008).
Additionally, while animal models and cell culture applications have greatly facilitated
studies centered on the molecular pathways involved in breast cancer development and
progression, the cell lines utilized display few of the cellular properties characteristic of
normal MEC since cell lines are often derived from late-stage tumors. Here, there exists
a need to improve the current models of the cellular microenvironment and their
influence in aiding breast cancer development (Thompson et al., 2008). While recent
genomic studies have highlighted the molecular profiles of different cancer types,
comprehending and applying the vast amount of information thus obtained towards
improved clinical care is in its infancy (Eccles et al., 2013). Fortunately, bioinformatics
can provide a global illustration of the complex molecular mechanisms specific to breast
cancer prevention and treatment.

1.5 Global Profiling through Transcriptomic Analyses
Conventional scientific research, which typically adopts a series of sequential
approaches, limits itself in its ability to understand the interacting biological processes
and signaling pathways occurring at the molecular level. However, within the past
decade, the development of -omic technologies has enabled the analyses of thousands of
biomolecules simultaneously, providing a unique approach to better understanding the
biology of the organism of interest (Klopfleisch and Gruber, 2012). Such systems-level
research represents a more global approach aimed at comprehensively illustrating the
complex molecular mechanisms underlying cell physiology and pathology. As further
technological advances ameliorate the financial and experimental aspects of -omic
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technologies, there also exists an increasing requirement for the ability of researchers to
interpret the information thus generated (Kitano, 2002).
Bioinformatics, the scientific discipline and computational study of biological
data, has only recently emerged in tandem with the advances and breakthroughs in -omic
technologies. Following the development of sequencing technologies, for example,
computer applications became necessary to store, organize, and analyze the immense
amount of information obtained from those outputs (Pop and Salzberg, 2007). This
interdisciplinary science has revolutionized biological research by integrating quantitative
experimental data with the available software infrastructure to allow for a computational
system analysis that illustrates the underlying molecular dynamics (Kitano, 2002). The
primary focus of bioinformatics applications includes the identification, quantification,
and analysis of the genome, transcriptome, or proteome, the complete set of genes, RNA,
or proteins within a tissue, respectively. Still other biochemical elements such as the
complete set of metabolic intermediates comprising the metabolome and the complete set
of cellular sugars comprising the glycome have likewise recently emerged as research
emphases (Klopfleisch and Gruber, 2012). However, comparison of the diversity and
illustrations made from the analyses on these varying biochemical elements remains
relatively unexplored (Pop and Salzberg, 2008).
Bioinformatics and global profiling enable the explorative identification of
expression patterns specific to a particular phenotype. Such “data mining” functions to
identify and characterize these patterns and profiles for the inference of hypotheses that
drive subsequent studies (Klopfleisch and Gruber, 2012; Kitano, 2002). While advances
in all applications of “-omic” technologies have been made, those methods specific to
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analyzing the transcriptome, especially that of RNA sequencing, have made the greatest
progress to date (Klopfleisch and Gruber, 2012; Garber et al., 2011; Ozsolak and Milos,
2011; Costa et al., 2010). RNA sequencing (RNA-seq), the generation of complimentary
DNA (cDNA) fragments derived from RNA molecules for the sequencing,
characterization, and quantification of the entire transcriptome, has provided a means for
a more complete understanding of the molecular mechanisms underlying cell biology
(Ozsolak and Milos, 2011). Not only does RNA-seq allow for the absolute quantification
of transcript abundance compared to the relative quantification of microarray
technologies, but it also permits transcript sequencing independent of transcript size or
prior knowledge of the genome from which it originates (Mortazavi et al., 2008;
Marguerat and Bahler, 2010). Although only first utilized in 2008, RNA-seq experiments
have since given insight into novel regulatory mechanisms, differential splicing, single
nucleotide polymorphisms (SNP), and allele-specific transcript expression, leading some
researchers to suggest it may supersede all other established transcriptomic technologies
(Marguerat and Bahler, 2010; Costa et al., 2010). However, the advantages of RNA-seq
are not without their own complexities because the unprecedented amount of information
thus generated consequently relies heavily upon bioinformatics for the interpretation of
the underlying molecular dynamics (Costa et al., 2010).

1.6 Summary
The mammary gland is a dynamic organ. Development occurs across several yet
distinct stages, from the gestational development of a rudimentary bud to the priming of
the gland during pregnancy to the functional differentiation of the lactating phenotype to
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the regression and tissue remodeling of the post-involutional gland. Regulation through
these developmental stages results from an intricate endocrine and epithelial interplay
according to sexual maturity and reproductive requirements. However, for all that is
known about the fundamental factors affecting mammary gland morphology, much
remains to be analyzed intracellularly at the molecular level. Understanding the impact
and influence of the mechanism behind this regulation is significant for future advances
and implications in dairy production and breast cancer research.
To provide a more complete characterization of the developmental cycle, gene
expression comparisons will be made to identify the intracellular changes taking place
during transitional stages within murine primary MEC. Specifically, RNA-seq and
differential analysis will enable an explorative whole system approach, with the resulting
bioinformatics and global profiling providing a comprehensive illustration of the complex
molecular mechanisms influencing MEC physiology and pathology. Comparison of the
virgin to pregnant expression profiles will allow for the analysis of the developmental
stage that establishes the lactational capacity. This comparison may provide insight into
selection or intervention strategies that best support initial mammary gland development
and subsequent milk production. Comparison of the virgin to post-involutional quiescent
expression profiles may lead to insight into the molecular mechanism underlying early
parity-induced protection against the development of breast cancer. Last, parallel
analysis of the transcriptome and proteome from the same sample source will allow for
the comparison of two differing means of analyzing the molecular phenotype. This is a
novel joint approach unique to mammary gland development that has not yet been
previously reported.
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CHAPTER 2 – Transcriptomic Analysis to Identify Differentially Expressed Genes
Associated with the Developmental Stages of Mammary Epithelial Cells
2.1 Introduction
Various methods exist through which the transcriptome may be analyzed,
including quantitative polymerase chain reaction (qPCR), hybridization-based
microarrays, and Sanger sequencing-based technologies. While these technologies were
developed to characterize and quantify a set of transcripts within a cell, they lack the
sensitivity and resolution obtained from RNA-seq (Nagalakshmi, et al., 2010). The
platforms that conduct high-throughput next generation sequencing technologies can
detect hundreds of millions of raw bases in a single run by directly sequencing cDNA
produced from the RNA of interest (Nagalakshmi, et al., 2010; Pareek et al., 2011). In
brief, the extracted RNA is fragmented, ligated to adaptors, and retrotranscribed by
complementary primers to produce fragmented, double stranded cDNA. This cDNA
library is allowed to hybridize to the surface of a flow cell, where it undergoes cluster
generation through isothermal bridge amplification, producing up to 200 million spatially
separated template clusters. Sequencing primers are hybridized to the templates, which
are then sequenced base-by-base, in parallel, using fluorescently labeled nucleotides.
Through the process of cyclic reversible termination (CRT), the clusters are excited by a
laser to emit a light that identifies each newly incorporated base within the sequencing
reaction. Thus, the basic output of RNA-seq is a list of short sequences along with their
detected quantities that may then be assessed for quality control, aligned to a reference
genome, and analyzed for differential gene expression. A further detailed discussion of
the technical and methodological aspects to RNA-seq is beyond the scope of this
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experiment and can be found elsewhere (Mardis 2008; Ansorge, 2009; Costa et al., 2010;
Mortazavi et al., 2008; Ozsolak and Milos, 2011; Pareek et al., 2011; Garber et al., 2011).
RNA-seq thus offers the ability to accurately measure transcript expression in a
single assay, however the resulting output must be analyzed with equally accurate and
robust mathematical and statistical algorithms. In practice, the focus of RNA-seq has
shifted from the generation of experimental data to its biological interpretation (Costa et
al., 2010). Compared to other biomolecules, RNA itself is relatively fragile and prone to
degradation by ribonucleases. The success of an RNA-seq experiment depends heavily
on the quality of the extracted RNA and the generation of equally high quality, fulllength, cDNA (Alberts et al., 2008; Nagalakshmi, et al., 2010). Quality control and
statistical analysis of the sequenced fragments are likewise critical to the data
interpretation process. For example, the sequence alignment process, mapping short
sequence reads to their corresponding location along the reference genome, is essential
for all subsequent analytical applications and interpretations (Li and Homer, 2010).
Numerous commercially available and open-source software packages have been
developed to facilitate in these analytical procedures, each with its own application of
mathematical and statistical algorithms. To date, more than 80 individual tools are
available for the mapping of high-throughput sequencing data to a reference sequence
(Fonseca et al., 2012). Indeed, variations exist in the application of read-alignments,
transcriptome reconstruction, quantification, and differential expression (Trapnell et al.,
2012). Theoretically, the algorithms specific to each software program are similar.
Although not novel, a comparison between two differing programs using the same
sample source would be of interest to the bioinformatics community (Costa et al., 2012).
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While transcriptomic analyses have been applied to cultured MEC and to whole
mammary gland samples, few have studied purified MEC isolated directly from the gland
in vivo. Furthermore, and prior to 2012, all published transcriptomic studies conducted
on mammary tissue primarily utilized microarray technologies (Wickramasinghe et al.,
2012). Thus, the application of RNA-seq to mammary tissue is a novel assessment of
mammary gland development, and this is the first known examination of RNA-seq
analysis on isolated murine MEC. Considering the variation that exists in the software
programs currently available, the computational analysis of the RNA-seq output will be
performed twice, using both the commercially-available CLC Genomics Workbench and
the recently-launched, publicly-available Green Line Analysis, a line within the DNA
Subway provided by CyVerse (formerly the iPlant Collaborative). The characteristics
and approaches specific to these two programs will be discussed later; however, a further
detailed discussion specific to the mathematical and computational aspects to sequence
alignment and differential analysis is beyond the scope of this experiment and can be
found elsewhere (Li and Homer, 2010; Fonesca et al., 2012; Li and Durbin, 2010; Pepke
et al., 2009; Trapnell et al., 2012; Trapnell et al., 2013).

2.2 Methods
2.2.1 Animal Management for Material Extraction
ICR mice (Taconic, Hudson, NY) were selected for the study and were housed in
the Cal Poly Rodent Colony with a 12 h light schedule and ad libitum access to food and
water. Samples were taken from virgin, pregnant, and post-involutional quiescent mice
following euthanasia using CO2 asphyxiation and cervical dislocation. Virgin and
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pregnant mice were between 10 and 11 weeks of age, with pregnant mice on day 10 of
pregnancy. Post-involutional quiescent mice were approximately 23 weeks of age, with
pups having been weaned at day 21 of lactation and samples collected 18 days postweaning. The estrous cycle was not taken into account for the either the virgin or the
post-involutional quiescent samples. The Cal Poly Institutional Animal Care and Use
Committee (IACUC) approved all animal procedures.

2.2.2 Primary Mammary Epithelial Cell Isolation
Immediately following euthanasia, mammary tissue was removed from the left
and right cervical, thoracic, abdominal, and inguinal glands and rinsed in 1X Hank’s
Balanced Salt Solution. The excised tissue was transferred to a digestion media
containing collagenase, trypsin, and EDTA in Dulbecco’s Modified Eagle Medium and
minced to approximately 3 mm3 particles. The digestion media and minced tissue were
incubated with constant swirling at 37 °C for 90 minutes, with disruption by pipet every
30 minutes. Cells were pelleted via centrifugation and then removed of red blood cells
following a water bath incubation in red blood cell lysis buffer (8.3 g/L ammonium
chloride in 0.01 M Tris-HCl) at 37 °C for 5 minutes. Cells were again pelleted via
centrifugation and then removed of fibroblasts following incubation in T-75 flasks at
37°C for 1 hour. Cell suspensions were washed with centrifugations using EDTA and
DNase solutions and then filtered through a 100 µm filter. The isolated epithelial cells
were resuspended in DMSO cell freezing media, brought down to -80 °C at
approximately -1 °C/minute, and stored in liquid nitrogen until processing.
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2.2.3 RNA Extraction and Sequencing Library Preparation
Total RNA was extracted from 3 samples per developmental stage (n=3) using an
RNeasyÒ Mini Kit (Qiagen, Valencia, CA) according to the manufacturer’s instructions.
RNA was quantified by a BioTek Synergy 2 microplate spectrophotometer (BioTek
Instruments, Winooski, VT) and the quality and integrity were assessed with an Experion
bio-analyzer (Bio-Rad, Hercules, CA) according to the manufacturer’s instructions.
Messenger RNA (mRNA) was isolated and purified using a TruSeq RNA Sample
Preparation Kit (Illumina, San Diego, CA) by the Medrano Lab at UC Davis. The
mRNA was fragmented to approximately 200 bp fragments, synthesized to cDNA, and
ligated with adapters and sequencing indexes according to the manufacturer’s
instructions.

2.2.4 RNA Sequencing
The cDNA libraries were sequenced by the Vincent J. Coates Genomics
Sequencing Laboratory in the California Institute for Quantitative Biosciences (QB3)
Facility at UC Berkeley. Sequencing was performed in one lane, multiplexing all
samples within that lane, using a HiSeq 2000 Sequence Analyzer (Illumina, San Diego,
CA). Single-end sequence read files were made available for download from the host to
a local server, and were accessed through file transfer protocol (FTP) FileZilla software.

46

2.2.5 Quality Control Analysis
Quality control was performed twice, using both the commercially-available CLC
Genomics Workbench version 6.5 (CLC Bio, Aarhus, Denmark) and the recentlylaunched, publicly-available Green Line Analysis (iPlant Collaborative, Tucson, AZ).

2.2.5.1 CLC Genomics Workbench
Single read sequences of 100 bp from each sample were assessed for quality
control as directed through the Toolbox: NGS Core Tools expression analysis
application. Graphical reports were created for all virgin, pregnant, and post-involutional
quiescent sequenced samples to depict the quality control analysis according to persequence parameters such as length distribution, GC-content, ambiguous base content,
and quality distribution, and according to per-base parameters such as coverage,
nucleotide contributions, GC-content, ambiguous base-content, and quality distribution.
Any sample that did not meet the quality control parameter requirements was eliminated
from further analyses.

2.2.5.2 Green Line Analysis
Single read sequences of 100 bp from each sample were assessed for quality
control as directed through the Manage Data QC application. Graphical reports were
created for all virgin, pregnant, and post-involutional quiescent sequenced samples to
depict the quality control analysis according to per-sequence parameters such as length
distribution, GC-content, and quality distribution, and according to per-base parameters
such as nucleotide contributions, GC-content, ambiguous base-content, and quality

47

distribution. Any sample that did not meet the quality control parameter requirements
was eliminated from further analyses.

2.2.6 Differential Gene Expression Analysis
Differential analysis was performed twice, likewise using both CLC Genomics
and Green Line Analysis.

2.2.6.1 CLC Genomics
Those samples indicative of good quality were assembled on the annotated
GRCm38.71 Mus musculus reference genome (http://www.ncbi.nlm.nih.gov/genome) as
directed through the Toolbox: Transcriptomic: RNA-seq Analysis application. Map
settings were dictated as follows: a minimum length fraction of 0.9, a minimum similarity
fraction of 0.8, and a maximum number of 10 hits for a read. Exon discovery settings
were dictated as follows: a required relative expression level of 0.20, a minimum number
of 10 reads, and a minimum read length of 50 bp. The data were normalized by
calculating the reads per kilo base per million mapped reads (RPKM = total exon
reads/mapped reads in millions x exon length in kb) for each gene and annotated with
Mus musculus genome assembly (38,124 genes). For the statistical analysis, a t-test was
performed on log10-transformed data to identify the genes with significant changes in
expression (p < 0.05) between virgin and pregnant samples and between virgin and postinvolutional quiescent samples. Overall expression data was reported as the number of
genes identified as expressed, the number of genes differentially expressed, and the
number of genes detected but not differentially expressed. Expression data was further
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reported as the number of differentially expressed genes detected with high expression
(>500 RPKM), medium expression (10-500 RPKM), and low expression (0.02-9.99
RPKM). Samples were sequenced on one lane, negating the normalization against any
confounding factors due to lane or batch.

2.2.6.2 Green Line Analysis
Those samples indicative of good quality were aligned to the annotated
GRCm38.74 Mus musculus reference genome (http://www.ncbi.nlm.nih.gov/genome)
(39,174 genes) as directed through the TopHat application of the Analyze Transcriptome.
Default parameter settings were used, except advanced parameter settings were dictated
to match those of the CLC Genomics Workbench analysis as follows: a maximum
number of 10 hits for a read, a minimum isoform fraction of 0.20, a segment length of 80
and the enabling of the “no novel junctions” option. Following alignment and
annotation, the RPKM for each gene were accessed and downloaded using the
cummerbund R package within the CyVerse Discovery Environment. Replicate values
were fetched using the command gene.rep.matrix<-repFpkmMatrix(genes(cuff)). For the
statistical analysis, a t-test was performed on log10-transformed data to identify the genes
with significant changes in expression (p < 0.05) between virgin and pregnant samples
and between virgin and post-involutional quiescent samples. Overall expression data was
reported as the number of genes identified as expressed, the number of genes
differentially expressed, and the number of genes detected but not differentially
expressed. Expression data was further reported as the number of differentially
expressed genes detected with high expression (>500 RPKM), medium expression (10-
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500 RPKM), and low expression (0.02-9.99 RPKM). Samples were sequenced on one
lane, negating the normalization against any confounding factors due to lane or batch.

2.2.7 Platform Comparison of Expressed and Dually Detected Genes between CLC
Genomics and Green Line Analysis
Platform comparisons were performed using those genes identified as being
dually differentially expressed by both CLC Genomics Workbench and Green Line
Analysis. Overall expression was compared for the dually differentially expressed genes
between the virgin and pregnant developmental stages and between virgin and postinvolutional quiescent developmental stages. Expression was also compared for the
dually differentially expressed genes detected with high expression (>500 RPKM),
medium expression (10-500 RPKM), and low expression (0.02-9.99 RPKM) between the
virgin and pregnant developmental stages and between virgin and post-involutional
quiescent developmental stages.
Simultaneously considering both the virgin-to-pregnant and the virgin-to-postlactational quiescent developmental comparisons, a general linear model (GLM) was
used to compare the observed fold change in expression for those genes identified as
being dually differentially expressed by both CLC Genomics Workbench and Green Line
Analysis. The corresponding R2 values were calculated using Statistical Analysis System
(SAS) JMP Pro version 12.2.0. (SAS, Cary, NC).
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2.3 Results
2.3.1 CLC Genomics Workbench
As mentioned in Chapter 2.2.5.1, graphical reports were created for all virgin,
pregnant, and post-involutional quiescent sequenced samples to depict the quality control
analysis (see Appendix A). All samples met the quality control parameter requirements,
with the exception of Virgin Mouse 2. This sample yielded very low reads and was
therefore eliminated from further analyses. Of the 8 remaining samples analyzed, a total
of approximately 151.6 million sequence reads were obtained, with an average of 19
million reads for each sample, of which greater than 90 percent were categorized as
mapped reads to the Mus musculus genome. The number of expressed genes for each
sample assembled on the annotated GRCm38.71 Mus musculus genome were determined
and calculated as a percentage out of 38,124 genes (Table 1).
Accordingly, three biological replicates were analyzed for the pregnant and postinvolutional quiescent stages of MEC development, while only 2 replicates could be
analyzed for the virginal stage. Comparing the virginal state to the pregnant state, 2,681
(7.03%) genes were detected as differentially expressed (p < 0.05), 15,582 (40.87%)
genes were detected but not differentially expressed (p> 0.05), and 19,861 (52.10%)
genes were not expressed. Of the 2,681 genes differentially expressed between the virgin
and pregnant samples, 1,037 genes were down-regulated while the remaining 1,644 genes
were up-regulated (p< 0.05). Comparing the virginal state to the post-involutional
quiescent state, 2,341 (6.14%) genes were detected as differentially expressed (p< 0.05),
15,980 (41.92%) genes were detected but not differentially expressed (p> 0.05), and
19,803 (51.94%) genes were not expressed. Of the 2,341 genes differentially expressed
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between the virgin and post-involutional quiescent samples, 1,820 genes were downregulated while the remaining 521 genes were up-regulated (p< 0.05) (Table 2).

Table 1: Total and Mapped Reads Detected by CLC Genomics Workbench Analysis
MEC were isolated from virgin, pregnant, and post-lactational quiescent mouse mammary glands. RNA
was extracted, sequenced, and aligned to the annotated GRCm38.71 Mus musculus genome (38,124 genes).
Graphical reports were created to depict the quality control analysis according to per-sequence parameters
such as length, distribution, GC-content, ambiguous base-content, and quality distribution. The number of
reads detected per sample analyzed, the number of those reads that were mapped to the reference genome,
the percentage of those mapped reads, the number of genes expressed, and the percentage of those genes
expressed have been listed for each mouse sample analyzed through the CLC Genomics Workbench. With
the exception of the limited number reads derived from Virgin Mouse 2, an average of 19 million reads
were obtained for each sample, with greater than 93 percent being mapped to the reference genome.

Sample
Description

Reads (n)

Mapped Reads
(n)

% Mapped
Reads

Genes
Expressed
(n)

% Genes
Expressed

Virgin Mouse 1

31,241,022

29,428,183

94.20

17,087

44.82

Virgin Mouse 2

6,176

N/A

N/A

N/A

N/A

Virgin Mouse 3

16,864,550

15,881,378

94.17

16,657

43.69

Pregnant Mouse 1

16,666,247

15,318,291

91.91

16,484

43.24

Pregnant Mouse 2

11,861,826

11,170,110

94.17

16,170

42.41

Pregnant Mouse 3

15,686,433

14,777,213

94.20

16,374

42.95

Quiescent Mouse 1

18,222,830

17,173,154

94.24

16,552

43.42

Quiescent Mouse 2

20,998,909

19,693,821

93.78

16,433

43.10

Quiescent Mouse 3

20,109,186

18,741,292

93.20

16,518

43.33

Total Reads

151,657,179

112,755,259

93.73

-

-
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Table 2: Differentially Expressed Genes Detected by CLC Genomics Workbench Analysis
Differential analysis was performed for the detected genes successfully mapped to the Mus musculus
genome. Developmental comparisons were made for the pregnant state relative to the virgin state, and for
the post-lactational quiescent state relative to the virgin state. The numbers and percentages of those genes
differentially expressed, detected but not differentially expressed, and not expressed are given for each
developmental comparison. A total of 2,681 (7.03%) and 2,341 (6.14%) genes were differentially
expressed (p < 0.05), with the corresponding number of down-regulated genes indicated in red and the
corresponding number of up-regulated genes indicated in green.

Developmental Comparison

Virgin vs Pregnant
Downregulated/Upregulated
Virgin vs Quiescent
Downregulated/Upregulated

Genes Differentially
Expressed
n

%

2,681

7.03

1,037

1,644

2,341
1,820

521

2.72

15,582

4.31

6.14
4.77

Genes Detected but
not Differentially
Expressed
n
%

1.37

40.87

Genes not
Detected
n

%

19,861

52.10

19,803

51.94

N/A
15,980

41.92
N/A

Of the 2,681 genes detected as differentially expressed in the comparison of the
virginal state to the pregnant state (p <0.05), 23 genes were detected with high expression
(>500 RPKM), 1,201 genes were detected with medium expression (10-500 RPKM), and
1,767 genes were detected with low expression (0.02-9.99 RPKM). Of the 2,341 genes
detected as differentially expressed in the comparison of the virginal state to the postinvolutional quiescent state (p <0.05), 70 genes were detected with high expression (>500
RPKM), 969 genes were detected with medium expression (10-500 RPKM), and 1,655
genes were detected with low expression (0.02-9.99 RPKM) (Table 3).
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Table 3: High, Medium, and Low Differentially Expressed Genes Detected by CLC Genomics
Workbench Analysis
Differential analysis was performed for the detected genes successfully mapped to the Mus musculus
genome. The data were normalized by calculating RPKM for each gene, where RPKM = total exon
reads/mapped reads in millions x exon length in kb. Developmental comparisons were made for the
pregnant state relative to the virgin state, and for the post-lactational quiescent state relative to the virgin
state. Of the 2,681 and 2,341 genes differentially expressed within each developmental comparison (p
<0.05), the number of genes detected with high, medium, and low expression are given, with the
corresponding number of down-regulated genes indicated in red and the corresponding number of upregulated genes indicated in green. The number of high, medium, and low genes for each developmental
comparison sums to more than the number of differentially expressed genes considering a given gene may
be expressed with a specific strength in one developmental state and a different strength in the other
developmental state.

Expression
High
>500 RPKM
Downregulated/Upregulated
Medium
10-500 RPKM
Downregulated/Upregulated
Low
0.02-9.99 RPKM
Downregulated/Upregulated

Virgin vs Pregnant

Virgin vs Quiescent

n

n

23

70

10

13

5

1,201
457

969
744

654

1,767
694

65

315
1,655

1,073

1,409

246

2.3.2 Green Line Analysis
As mentioned in Chapter 2.2.5.2, graphical reports were created for all virgin,
pregnant, and post-involutional quiescent sequenced samples to depict the quality control
analysis (see Appendix B). All samples met the quality control parameter requirements,
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with the exception of Virgin Mouse 2. Again, this sample yielded very low reads and
was therefore eliminated from further analyses. Of the 8 remaining samples analyzed, a
total of approximately 154.1 million sequence reads were obtained, with an average of 19
million reads for each sample, of which greater than 90 percent were categorized as
mapped reads to the Mus musculus genome. The number of expressed genes for each
sample assembled on the annotated GRCm38.75 Mus musculus genome were determined
and calculated as a percentage out of 39,174 genes (Table 4).
Accordingly, 3 biological replicates were analyzed for the pregnant and postinvolutional quiescent stages of MEC development, while only 2 replicates could be
analyzed for the virginal stage. Comparing the virginal state to the pregnant state, 1,470
(3.75%) genes were detected as differentially expressed (p < 0.05), 14,959 (38.19%)
genes were detected but not differentially expressed (p > 0.05), and 22,745 (58.06%)
genes were not expressed. Of the 1,470 genes differentially expressed between the virgin
and pregnant samples, 756 genes were down-regulated while the remaining 715 genes
were up-regulated (p< 0.05). Comparing the virginal state to the post-involutional
quiescent state, 1,392 (3.56%) genes were detected as differentially expressed (p< 0.05),
15,201 (38.80%) genes were detected but not differentially expressed (p> 0.05), and
22,581 (57.64%) genes were not expressed. Of the 1,392 genes differentially expressed
between the virgin and post-involutional quiescent samples, 725 genes were downregulated while the remaining 667 genes were up-regulated (p< 0.05) (Table 5).
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Table 4: Total and Mapped Reads Detected by Green Line Analysis
MEC were isolated from virgin, pregnant, and post-lactational quiescent mouse mammary glands. RNA
was extracted, sequenced, and aligned to the GRCm38.75 Mus musculus genome (39,174). Graphical
reports were created for all virgin, pregnant, and post-involutional quiescent sequenced samples to depict
the quality control analysis according to per-sequence parameters such as length distribution, GC-content,
and quality distribution, and according to per-base parameters such as nucleotide contributions, GCcontent, ambiguous base-content, and quality distribution. The number of reads detected per sample
analyzed, the number of those reads that were mapped to the reference genome, the percentage of those
mapped reads, the number of genes expressed, and the percentage of those genes expressed have been
listed for each mouse sample analyzed through the Green Line Analysis. With the exception of the limited
number reads derived from Virgin Mouse 2, an average of 19 million reads were obtained for each sample,
with greater than 91 percent being mapped to the reference genome.

Sample
Description

Reads (n)

Mapped Reads
(n)

% Mapped
Reads

Genes
Expressed
(n)

% Genes
Expressed

Virgin Mouse 1

31,772,780

29,209,123

91.93

20,127

51.38

Virgin Mouse 2

6,424

N/A

N/A

N/A

N/A

Virgin Mouse 3

17,146,830

15,780,379

92.03

19,269

49.19

Pregnant Mouse 1

16,944,508

15,393,785

90.84

18,988

48.47

Pregnant Mouse 2

12,063,133

11,166,600

92.56

18,473

47.16

Pregnant Mouse 3

15,952,008

14,737,176

92.38

18,879

48.19

Quiescent Mouse 1

18,503,205

17,184,240

92.87

19,224

49.07

Quiescent Mouse 2

21,352,039

19,558,433

91.59

18,952

48.38

Quiescent Mouse 3

20,441,670

18,535,917

90.67

19,062

48.66

Total Reads

154,182,597

141,565,653

91.81

-

-
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Table 5: Differentially Expressed Genes Detected by Green Line Analysis
Differential analysis was performed for the detected genes successfully mapped to the Mus musculus
genome. Developmental comparisons were made for the pregnant state relative to the virgin state, and for
the post-lactational quiescent state relative to the virgin state. The numbers and percentages of those genes
differentially expressed, detected but not differentially expressed, and not expressed are given for each
developmental comparison. A total of 1,470 (3.75%) and 1,392 (3.56%) genes were differentially
expressed (p < 0.05), with the corresponding number of down-regulated genes indicated in red and the
corresponding number of up-regulated genes indicated in green.

Developmental Comparison

Virgin vs Pregnant
Downregulated/Upregulated
Virgin vs Quiescent
Downregulated/Upregulated

Genes Differentially
Expressed
n

%

1,470

3.75

756

715

1,392
725

667

1.92

14,959

1.83

3.56
1.85

Genes Detected but
not Differentially
Expressed
n
%

1.71

38.19

Genes not
Detected
n

%

22,745

58.06

22,581

57.64

N/A
15,201

38.80
N/A

Of the 1,470 genes detected as differentially expressed in the comparison of the
virginal state to the pregnant state (p <0.05), 16 genes were detected with high expression
(>500 RPKM), 741 genes were detected with medium expression (10-500 RPKM), and
887 genes were detected with low expression (0.02-9.99 RPKM). Of the 1,392 genes
detected as differentially expressed in the comparison of the virginal state to the postinvolutional quiescent state (p <0.05), 27 genes were detected with high expression (>500
RPKM), 672 genes were detected with medium expression (10-500 RPKM), and 564
genes were detected with low expression (0.02-9.99 RPKM) (Table 6).
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Table 6: High, Medium, and Low Differentially Expressed Genes Detected by Green Line Analysis
Differential analysis was performed for the detected genes successfully mapped to the Mus musculus
genome. The data were normalized by calculating RPKM for each gene, where RPKM = total exon
reads/mapped reads in millions x exon length in kb. Developmental comparisons were made for the
pregnant state relative to the virgin state, and for the post-lactational quiescent state relative to the virgin
state. Of the 1,470 and 1,392 genes differentially expressed within each developmental comparison (p
<0.05), the number of genes detected with high, medium, and low expression are given, with the
corresponding number of down-regulated genes indicated in red and the corresponding number of upregulated genes indicated in green. The number of high, medium, and low genes for each developmental
comparison sums to more than the number of differentially expressed genes considering a given gene may
be expressed with a specific strength in one developmental state and a different strength in the other
developmental state.

Expression

Virgin vs Pregnant

Virgin vs Quiescent

n

n

16

27

High
>500 RPKM
Downregulated/Upregulated
Medium
10-500 RPKM

8

Downregulated/Upregulated

372

13

741

Low
0.02-9.99 RPKM
Downregulated/Upregulated

8

672
369

340

887
694

14

332
564

422

315
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2.3.3 Platform Comparison of Differential Analysis between CLC Genomics and Green
Line Analysis
For the virgin-to-pregnant comparison, of the 4,151 total number of genes
differentially detected by the CLC Genomics Workbench and the Green Line Analysis (p
< 0.05), 983 (31.02%) of those genes were dually detected by both platforms. Of the
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remaining genes, 1,698 were detected only by the CLC Genomics Workbench platform
while 487 were detected only by the Green Line Analysis (Figure 1). For the 39 total
number of genes detected with high expression within the virgin-to-pregnant comparison
(>500 RPKM, p <0.05), 9 (30.00%) of those genes were dually detected by both
platforms. Of the remaining genes, 14 were detected only by the CLC Genomics
Workbench platform while 7 were detected only by the Green Line Analysis. For the
1,942 total number of genes detected with medium expression within the virgin-topregnant comparison (10-500 RPKM, p <0.05), 454 (30.51%) of those genes were dually
detected by both platforms. Of the remaining genes, 747 were detected only by the CLC
Genomics Workbench platform while 287 were detected only by the Green Line
Analysis. For the 2,654 total number of genes detected with low expression within the
virgin-to-pregnant comparison (0.20-9.99 RPKM, p <0.05), 599 (26.68%) of those genes
were dually detected by both platforms. Of the remaining genes, 1,208 were detected
only by the CLC Genomics Workbench platform while 328 were detected only by the
Green Line Analysis (Figure 2). For the virgin-to-post-lactational quiescent comparison,
of the 3,733 total number of genes differentially detected by the CLC Genomics
Workbench and the Green Line Analysis (p < 0.05), 793 (26.97%) of those genes were
dually detected by both platforms. Of the remaining genes, 1,548 were detected only by
the CLC Genomics Workbench platform while 599 were detected only by the Green Line
Analysis (Figure 3). For the 97 total number of genes detected with high expression
within the virgin-to-post-lactational quiescent comparison (>500 RPKM, p <0.05), 1
(1.04%) of those genes were dually detected by both platforms. Of the remaining genes,
69 were detected only by the CLC Genomics Workbench platform while 26 were
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detected only by the Green Line Analysis. For the 1,641 total number of genes detected
with medium expression within the virgin-to-post-lactational quiescent comparison (10500 RPKM, p <0.05), 116 (7.60%) of those genes were dually detected by both
platforms. Of the remaining genes, 853 were detected only by the CLC Genomics
Workbench platform while 556 were detected only by the Green Line Analysis. For the
2,219 total number of genes detected with low expression within the virgin-to-postlactational quiescent comparison (0.20-9.99 RPKM, p <0.05), 226 (11.33%) of those
genes were dually detected by both platforms. Of the remaining genes, 1,429 were
detected only by the CLC Genomics Workbench platform while 338 were detected only
by the Green Line Analysis (Figure 4).
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1698%

983%
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Figure 1: Platform Comparison of Differentially Detected Genes from the Analysis of Virgin vs.
Pregnant MEC
An area-proportional Venn diagram was created to depict the number of dually differentially detected
genes between the two transcriptomic platforms. While 983 genes were dually detected by both the CLC
Genomics Workbench and the Green Line Analysis for the virgin-to-pregnant developmental comparison
http://jura.wi.mit.edu/bioc/tools/tmp/temp23303.svg
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(p-value < 0.05), 2,185 genes were detected in one platform but not the other. Those genes specific to the
CLC Genomics Workbench are represented in blue while those genes specific to the Green Line Analysis
are represented in green, with the dually differentially detected genes represented in the enclosed section.
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Figure 2: Platform Comparison of Genes from the Analysis of Virgin vs. Pregnant MEC
Differentially Detected with High, Medium, and Low Expression
Area-proportional Venn diagrams were created to depict not only the number of dually differentially
detected genes between the two transcriptomic platforms, but also the number of genes with high, medium,
and low expression. While 9 genes were dually detected with high expression by both the CLC Genomics
Workbench and the Green Line Analysis for the virgin-to-pregnant developmental comparison (>500
RPKM p-value < 0.05), 21 genes were detected in one platform but not the other. While 454 genes were
dually detected with medium expression by both the CLC Genomics Workbench and the Green Line
Analysis for the virgin-to-pregnant developmental comparison (10-500 RPKM, p <0.05), 1,034 genes were
detected in one platform but not the other. While 559 genes were dually detected with low expression by
both the CLC Genomics Workbench and the Green Line Analysis for the virgin-to-pregnant developmental
comparison (0.20-9.99 RPKM, p <0.05), 1,536 genes were detected in one platform but not the other. For
all three comparisons, those genes specific to the CLC Genomics Workbench are represented in blue while
those genes specific to the Green Line Analysis are represented in green, with the dually differentially
detected genes represented in the enclosed sections.
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Figure 3: Platform Comparison of Differentially Detected Genes from the Analysis of Virgin vs.
Quiescent MEC
An area-proportional Venn diagram was created to depict the number of dually differentially detected
genes between the two transcriptomic platforms. While 793 genes were dually detected by both the CLC
Genomics Workbench and the Green Line Analysis for the virgin-to-post-lactational quiescent
developmental comparison (p-value < 0.05), 2,147 genes were detected in one platform but not the other.
Those genes specific to the CLC Genomics Workbench are represented in blue while those genes specific
to the Green Line Analysis are represented in green, with the dually differentially detected genes
represented in the enclosed section.
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Figure 4: Platform Comparison of Genes from the Analysis of Virgin vs. Quiescent MEC
Differentially Detected with High, Medium, and Low Expression
Area-proportional Venn diagrams were created to depict not only the number of dually differentially
detected genes between the two transcriptomic platforms, but also the number of genes with high, medium,
and low expression. While 1 gene was dually detected with high expression by both the CLC Genomics
Workbench and the Green Line Analysis for the virgin-to-post-lactational quiescent developmental
comparison (>500 RPKM p-value < 0.05), the remaining 95 genes were detected in one platform but not
the other. While 116 genes were dually detected with medium expression by both the CLC Genomics
Workbench and the Green Line Analysis for the virgin-to-post-lactational developmental comparison (10500 RPKM, p <0.05), 1,409 genes were detected in one platform but not the other. While 226 genes were
dually detected with low expression by both the CLC Genomics Workbench and the Green Line Analysis
for the virgin-to-post-lactational quiescent developmental comparison (0.20-9.99 RPKM, p <0.05), 1,767
genes were detected in one platform but not the other. For all three comparisons, those genes specific to
the CLC Genomics Workbench are represented in blue while those genes specific to the Green Line
Analysis are represented in green, with the dually differentially detected genes represented in the enclosed
section.
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Considering only those dually detected genes as determined by either platform,
983 genes from the virgin-to-pregnant comparison and 793 genes from the virgin-to-postlactational quiescent comparison were plotted against each other in a regression analysis,
using the detected fold change values from CLC Genomics Workbench along the
horizontal axis and the detected fold change values from the Green Line Analysis along
the vertical axis. The corresponding coefficient of determination values were calculated
as R2 = 0.70 for the virgin-to-pregnant comparison and R2 = 0.78 for the virgin-to-postlactational quiescent comparison (Figure 5). A line of best fit was matched for each
developmental comparison, with the corresponding slopes calculated as 0.6355x for the
virgin-to-pregnant comparison and 0.7824x for the virgin-to-post-lactational quiescent
comparison.
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Figure 5: Platform Comparison Regression Analysis of Differentially Expressed Genes Dually
Detected by CLC Genomics Workbench and Green Line Analysis
Considering only those dually detected genes as determined by either platform, 983 genes from the virginto-pregnant comparison and 793 genes from the virgin-to-post-lactational quiescent comparison were
plotted against each other in a regression analysis, using the detected fold change values from CLC
Genomics Workbench along the horizontal axis and the detected fold change values from the Green Line
Analysis along the vertical axis. Those dually detected genes from the virgin-to-pregnant developmental
comparison are shown in red, while those dually detected genes from the virgin-to-post-lactational
quiescent developmental comparison are shown in purple.

A line of best fit was drawn for each

developmental comparison, with the corresponding as R2 values calculated as an estimate of the amount of
variation explained by the results obtained.

2.4 Discussion
MEC are responsible for the synthesis and secretion of milk components;
however, the molecular mechanisms taking place within MEC remain relatively
unexplored. To provide a more complete characterization of the developmental cycle,
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single-ended RNA-seq was performed on MEC isolated from virgin, pregnant, and postinvolutional quiescent sibling mice. The objective of this experiment is to identify the
differentially expressed genes influencing MEC development during pregnancy and the
differences between the nulliparous and primiparous states. Although sequencing reads
in pairs can help detect alignment errors and improve the sensitivity and specificity
compared to that of single-end reads, such an experimental approach is necessary only
when isoform annotation and exploration of the genetic architecture are the primary goals
(Li and Homer, 2010).
Numerous commercially available and open-source software packages have been
developed to facilitate in the assembly and differential analysis of RNA-seq data.
However, while these computer programs all share a common goal to RNA-seq analysis,
variations exist in their application of mathematical and statistical algorithms and
computer science programming (Trapnell et al., 2012). For this reason the computational
analysis of the RNA-seq output was performed twice, using both the CLC Genomics
Workbench and Green Line Analysis platforms.
The CLC Genomics Workbench is a commercially-available software program
for the analysis of RNA-seq data generated through Illumina sequencing technologies.
The alignment algorithms applied by this program are based on hash tables, data
structures that are used to store and sort information. Through a process known as
“seeding,” algorithms based on hash tables use the short sequenced reads as queries
against a reference genome, finding areas of local alignment along the reference genome,
and then using a q-gram calculation to filter out poor matches. A vectorized adaptation
of Smith-Waterman programming accelerates this process and avoids repeated alignment
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of identical subsequences. The output is thus statistically significant alignments of the
sequenced reads along the reference genome (Li and Homer, 2010; Li and Durbin, 2010;
Fonesca et al., 2012; Mortazavi et al., 2008). The subsequent differential analysis is
based on the methods by Mortazavi et al., 2008. In brief, through the application of an
Enhanced Read Analysis of Gene Expression (ERANGE) program, the prevalence of
transcripts against the reference genome is calculated and then normalized to a RPKM
expression measure. Each RPKM is generated with a corresponding p-value, the
probability of obtaining that value—or a value more extreme—given that the null
hypothesis is true (Grafen and Hails, 2002). This normalization is a necessary process,
considering that the length of each transcript must be taken into account when comparing
the detected expression of transcripts since longer transcripts would naturally yield
greater detection reads (Mortazai et al., 2008; Trapnell et al., 2012).
In contrast, the Green Line Analysis is an open-source program for the same
analysis of Illumina-generated RNA-seq data. This line, which is currently in Beta
testing for user acceptability and feedback, was developed as part of the DNA Subway, a
publicly accessible analytical platform managed by the iPlant Collaborative. Although it
is in the Green Line Analysis roadmap to add an assembly workflow as part of their
analytical processes, unfortunately this feature is unavailable at present since the platform
accepts only one FASTQ file for upload per replicate. As such, the assembled sequence
files were generated by the bioinformatics directors of the Cold Springs Harbor
Laboratory using a simple concatenation and then uploaded onto the Green Line Analysis
for alignment to the mouse genome. TopHat, Cufflinks, and Cuffdiff are software tools
composing what is known as the Tuxedo Protocol and which the Green Line Analysis
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utilizes for assessing RNA-seq data. Specifically, TopHat aligns sequenced reads to a
reference genome using a Bowtie program, which in turn uses an FM index data structure
to store and sort the sequence information (Trapnell et al., 2012). Distinct from the hash
table algorithms discussed above, the FM index algorithms are based on suffice/prefix
tries. Whereas non-vectorized Smith-Waterman hash table alignments are performed for
each identical copy of a substring sequence within the reference genome, algorithms built
upon suffice/prefix tries align multiple identical copies of the reference substring (Li and
Homer, 2010). The resulting alignment files are then used to calculate differential
expression levels and test the statistical significance of the observed changes (Trapnell et
al., 2012). To normalize the expression data for transcript length, TopHat calculates the
RPKM, essentially analogous to the RPKM. The two remaining tools within the Tuxedo
protocol were not utilized in this experiment considering CuffLinks is only needed for the
detection of novel isoform discovery and CuffDiff does not allow transformation of the
raw data. Additionally, in CuffDiff each RPKM is generated with a corresponding qvalue, a similar measure of the statistical significance of a p-value except it also considers
conditionality and takes into account the fact that thousands of features are being tested
simultaneously. In theory q-values, which are an extension of the FDR, are more
intuitive for transcriptomic studies where a much higher FDR can be tolerated than with a
p-value (Storey and Tibshirani, 2003). To avoid the compounding comparison of
differential genes as determined by both p-values and q-values, the raw FKMP values
were accessed and downloaded by the External Collaborations Directors of the Cold
Springs Harbor Laboratory using the cummerbund R package within the CyVerse
Discovery Environment. This accession then allowed the same statistical analysis to be
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performed on the expression values detected by the Green Line Analysis as was
performed on those expression values detected by the CLC Genomics Workbench.
Here, we have dually demonstrated that high-quality cDNA was generated and
successfully sequenced from eight of the nine samples analyzed. Both the CLC
Genomics Workbench and the Green Line Analysis programs assessed several quality
control conditions according to per-sequence and per-base parameters such as base
content, ambiguous base content, quality scores, and length distribution. Base content
considers the proportion of each nucleotide base, where no biases or overrepresentation
should be detected within the sequence libraries. If the sequence analyzer is unable to
identify a specific nucleotide during the sequencing processes, that base is considered
ambiguous. Ideally, the proportion of ambiguous base content should be minimal,
indicating successful base calling and data interpretation by the sequence analyzer when
the library clusters are being fluorescently excited. Quality scores are calculated to assess
the error probability of base detection. By measuring the accuracy of the sequencing
process, systematic errors can be detected if a significant proportion of the sequences
analyzed yield a low-quality score. Length distribution considers the fragment size for
the libraries sequenced, where all fragments should be of a uniform length.
Sequence reads indicative of poor quality provide less biological information,
hinder the assembly and alignment processes, and should therefore be eliminated from
subsequent analyses. Although all nine samples were indicative of good quality, both
software programs detected only approximately 6,000 reads for Virgin Mouse 2. Such
low read detection is most likely due to degradation of the extracted RNA. Although it
cannot be stated definitively where the degradation might have occurred, possible sources
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include the library construction and amplification processes, transportation between UC
Davis and UC Berkeley, or any cleaning procedure performed by the QB3 Facility at UC
Berkeley. How accurately RNA-seq reflects the original RNA population is dependent
upon the quality of the extracted RNA throughout the sequencing process (Costa et al.,
2010). Considering the eight remaining samples averaged approximately 19 million
reads each, Virgin Mouse 2 was eliminated from the subsequent differential analysis.
Differential analysis individually performed by the CLC Genomics Workbench
and the Green Line Analysis each produced relatively large sets of differentially
expressed genes for the two developmental comparisons being considered. Figures 1
through 4 have illustrated the detection comparison between the two platforms. It was
surprising to find that while some similarities are shared between the two platforms, the
majority of those differentially expressed genes were found in one platform but not the
other. A portion of this striking amount of dissimilarity may be attributed to the differing
versions of the Mus musculus genome to which the sequenced reads were aligned. While
feasibly impossible to interpret manually, regression analysis provides a method to
interpret how similar the two gene lists are to each other. A GLM is a method of
regression analysis that estimates how well a dataset is described by explanatory
parameters, also known as independent variables. As part of the output from a GLM
analysis, the coefficient of determination (R2) is calculated for measuring the proportion
of variance that is being explained. The greater R2 is, the greater the fraction of variance
or “goodness of fit” being explained by the model (Grafen at Hails, 2002). The
comparison of those dually differentially detected genes was weakly similar, with
unremarkable R2 values. As shown in Figure 5, only 70% and 78% of the variation in the
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data can be explained by the fold changes detected by the two platforms within the
virgin-to-pregnant and virgin-to-quiescent developmental comparison, respectively.
Important to note, no gene can be found in quadrants II or IV, meaning no gene was
differentially detected in a direction of regulation by one platform but detected in a
differing direction of regulation by the other platform.
Considering the same input data were used in the analysis performed by the two
RNA-seq platforms, these resulting differences and similarities question the validity of
transcriptomic data. Several topics concerning technical and biological reproducibility
will now be discussed. Reproducibility of biological data is of concern within every
scientific discipline. Since the introduction of RNA-seq techniques in 2008, the
reproducibility of transcriptomic expression data, particularly that of microarrays, has
come under scrutiny (Mortazavi et al., 2008; Ioannidis et al., 2009). In a key evaluation
of the repeatability of gene expression profiling from eighteen differing and independent
microarray-based studies published between 2005-2006, Ioannidis and colleagues failed
to reproduce the reported analyses in principle in sixteen of those studies (Ioannidis et al.,
2009). In contrast to this apparent limited repeatability of microarrays, RNA-seq has
consistently been demonstrated more repeatable, with few systematic differences among
replicates. In a comparison of two technical replicates from isolated mouse brain
samples, Mortazavi and colleagues observed the sequenced transcript abundances as
being highly reproducible, with a correlation of R2 = 0.96 (Mortazavi et al., 2008).
Additionally, to further assess technical variance, Marioni and colleagues compared the
RNA-seq results from liver and kidney samples, sequencing each sample seven times, to
that of the microarray results from the same samples. Again, while sequenced transcript
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abundances across the technical replicates were observed as being highly reproducible,
with a correlation of R2 = 0.96, comparison of the differential results from two
technologies was observed as being less similar, with a correlation of R2 = 0.73. Specific
to that study, despite that 6,534 genes were identified as being differentially expressed by
both technologies, an additional 4,949 genes were identified through RNA-seq that were
not identified through microarray analysis (Marioni et al., 2008). Thus, the strength and
repeatability of RNA-seq across technical replicates is far superior to that of microarray
hybridization technologies. While such technical replication is significant, the
implementation of biological replicates and proper sample size is inarguably essential to
the statistical power of any scientific study (Li et al., 2013).
Biological replication and proper sample size are crucial design considerations for
the accuracy of any RNA-seq experiment, however their applications can be difficult
considering possible financial or technical restrictions (Auer and Doerge, 2010). While
analyses on unreplicated data that consider only a single subject per treatment group are
not uncommon in the RNA-seq literature (Marioni et al., 2008; Brawand et al., 2001;
Graveley et al., 2011; Hah et al., 2011; Soneson and Delorenzi, 2013), they provide no
estimation of within-treatment-group variability (Auer and Doerge, 2010). Accordingly,
inclusion of biological replicates is desirable as it allows for the estimation of withintreatment-group variability for the comparison to between-group variability and the
ultimate generalization to the population of interest (Grafen and Hails, 2002).
Researchers have recently begun to address the statistical principle of replication for
proper sample size selection as applied to RNA-seq experimental design and analysis.
While many equations have been proposed for the determination of the optimal number
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of biological replicates necessary to achieve a desired statistical power, all agree that
replicated data are superior to unreplicated data, where each additional biological
replicate increasingly improves the analytical accuracy and power of differential gene
detection (Auer and Doerge, 2010; Li et al., 2013; Liu et al., 2014; Hart et al., 2013).
Thus, it is possible to consider experiments with smaller numbers of replicates per
condition, such as the transcriptional analysis of developmental stages of isolated MEC
being considered here, for interpretation of biological insight (Anders and Huber, 2010).
Taken together, these data and findings are in support of successful RNA
extraction, library generation, and sequencing application. Quality control analysis of the
RNA-seq output through both the CLC Genomics Workbench and the Green Line
Analysis further support the individual sequencing processes. Although unfortunate that
the sequencing of RNA from Virgin Mouse 2 had to be eliminated from further analyses,
the resulting experimental design and biological replicates themselves are sufficient for
subsequent gene ontological and pathway analyses. However, there does exist a
surprising dissimilarity in the differential expression of the two platforms, as shown by
the strikingly small number of dually detected genes. While the detection was similar in
direction of regulation, the parity of those dually-detected differentially-expressed genes
from each developmental comparison was interestingly found to be weakly similar, as
supported by relatively unremarkable R2 values. The effect these global profiling
differences and similarities have on the underlying molecular mechanisms influencing
MEC physiology and pathology will be considered in the following experiment, which
may also be thought of as the subsequent analytical effort to that just described.
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CHAPTER 3 – Identification of Key Regulator Genes Affecting Developmental Stages in
Mice using Functional Analysis
3.1 Introduction
The basic output from an RNA-seq experiment is a list of short sequences along
with their detected quantities that may then be assessed for quality control, aligned to a
reference genome, and analyzed for differential gene expression. Accordingly,
differential analysis yields a set of genes showing different average expression levels
across two populations. However, the interpretation and extraction of biological insight
from such information poses a challenge to researchers as these sets often contain
thousands of genes. The recent advances in high-throughput next generation sequencing
technologies and the data thus generated have consequently made manual investigations
in the literature for analysis and interpretation dauntingly exhaustive (Jiline et al., 2011).
Differentially expressed genes can be ordered in a ranked list according to their change in
magnitude of expression; yet, individual gene-by-gene analysis often fails to recognize
the underlying themes of molecular biology such as cellular processes, metabolic
pathways, and transcriptional programs (Subramanian et al., 2005).
To facilitate the secondary analysis of RNA-seq experiments, thereby providing
insight into the relevant biological themes, structured vocabularies known as ontologies
have been developed for the management of information in biological databases. By
providing a centralized collection of known relationships between biological terms and
all genes related to those terms, Gene Ontology (GO) databases automate the process of
assigning attributes to experimentally-derived, differentially expressed gene sets for
biological interpretation (Harris et al., 2004). Ontologies in and of themselves are not a
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novel concept to scientific applications since historical examples include the anatomical
classification of body parts by Aristotle and the chemical classification of the periodic
table of elements by Mendeleev (Splendiani et al., 2014). Similar to the numerous
commercially available and open-source software packages developed for the initial
RNA-seq data analysis, each with its own application of mathematical and statistical
algorithms and computer science programming, numerous databases likewise exist for
the functional analysis of differential gene sets. Since the launch of the first GO database
in 2002, to date more than 70 additional databases have been developed as researchers
increasingly depend upon them for the validation of large gene sets with more
manageable and well-established sources of knowledge (Kitano, 2002; Huang et al.,
2009a). Regardless of their distinctions or differences, all GO databases aim to represent
the current knowledge of biological entities and their relationships and to statistically
examine the enrichment of ontologies by relevant genes (Hill et al., 2002; Huang et al.,
2009a).
Three domains of GO have been proposed to describe the molecular biology
concepts universal to all living systems: cellular component, molecular function, and
biological process. Cellular component, such as plasma membrane or ubiquitin ligase
complex, refers to the area within a cell where a specific gene product is active.
Molecular function, such as kinase activity or regulation of transcription, refers to the
biochemical activity of a specific gene product. Biological process, such as cell death or
oxidation reduction, refers to the biological objective, often a chemical or physical
transformation, to which a specific gene product contributes. GO terms are
interconnected in a dynamic network of relationships since any biological process is
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accomplished by one or more assemblies of molecular functions that take place within a
designated cellular component (Harris et al., 2004). Furthermore, how closely a set of
differentially expressed genes matches an ontology can be quantitatively assessed by
determining that which best describes the experimental data. Specifically, the probability
that an identified GO term meaningfully relates to the data set is calculated given that the
input data set is a random list of genes. The lower the probability, the more likely the GO
terms describe the underlying themes of molecular biology for the experimental data
being analyzed (Splendiani et al., 2012). Such an analysis is more exploratory in nature,
aiming to systematically extract biological meaning from large gene lists as opposed to
confirming or refuting theories specific to a particular biological phenomenon (Huang et
al., 2009b). To assimilate the down- and up-regulated genes detected by RNA-seq
differential analysis between the virgin, pregnant, and post-involutional quiescent
samples, GO and pathway analysis will provide a comprehensive illustration of the
complex molecular mechanisms influencing MEC physiology and pathology.

3.2 Methods
GO and pathway analysis were performed twice, first on the differentially up- and
down-regulated genes detected with high, medium, and low expression by the CLC
Genomics Workbench, and second on the differentially up- and down-regulated genes
detected with high, medium, and low expression by Green Line Analysis.
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3.2.1 Gene Ontology Analysis
Detection of over-represented themes and classification into GO terms was
performed using the Database for Annotation, Visualization, and Integrated Discovery
(DAVID) (Huang et al., 2009b). The complete mouse transcriptome was used as
background to calculate expected frequencies of over-represented themes as directed by
the default parameters and singular enrichment analysis (SEA) computations intrinsic to
DAVID (Huang et al., 2009a). Specific to the DAVID database, observed frequencies
and their associated p-values are calculated to that expected by chance using Benjamini
statistics (Huang et al., 2009a). Adopting an exploratory approach to extracting
biological meaning, over-represented GO terms were determined among the up- and
down-regulated differentially detected genes with high, medium, and low expression
between the virgin and pregnant developmental comparison and among the up- and
down-regulated differentially detected genes with high, medium, and low expression
between the virgin and post-involutional quiescent developmental comparison for both
the CLC Genomics Workbench and Green Line Analysis.

3.2.2 Pathway Analysis
To identify the biological pathways significantly enriched in the data sets of the
up- and down-regulated differentially detected genes with high, medium, and low
expression between the virgin and pregnant developmental comparison and between the
virgin and post-involutional quiescent developmental comparison, the corresponding
gene data sets were mapped to the Kyoto Encyclopedia of Genes and Genomes (KEGG)
(Kanehisa and Goto, 2000).
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3.3 Results
3.3.1 CLC Genomics Workbench
All up- and down-regulated genes differentially detected with high, medium, and
low expression between the virgin and pregnant developmental comparison and all upand down-regulated genes differentially detected with high, medium, and low expression
between the virgin and post-involutional quiescent developmental comparison were
individually uploaded into DAVID for GO term identification and pathway analysis. The
number of high, medium, and low genes for each developmental comparison summed to
more than the number of differentially detected genes considering a given gene may be
expressed with a specific strength in one developmental state and a different strength in
the other developmental state. GO term identification was utilized for a general
description of the underlying themes influencing the MEC phenotype. Export from the
DAVID database into KEGG was utilized for pathway analysis to provide a
comprehensive illustration of the molecular mechanisms influencing the MEC phenotype.

3.3.1.1 Gene Ontology Analysis
For the virgin-to-pregnant developmental comparison, 1,037 differentially downregulated and 1,644 differentially up-regulated genes were detected by the CLC
Genomics Workbench (p<0.05). Of the 10 down-regulated genes detected with high
expression 3, 4, and 14 ontological records were identified for cellular component,
molecular function, and biological process functional annotation terms, respectively. Of
the 457 down-regulated genes detected with medium expression, 57, 90, and 293
ontological records were identified for cellular component, molecular function, and
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biological process functional annotation terms, respectively. Of the 694 down-regulated
genes detected with low expression, 64, 79, and 252 ontological records were identified
for cellular component, molecular function, and biological process functional annotation
terms, respectively. Of the 13 up-regulated genes detected with high expression, 4, 3,
and 6 ontological records were identified for cellular component, molecular function, and
biological process functional annotation terms, respectively. Of the 744 up-regulated
genes detected with medium expression, 76, 62, and 111 ontological records were
identified for cellular component, molecular function, and biological process functional
annotation terms, respectively. Of the 1,073 up-regulated genes detected with low
expression 32, 51, and 86 ontological records were identified for cellular component,
molecular function, and biological process functional annotation terms, respectively.
For the virgin-to-post-involutional quiescent developmental comparison, 1,820
differentially down-regulated genes and 521 up-regulated genes were detected by the
CLC Genomics Workbench (p<0.05). Of the 70 down-regulated genes detected with
high expression, 5, 3, and 3 ontological records were identified for cellular component,
molecular function, and biological process functional annotation terms, respectively. Of
the 654 down-regulated genes detected with medium, expression, 118, 102, and 289
ontological records were identified for cellular component, molecular function, and
biological process functional annotation terms, respectively. Of the 1,409 downregulated genes detected with low expression, 93, 94, and 294 ontological records were
identified for cellular component, molecular function, and biological process functional
annotation terms, respectively. Of the 65 up-regulated genes detected with high
expression, 22, 11, and 31 ontological records were identified for cellular component,
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molecular function, and biological process functional annotation terms, respectively. Of
the 315 up-regulated genes detected with medium expression, 55, 33, and 77 ontological
records were identified for cellular component, molecular function, and biological
process functional annotation terms, respectively. Of the 246 up-regulated genes
detected with low expression, 5, 4, and 8 ontological records were identified for cellular
component, molecular function, and biological process functional annotation terms,
respectively.
For each comparison made, considering the biological relevance and associated pvalue for that GO term as determined using Benjamini statistics, an exploratory approach
was taken to extract biological meaning and consideration for mapping to pathway
analysis. A snapshot of applicable and compelling GO terms within each annotation
category have been depicted (Figure 6), along with the corresponding number of genes
pertaining to that GO term and the calculated p-value.
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HIGH Expression
Glutathione metabolic process (BP) n=2, p-value = 2.9E-2
Extracellular exosome (CC) n=7, p-value= 2.8E-3
Extracellular space (CC) n=5, p-value= 1.0E-2

Virgin-to-Pregnant Developmental Comparison

MEDIUM Expression
Oxidation-reduction process (BP) n=63, p-value=9.1E-12
Translation (BP) n=44, p-value=1.3E-10
Transport (BP) n=114, p-value= 3.0E-9
mRNA processing (BP) n=25, p-value= 6.1E-6
Protein folding (BP) n=16, p-value= 5.3E-5
Cell division (BP) n=27, p-value= 9.9E-4
Cell cycle (BP) n=35, p-value= 7.8E-3
Mitochondrion (CC) n=197 p-value = 1.2E-51
Ribosome (CC) n=36 p-value= 7.6E-16
Structural constitute of ribosome
(MF) n= 32, p-value = 4.1E-9

MEDIUM Expression
Translation (BP) n=24, p-value= 9.3E-10
Oxidation-reduction process (BP)
n=20, p-value= 7.0E-4
Mitochondrion (CC) n=70, p-value= 7.0E-20
Extracellular exosome (CC) n=80), p-value= 5.3E-15
Ribosome (CC) n=15, p-value= 7.0E-8
Structural constituent of ribosome (MF)
n=17, p-value= 1.1E-7
NADH dehydrogenase (ubiquitone) activity (MF)
n=6, p-value= 5.4E-5

Up-regulated

LOW Expression
Mitochondrion (CC) n=206, p-value=6.1E-36
Catalytic activity (MF) n=56, p-value=6.9E-10
Transferase activity (MF) n= 119, p-value= 3.5E-9
Lyase activity (MF) n=25, p-value= 2.7E-8
Hydrolase activity (MF) n=111, p-value = 3.3E-6
Cell cycle (BP) n=65, p-value = 2.8E-9
Cell division (BP) n=43 p-value=2.1E-7
Oxidation-reduction process (BP)
n=60, p-value= 4.7E-6
Metabolic process (BP) n=41, p-value= 2.0E-4

LOW Expression
Lipid metabolic process (BP) n=15, p-value= 8.8E-6
Cell-cell signaling (BP) n=4, p-value= 4.2E-2
Mitochondrion (CC) n=26, p-value= 1.9E-3
Catalytic activity (MF) n=12, p-value= 5.8E-4

Virgin-to-Quiescent Developmental Comparison

HIGH Expression
Translation (BP) n=44, p-value=2.1E-58
Ribosomal small unit assembly (BP) n=7, p-value= 5.4E-11
rRNA processing (BP) n=10, p-value=3.2E-10
Ribosomal large unit assembly (BP) n=4, p-value=8.6E-5
Ribosome (CC) n=44, p-value= 9.5E-75
Intracellular ribonucleoprotein complex (CC)
n=40, p-value =2.7E-55
Extracellular exosome (CC) n=35, p-value= 1.0E-14
Structural constituent of ribosome (MF)
n=46, p-value= 1.1E-70

HIGH Expression
Positive regulation of translation (BP) n=3, p-value= 5.8E-5
Extracellular exosome (CC) n= 5, p-value= 3.4E-4
Protein binding (MF) n=5, p-value= 3.0E-3

HIGH Expression
Immune response (BP) n=3, p-value= 7.6E-3
Cell growth (BP) n= 2, p-value= 2.4E-2
Extracellular space (CC) n=5, p-value= 3.1E-3
Growth factor activity (MF) n=3, p-value=4.0E-3
Protease binding (MF) n=2, p-value=5.2E-2

MEDIUM Expression
Cell migration (BP) n=20, p-value= 1.3E-7
Leukocyte cell-cell adhesion (BP) n=7, p-value =1.5E-5
Cell adhesion (BP) n=5, p-value=2.5E-4
Nucleus (CC) n=200, p-value=1.9E-11
Cytoplasm (CC) n=211 p-value= 2.2E-10
Cell surface (CC) n=42 p-value=7.4E-10
Protein binding (MF) n=168, p-value= 6.4E-15
Receptor binding (MF) n=27, p-value= 6.1E-6

MEDIUM Expression
Positive regulation of cell migration (BP)
n=23, p-value= 9.9E-7
Cell adhesion (BP) n=37, p-value= 5.1E-6
Positive regulation of gene expression (BP)
n=31, p-value= 2.4E-5
Regulation of protein binding (BP) n=7, p-value= 4.4E-5
Cytoplasm (CC) n=323
p-value= 2.8E-20
Membrane (CC) n=315 p-value= 6.9E-14
Cell-cell adherens junction (CC) n=38, p-value= 1.1E-11
Protein binding (MF) n= 247, p-value= 5.7E-26

Down-regulated

LOW Expression
Cell differentiation (BP) n=54, p-value=1.2E-6
Cell migration (BP) n=21, p-value= 8.1E-6
Membrane (CC) n=299, p-value= 8.6E-10
Cell surface (CC) n=41, p-value= 3.5E-5
Plasma membrane (CC) n=200, p-value=6.7E-5
Protein binding (MF) n=196, p-value= 8.3E-7
ATP binding (MF) n=82, p-value= 7.0E-5
ATPase activity, coupled to transmembrane movement of
substances (MF) n=9, p-value= 2.8E-4

LOW Expression
Protein phosphorylation (BP) n= 79, p-value= 1.9E-9
Wnt signaling pathway (BP) n=39, p-value= 2.6E-8
Cell differentiation (BP) n=88, p-value= 1.7E-6
Cell adhesion (BP) n= 59, p-value= 1.2E-5
Cell migration (BP) n=29, p-value= 7.6E-5
Membrane (CC) n=596, p-value= 3.4E-16
Cytoplasm (CC) n= 533, p-value= 2.3E-9
Protein binding (MF) n=397, p-value= 2.0E-18
Wnt-protein binding (MF) n=12, p-value= 1.7E-6
Kinase activity (MF) n=74, p-value= 2.2E-5

FIGURE 6: DAVID GO Terms Originating from CLC Genomics Workbench Differential Analysis
of Genes Detected with High, Medium, and Low Expression
Detection of over-represented themes and classification into GO terms was performed using DAVID. The
complete mouse transcriptome was used as background to calculate expected frequencies of overrepresented themes as directed by the default parameters. GO terms were determined among genes detected
with high, medium, and low differential expression for the virgin-to-pregnant developmental comparison
and for the virgin-to-post-involutional quiescent developmental comparison. For each GO term depicted in
the snapshot, the number of genes matching that term and the associated p-values are calculated to that
expected by chance using Benjamini statistics. The corresponding GO domains representing the molecular
biology concepts universal to all living systems are also indicated as either cellular component (CC),
molecular function (MF), or biological process (BP).
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3.3.1.2 Pathway Analysis
GO term identification was utilized for a general description of the underlying
themes influencing the MEC phenotype. Export from the DAVID database into KEGG
was utilized for pathway analysis to provide a comprehensive illustration of the
molecular mechanisms significantly enriched and influencing the MEC phenotype.
Following export into KEGG, for the virgin-to-pregnant developmental comparison, of
the 10 down-regulated genes detected with high expression, 6 chart records were
identified as compatible within a KEGG pathway. Of the 457 down-regulated genes
detected with medium expression, 51 chart records were identified as compatible within a
KEGG pathway. Of the 694 genes detected with low expression, 27 chart records were
identified as compatible within a KEGG pathway. Of the 13 up-regulated genes detected
with high expression, 1 chart record was identified as compatible within a KEGG
pathway. Of the 744 up-regulated genes detected with medium expression, 32 chart
records were identified as compatible within a KEGG pathway. Of the 1,073 genes
detected with low expression, 33 chart records were identified as compatible within a
KEGG pathway.
For the virgin-to-post-involutional quiescent developmental comparison, of the 5
down-regulated genes detected with high expression, no chart records were identified as
compatible within a KEGG pathway. Of the 654 down-regulated genes detected with
medium expression, 23 chart records were identified as compatible within a KEGG
pathway. Of the 1,409 genes detected with low expression, 44 chart records were
identified as compatible within a KEGG pathway. Of the 65 up-regulated genes detected
with high expression, 2 chart records were identified as compatible within a KEGG
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pathway. Of the 315 up-regulated genes detected with medium expression, 18 chart
records were identified as compatible within a KEGG pathway. Of the 246 genes
detected with low expression, 4 chart records were identified as compatible within a
KEGG pathway.
For each comparison made, considering the biological relevance and associated pvalue identified for each pathway as determined using Benjamini statistics, an
exploratory approach was taken to identify biological pathways significantly enriched
within the data sets. A snapshot of applicable and compelling KEGG pathways have
been depicted (Figure 7), along with the corresponding number of genes pertaining to that
pathway and the calculated p-value.
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HIGH Expression
Lysosome n= 2, p-value= 9.1E-2

HIGH Expression
Ribosome n=46, p-value= 8.9E-73
MEDIUM Expression
Oxidative phosphorylation n=21, p-value= 5.5E-14
Ribosome n= 14, p-value= 5.8E-7
Metabolic pathways n= 44, p-value= 9.7E-7
Phagosome
n= 11, p-value= 5.3E-4
RNA polymerase n= 5, p-value= 1.3E-3
Proteasome n= 5, p-value= 6.0E-3
Peroxisome n= 5, p-value= 4.6E-2

Up-regulated

LOW Expression
Metabolic pathways n= 106, p-value = 1.3E-12
Peroxisome n= 17, p-value= 3.0E-7
Fatty acid metabolism n= 11, p-value= 4.5E-5
Carbon metabolism n= 13, p-value= 3.7E-3
Cell cycle n= 12, p-value= 1.6E-2
Amino sugar and nucleotide sugar metabolism
n= 7, p-value= 1.7E-2
Alanine, aspartate, and glutamate metabolism
n= 6, p-value= 1.9E-2
Fatty acid biosynthesis n= 4, p-value= 2.0E-2

LOW Expression
Peroxisome n= 6, p-value= 3.4E-4
Metabolic pathways n=17, p-value= 2.0E-2

HIGH Expression
TNF signaling pathway n=3, p-value= 4.0E-3

HIGH Expression
N/A

MEDIUM Expression
TNF signaling pathway n=19, p-value= 8.2E-10
Cytokine-cytokine receptor interaction
n= 18, p-value= 4.4E-4
Proteoclycans in cancer n=16, p-value= 4.9E-4
Ras signaling pathway n=17, p-value= 6.0E-4
MAPK signaling pathway n= 18, p-value= 6.3E-4
Pathways in cancer n=23, p-value= 1.4E-3
Rap1 signaling pathwa n= 15, p-value= 2.4E-3
Focal adhesion n=14, p-value= 4.9E-3
Apoptosis n=7, p-value= 6.1E-3
Jak-STAT signaling pathway
n= 11, p-value= 6.9E-3
Insulin resistance n= 9, p-value= 1.1E-2

MEDIUM Expression
Focal adhesion n= 29, p-value= 3.2E-9
Protein processing in endoplasmic reticulum
n= 23, p-value= 3.0E-7
Proteoglycans in cancer n= 21, p-value= 7.8E-5
Regulation of actin cytoskeleton
n= 19, p-value= 1.2E-3
Adherens junction n= 9, p-value= 5.6E-3
Pathways in cancer
n= 24, p-value= 2.7E-2

Down-regulated

Virgin-to-Quiescent Developmental Comparison

Virgin-to-Pregnant Developmental Comparison

MEDIUM Expression
Oxidative phosphorylation n= 34, p-value= 2.3E-16
Metabolic pathways n= 108, p-value= 4.9E-13
Ribosome n= 21, p-value= 3.4E-6
Spliceosome n= 19, p-value= 1.4E-5
Proteasome n= 10, p-value= 1.0E-4
Protein processing in endoplasmic reticulum
n= 20, p-value= 1.0E-4
Fatty acid elongation n= 7, p-value= 6.7E-4
Citrate cycle (TCA cycle) n= 7, p-value= 2.1E-3
Glutathione metabolism
n= 6, p-value= 8.6E-2

LOW Expression
Proteoglycans in cancer n= 31, p-value= 2.0E-6
Rap1 signaling pathway n=31, p-value= 6.1E-6
Basal cell carcinoma n= 13, p-value= 6.0E-5
Wnt signaling pathway n= 21, p-value= 1.9E-4
Focal adhesion n= 16, p-value= 4.1E-4
Pathways in cancer n= 40, p-value= 8.7E-4
cGMP-PKG signaling pathway n= 22, p-value= 9.4E-4
mTOR signaling pathway n= 10, p-value= 6.8E-3
Ras signaling pathway n=23, p-value= 1.4E-2
ABC transporters n= 8, p-value= 1.6E-2
Adherens junction n= 10, p-value= 2.4E-2

LOW Expression
ABC transporters n= 10, p-value= 1.8E-5
Rap1 signaling pathway n= 21, p-value= 3.4E-5
Transcriptional misregulation in cancer
n= 15, p-value= 1.4E-3
Ras signaling pathway n= 18, p-value= 1.9E-3
MAPK signaling pathway n=17, p-value= 1.2E-2
Phagosome n= 12, p-value= 3.4E-2
Focal adhesion n=13, p-value= 4.8E-2

FIGURE 7: KEGG Pathway Records Originating from CLC Genomics Workbench Differential
Analysis of Genes Detected with High, Medium, and Low Expression
To identify the biological pathways significantly enriched in the data sets of differentially down- and upregulated genes between virgin and pregnant samples and between virgin and post-involutional quiescent
samples as detected by the CLC Genomics Workbench, genes were mapped to KEGG directly from
DAVID. For each pathway identified, the number of genes matching that pathway and the percentage of
those genes matching that pathway as determined from the number of differentially detected input genes
have been listed. The associated p-values are calculated to that expected by chance using Benjamini
statistics.
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3.3.2 Green Line Analysis
All up- and down-regulated genes differentially detected with high, medium, and
low expression between the virgin and pregnant developmental comparison and all upand down-regulated genes differentially detected with high, medium, and low expression
between the virgin and post-involutional quiescent developmental comparison were
individually uploaded into DAVID for GO term identification and pathway analysis. The
number of high, medium, and low genes for each developmental comparison summed to
more than the number of differentially detected genes considering a given gene may be
expressed with a specific strength in one developmental state and a different strength in
the other developmental state. GO term identification was utilized for a general
description of the underlying themes influencing the MEC phenotype. Export from the
DAVID database into KEGG was utilized for pathway analysis to provide a
comprehensive illustration of the molecular mechanisms influencing the MEC phenotype.

3.3.2.1 Gene Ontology Analysis
For the virgin-to-pregnant developmental comparison, 756 differentially downregulated and 715 differentially up-regulated genes were detected by the Green Line
Analysis (p<0.05). Of the 8 down-regulated genes detected with high expression 3, 2,
and 3 ontological records were identified for cellular component, molecular function, and
biological process functional annotation terms, respectively. Of the 372 down-regulated
genes detected with medium expression, 43, 65, and 170 ontological records were
identified for cellular component, molecular function, and biological process functional
annotation terms, respectively. Of the 694 down-regulated genes detected with low

86

expression, 33, 49, and 121 ontological records were identified for cellular component,
molecular function, and biological process functional annotation terms, respectively. Of
the 8 up-regulated genes detected with high expression, 1, 1, and 2 ontological records
were identified for cellular component, molecular function, and biological process
functional annotation terms, respectively. Of the 369 up-regulated genes detected with
medium expression, 741 32, and 70 ontological records were identified for cellular
component, molecular function, and biological process functional annotation terms,
respectively. Of the 442 up-regulated genes detected with low expression 20, 17, and 28
ontological records were identified for cellular component, molecular function, and
biological process functional annotation terms, respectively.
For the virgin-to-post-involutional quiescent developmental comparison, 725
differentially down-regulated genes and 667 up-regulated genes were detected by the
CLC Genomics Workbench (p<0.05). Of the 13 down-regulated genes detected with
high expression, no ontological records were identified for cellular component, molecular
function, or biological process functional annotation terms. Of the 340 down-regulated
genes detected with medium, expression, 37, 25, and 105 ontological records were
identified for cellular component, molecular function, and biological process functional
annotation terms, respectively. Of the 315 down-regulated genes detected with low
expression, 32, 22, and 66 ontological records were identified for cellular component,
molecular function, and biological process functional annotation terms, respectively. Of
the 14 up-regulated genes detected with high expression, 2, 1, and 1 ontological records
were identified for cellular component, molecular function, and biological process
functional annotation terms, respectively. Of the 332 up-regulated genes detected with
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medium expression, 32, 26, and 38 ontological records were identified for cellular
component, molecular function, and biological process functional annotation terms,
respectively. Of the 249 up-regulated genes detected with low expression, 33, 28, and 29
ontological records were identified for cellular component, molecular function, and
biological process functional annotation terms, respectively.
For each comparison made, considering the biological relevance and associated pvalue for that GO term as determined using Benjamini statistics, an exploratory approach
was taken to extract biological meaning and consideration for mapping to pathway
analysis. A snapshot of applicable and compelling GO terms within each annotation
category have been depicted (Figure 8), along with the corresponding number of genes
pertaining to that GO term and the calculated p-value.
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MEDIUM Expression
Oxidation-reduction process (BP) n=29, p-value=1.4E-5
Transport (BP) n=71, p-value= 4.1E-11
ATP metabolic processes (BP) n=5, p-value= 4.6E-3
Protein binding (BP) n=93, p-value= 8.2E-4
Cell division (BP) n=18, p-value= 2.4E-4
Apoptotic processes (BP) n=24, p-value= 1.2E-4
Mitochondrion (CC) n=89 p-value = 3.2E-22
Ribosome (CC) n=23 p-value= 8.9E-13
Structural constitute of ribosome (MF)
n=17, p-value = 9.8E-6
Catalytic Activity (MF) n=14, p-value= 5.9E-2

MEDIUM Expression
Translation (BP) n=20, p-value= 3.2E-6
tRNA processing (BP) n=7, p-value=1.1E-3
mRNA processing (BP) n=11, p-value= 1.4E-2
Ribosome biogenesis (BP) n=5, p-value=3.5E-2
Mitochondrion (CC) n=61, p-value= 1.3E-11
Extracellular exosome (CC) n=80, p-value= 1.4E-11
Ribosome (CC) n=17, p-value= 7.9E-9
Cytoplasm (CC) n=6, p-value= 1.2E-3
Poly(A) RNA binding
n=39, p-value= 4.6E-8
Structural constituent of ribosome (MF)
n=16, p-value= 2.1E-6
GDP binding (MF) n=12, p-value=5.1E-2

Virgin-to-Pregnant Developmental Comparison

HIGH Expression
mRNA splicing, via spliceosome (BP) n=2, p-value=7.8E-2
Mitochondria (CC) n=4, p-value=6.5E-2
RNA binding (MF) n=3, p-value= 8.4E-2

Up-regulated

LOW Expression
Mitochondrion (CC) n=65, p-value=3.5E-10
Catalytic activity (MF) n=24, p-value=6.3E-6
Transferase activity (MF) n= 37, p-value= 1.4E-2
Lyase activity (MF) n=7, p-value= 3.0E-2
Hydrolase activity (MF) n=42, p-value = 1.8E-3
Cell cycle (BP) n=31, p-value = 1.2E-7
Cell division (BP) n=23 p-value=3.0E-7
Oxidation-reduction process (BP)
n=21, p-value= 9.0E-3
Metabolic process (BP) n=15, p-value= 2.3E-2

LOW Expression
Translation (BP) n=14, p-value= 1.4E-4
Protein folding (BP) n=6, p-value= 8.0E-3
Intracellular ribonucleoprotein complex (CC)
n=19, value=2.4E-9
Mitochondrion (CC) n=43, p-value= 1.8E-8
Ribosome (CC) n=13, p-value= 3.2E-7
Structural constituent of ribosome (MF)
n=13, p-value=8.7E-6

HIGH Expression
Extracellular space (CC) n=3, p-value= 7.1E-2
Enzyme binging (MF) n=4, p-value=2.0E-4
Protease binding (MF) n=2, p-value=4.0E-2

HIGH Expression
N/A

MEDIUM Expression
Transcription, DNA- Templated (BP)
n=74, p-value= 7.7E-10
mRNA processing (BP) n=21, p-value =2.8E-6
Intracellular signal transduction (BP) n=23, p-value=6.2E-6
Nucleus (CC) n=180, p-value=2.6E-16
Cytoplasm (CC) n=169 p-value= 8.5E-9
Focal Adhesion (CC)
n=15 p-value=9.9E-3
Protein binding (MF) n=134, p-value= 4.9E-12
Protein kinase activity (MF) n=23, p-value= 5.2E-4

MEDIUM Expression
Wnt signaling pathway (BP) n=10, p-value=7.0E-3
Protein phosphorylation (BP) n=18, p-value=1.0E-2
Membrane (CC) n=143, p-value=1.7E-6
Cell-cell junction (CC) n=9, p-value=1.0E-2
Cell surface (CC) n=17 p-value= 2.5E-2
Focal adhesion (CC) n=11, p-value=6.5E-2
ATP binding (MF) n=38, p-value=3.8E-3
Wnt-protein binding (MF)
n=3, p-value=7.9E-2

Down-regulated

LOW Expression
Cell differentiation (BP) n=33, p-value=1.3E-4
Cell migration (BP) n=13, p-value= 5.5E-4
Membrane (CC) n=182, p-value= 4.0E-6
Cell surface (CC) n=24, p-value= 3.5E-3
Plasma membrane (CC) n=120, p-value=4.7E-3
Cell junction (CC) n=25, p-value=8.7E-3
Protein binding (MF) n=117, p-value= 2.7E-4
ATP binding (MF) n=20, p-value= 1.9E-2
Positive regulation of transcription, DNA-templated (BP)
N=34, p-value= 8.9E-8

Virgin-to-Quiescent Developmental Comparison

HIGH Expression
Transport (BP) n=4, p-value = 2.6E-2
Transporter activity (MF) n=2, p-value= 7.2E-2
Extracellular space (CC) n=3, p-value= 9.5E-2

LOW Expression
Cell adhesion (BP) n=18, p-value=4.0E-4
Protein phosphorylation (BP) n=16, p-value=1.4E-2
Regulation of JNK cascade (BP) n=3, p-value=2.7E-2
Response to ATP (BP) n=3, p-value=30E-2
Cellular response to cAMP (BP) n=4, p-value=3.1E-2
Wnt signaling pathway (BP) n=7, p-value=7.4E-2
Membrane (CC) n=131, p-value= 1.1E-5
Cell-cell junction (CC) n= 31, p-value= 2.2E-5
Cell junction (CC) n=18, p-value=2.0E-2
Protein binding (MF) n=83, p-value= 4.4E-5
Protein kinase activity (MF) n=13, p-value= 5.6E-2

FIGURE 8: DAVID GO Terms Originating from Green Line Analysis Differential Analysis of Genes
Detected with High, Medium, and Low Expression
Detection of over-represented themes and classification into GO terms was performed using DAVID. The
complete mouse transcriptome was used as background to calculate expected frequencies of overrepresented themes as directed by the default parameters. GO terms were determined among genes detected
with high, medium, and low differential expression for the virgin-to-pregnant developmental comparison
and for the virgin-to-post-involutional quiescent developmental comparison. For each GO term depicted in
the snapshot, the number of genes matching that term and the associated p-values are calculated to that
expected by chance using Benjamini statistics. The corresponding GO domains representing the molecular
biology concepts universal to all living systems are also indicated as either cellular component (CC),
molecular function (MF), or biological process (BP).

89

3.3.2.2 Pathway Analysis
GO term identification was utilized for a general description of the underlying
themes influencing the MEC phenotype. Export from the DAVID database into KEGG
was utilized for pathway analysis to provide a comprehensive illustration of the
molecular mechanisms significantly enriched and influencing the MEC phenotype.
Following export into KEGG, for the virgin-to-pregnant developmental comparison, of
the 8 down-regulated genes detected with high expression, 1 chart record was identified
as compatible within a KEGG pathway. Of the 372 down-regulated genes detected with
medium expression, 33 chart records were identified as compatible within a
KEGG pathway. Of the 694 genes detected with low expression, 14 chart records were
identified as compatible within a KEGG pathway. Of the 8 up-regulated genes detected
with high expression, no chart records were identified as compatible within a KEGG
pathway. Of the 369 up-regulated genes detected with medium expression, 26 chart
records were identified as compatible within a KEGG pathway. Of the 422 genes
detected with low expression, 9 chart records were identified as compatible within a
KEGG pathway.
For the virgin-to-post-involutional quiescent developmental comparison, of the 13
down-regulated genes detected with high expression, no chart records were identified as
compatible within a KEGG pathway. Of the 340 down-regulated genes detected with
medium expression, 13 chart records were identified as compatible within a KEGG
pathway. Of the 315 genes detected with low expression, 3 chart records were identified
as compatible within a KEGG pathway. Of the 14 up-regulated genes detected with high
expression, no chart records were identified as compatible within a KEGG pathway. Of
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the 332 up-regulated genes detected with medium expression, 13 chart records were
identified as compatible within a KEGG pathway. Of the 249 genes detected with low
expression, 12 chart records were identified as compatible within a KEGG pathway.
For each comparison made, considering the biological relevance and associated pvalue identified for each pathway as determined using Benjamini statistics, an
exploratory approach was taken to identify biological pathways significantly enriched
within the data sets. A snapshot of applicable and compelling KEGG pathways have
been depicted (Figure 9), along with the corresponding number of genes pertaining to that
pathway and the calculated p-value.
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HIGH Expression
N/A

MEDIUM Expression
Oxidative phosphorylation n= 14, p-value= 2.9E-6
Metabolic pathways n= 44, p-value= 1.5E-4
Ribosome n= 10, p-value= 2.1E-3
Spliceosome n= 9, p-value= 4.4E-3
Proteasome n= 4, p-value= 5.7E-2
Protein processing in endoplasmic reticulum
n= 13, p-value= 1.0E-4
Fatty acid elongation
n= 3 p-value= 9.1E-2
Amino sugar and nucleotide sugar metabolism
n= 5, p-value= 1.5E-2
Carbon metabolism n= 6, p-value=7.7E-2

MEDIUM Expression
Oxidative phosphorylation n=15, p-value= 3.2E-8
Ribosome n= 14, p-value= 2.7E-6
Metabolic pathways n= 28, p-value= 6.5E-2
RNA transport n= 9, p-value= 5.4E-3
Proteasome n= 4, p-value= 3.4E-2
Peroxisome n= 5, p-value= 4.2E-2

Up-regulated

LOW Expression
Ribosome n=9, p-value=7.4E-5
Phagosome n=9, p-value=2.6E-4
Protein processing in edoplasmic reticulum
n=6, p-value= 2.3E-2
Oxidative phosphorylation n=5, p-value=4.6E-2

LOW Expression
Metabolic pathways n= 32, p-value = 2.0E-3
Peroxisome n= 10, p-value= 2.8E-6
Fatty acid biosynthesis n=3 , p-value= 1.7E-2
Apoptosis n=4, p-value=5.6E-2

HIGH Expression
N/A

HIGH Expression
N/A

MEDIUM Expression
TNF signaling pathway n=12, p-value= 1.8E-5
Ras signaling pathway n=11, p-value= 2.4E-2
Transcriptional misregulation in cancer
n=9, p-value= 2.5E-2
Prolactin signaling pathway
n=5, p-value=6.9E-2
HIF-1 signaling pathway n=6, p-value=7.0E-2
mRNA surveillance pathway n= 6, p-value= 5.3E-2
Insulin resistance n= 6, p-value= 8.5E-2

MEDIUM Expression
Insulin signaling pathway n=10 p-value=2.3E-4
Wnt signaling pathway n=8, p-value= 5.0E-3
Proteoglycans in cancer n= 8, p-value= 3.2E-2
mTOR signaling pathway
n=5, p-value=1.1E-2
cAMP signaling pathway
n=8, p-value=2.7E-2
MAPK signaling pathway n=8, p-value= 8.3E-2

Down-regulated

LOW Expression
Cell adhesion n=18, p-value=4.0E-4
Protein phosphorylation n=16, p-value=1.4E-2
Response to ATP n=3, p-value=3.0E-2
Cellular response to cAMP n=4, p-value=3.1E-2
Wnt signaling pathway n=7, p-value=7.4E-2

LOW Expression
ABC transporters n= 5, p-value= 1.1E-2E-5
Ras signaling pathway n= 11, p-value= 1.2E-3
PI3K signaling pathway n=13, p-value=3.5E-2
Pathways in cancer n=13, p-value=7.5E-2
Focal adhesion n=8, p-value= 1.0E-2

Virgin-to-Quiescent Developmental Comparison

Virgin-to-Pregnant Developmental Comparison

HIGH Expression
N/A

FIGURE 9: KEGG Pathway Records Originating from Green Line Analysis Differential Analysis of
Genes Detected with High, Medium, and Low Expression
To identify the biological pathways significantly enriched in the data sets of differentially down- and upregulated genes between virgin and pregnant samples and between virgin and post-involutional quiescent
samples as detected by the Green Line Analysis, genes were mapped to KEGG directly from DAVID. For
each pathway identified, the number of genes matching that pathway and the percentage of those genes
matching that pathway as determined from the number of differentially detected input genes have been
listed. The associated p-values are calculated to that expected by chance using Benjamini statistics.
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3.4 Discussion
In this experiment, which may be thought of as the subsequent analytical effort to
the prior experiment, GO and pathway analysis were utilized to provide functional
characterization and give biological meaning to the RNA-seq analysis of MEC isolated
from virgin, pregnant, and post-lactational quiescent sibling mice. While DAVID
interpreted the large differential data sets to provide relevant GO terms that identify the
underlying themes of molecular biology, KEGG pathway analysis provided a graphical
representation of the molecular systems that govern cellular processes and organism
behavior (Huang et al., 2009a; Kanehisa et al., 2010).
Functional analysis for biological meaning was first performed for the
commercially-available CLC Genomics Workbench and secondly performed for the
publicly-available Green Line Analysis. Despite the differences in the differential gene
lists generated by these two transciptomic platforms (discussed in the prior chapter), the
overall depiction of the underlying themes and relevant pathways were surprisingly
similar. Not only were numerous domains of gene ontology similarly represented within
the differential gene lists generated by the CLC Genomics Workbench and the Green
Line Analysis, but pathway analysis also produced similar representations of the
molecular systems underlying the MEC phenotype. As it appears, in spite of the
individual differences within the gene sets generated, the overall contribution and
collaboration of those genes functioning together within each developmental stage
analyzed are reflected and made apparent through systems biology. Therefore, the
interpretations of these individual platform analyses may be considered simultaneously
across the developmental comparison being made. The discussions that ensue are
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specific to those gleaned from the interpretations of the CLC Genomics Workbench to
explain the possible events occurring at the molecular level in the isolated MEC.
Several considerations should be kept in mind when analyzing the global
transcriptomic profiling of the isolated primary MEC. First, the focus of this experiment
is to interpret those identified potential factors affecting mammary gland physiology and
pathology by examining the transcriptomic global profiles of isolated MEC. Thus, the
overall question being asked is what changed? To identify the underlying biological
processes most pertinent to the biological phenotype being considered, the resulting
analytical interpretations are based on all relevant differentially-detected genes instead of
on a smaller set of restricted genes (Huang et al., 2009a). Second, the number of genes
within a data set that are recognized as relating to a particular GO term or pathway do not
directly affect the corresponding statistical significance of that term or pathway in
describing the phenotype. Rather, the probability that an identified GO term
meaningfully relates to the data set is calculated (Splendiani et al., 2012). This explains
why some GO terms and pathways can have the same number of related genes yet
differing calculated Benjamini statistics and p-values and vice versa. Third, it is assumed
that all primary MEC analyzed were isolated luminal epithelial cells. Although differing
buffer components, incubations, and washes were utilized in the MEC isolation protocol
to limit the presence of fibroblasts, adipocytes, and erythrocytes, nevertheless there exists
the potential for other cell type contamination, namely myoepithelial cells, endothelial
cells, and leukocytes. Last, the estrous cycle was neither monitored nor considered in
those mice from which the virgin and post-lactational quiescent mammary glands were
harvested. As discussed in Chapter 1 of this thesis, while the mammary gland of the
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virgin and post-lactation female is relatively quiescent, minute morphological changes do
take place in response to the cyclic endocrine regulation. This manifests primarily as a
transitory appearance of alveolar buds that develop and regress in accordance to the fourto-five day murine estrous cycle. Thus, while there are undoubtedly specific effects the
estrous cycle had on those MEC isolated from the virgin and post-lactational quiescent
mice, it cannot be stated definitely what those effects are in relation to the subsequent
RNA-seq and differential analyses performed. With these considerations in mind, a
discussion of the down- and up-regulated profiling for both the virgin-to-pregnant and the
virgin-to-quiescent comparisons and the possible events occurring at the molecular level
in the isolated MEC will follow.

Virgin vs. Pregnant Comparison
Dramatic changes in cell composition and function occur in the mammary gland
during pregnancy. Proper morphogenesis of a functional mammary gland is dependent
upon the coordination of endocrine induction, signaling pathways, and molecular
mediators to direct the extensive proliferation and then secretory differentiation of
alveolar units capable of milk secretion. Of those genes detected as being differentially
up-regulated from the virgin-to-pregnant developmental comparison, KEGG analysis
identified two encompassing biological themes. First, there was enrichment for
numerous metabolic pathways such as oxidative phosphorylation, citrate cycle, fatty acid
metabolism, amino sugar and nucleotide sugar metabolism, and fatty acid biosynthesis.
Second, pathways pertaining to the cell cycle and proliferation were likewise depicted as
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being enriched, as identified by those of the lysosome, ribosome, spliceosome,
proteasome, protein processing, peroxisome, and cell cycle (Table 7).
Considering those pathways pertaining to cellular metabolism, GO analysis for
cellular component strongly identified the mitochondria as the location where gene
products were up-regulated in pregnant MEC relative to virgin MEC. GO analysis for
molecular function and biological process likewise identified oxidation-reduction
processes, metabolic processes, and translation as those biological objectives supporting
cellular metabolism. Considering those pathways pertaining to cellular proliferation, GO
analysis for biological process identified cell division and cell cycle as up-regulated in
pregnant MEC relative to virgin MEC. GO analysis for molecular function identified
both lyase and transferace activity as up-regulated in pregnant MEC relative to virgin
MEC (Table 6).
These GO and KEGG results are in agreement with recent transcriptomic analyses
on mammary gland development. Studies by Zhou and colleagues found that cells of the
mammary gland from mice at day 12 of pregnancy were highly activated for pathways
related to cell cycle control and proliferation (Zhou et al., 2014). From a metabolic
standpoint, while glucose is required for the synthesis of lactose in the lactating
mammary gland, cells of the pregnant mammary gland generally utilize glucose for the
production of ATP through oxidative phosphorylation, which occurs in the
mitochondrion. Accelerated metabolic processes ensure sufficient ATP and metabolic
intermediaries that are essential for macromolecule biosynthesis compatible with the
demands of cell growth and proliferation (Anderson et al., 2007). When exploring
possible links between mitochondrial physiology and tumor cell maintenance, Fatin and
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colleagues have proposed lower oxidative phosphorylation processes are characteristic of
carcinoma cells and are thought to result from dissemination of the mitochondrial proton
gradient and resulting general inability of tumor cells to use mitochondria to meet their
energetic needs (Fatin et al., 2006). It is therefore exciting to note that enriched
mitochondrial processes not only make sense from a cellular proliferation standpoint, but
also hold potential as a factor influencing the association of parity and protection against
breast cancer. Although outside the scope of this global transcriptomic analysis, future
efforts should be focused on the expression levels of individual mitochondrial gene
products to further understand the cellular mechanisms occurring within MEC in
preparation for milk synthesis and parity-induced protection.
Interestingly, the glutathione metabolic process was identified as an up-regulated
biological objective in pregnant MEC relative to virgin MEC. Although glutathione is
not coded for by a gene, it is an antioxidant associated with lactation as its deregulation
has been documented in various pathologies (Zaragoza et al., 2015). Further
investigation found that glutathione utilization is understood to play an indirect role in
protein synthesis within MEC, and its decrease leads to apoptosis and involution of the
mammary gland (Zaragoza et al., 2003). Glutathione is thought to be initially hydrolyzed
extracellularly and further hydrolyzed intracellularly by nonspecific peptidases. The
resulting constituents are then available for either synthesis of milk proteins or resynthesis into intracellular glutathione (Baumrucker, 1985). Although glutathione is just
one antioxidant influencing amino acid abundance, the availability of those amino acids
within MEC is regarded as the limiting factor in the synthesis and secretion of milk
proteins (Boisgard et al., 2001). Subsequent research regarding the specific mechanisms
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through which the glutathione metabolism influences the lactational capacity would
therefore prove informative.
That pathways indicative of cellular proliferation were differentially up-regulated
from the virgin-to-pregnant developmental comparison was expected, as the alveolar
morphogenesis observed during pregnancy is orchestrated by progesterone (P) and
prolactin (PRL) and marked by functional differentiation and proliferation. However,
that Wnt4 and RankL signaling pathways specifically were not detected by KEGG in this
developmental comparison was surprising, as they have been previously proposed to
serve as the progesterone-induced mediators of alveolar differentiation (Oakes et al.,
2006; Tanos et al., 2013). MEC were isolated from pregnant mice on day 10 of
pregnancy, at which point pathways of the ribosome, splicosome, and proteasome were
identified as those enriched in the virgin-to-pregnant developmental comparison. A
possible explanation for this observation could be that the hormonal regulation of Wnt4
and RankL signaling pathways has already occurred by day 10 of pregnancy, resulting in
those enriched pathways indicative of differentiation and proliferation.
The synthesis of proteins is important not only for proper cell function and
survival but is also responsible for the generation of those secreted in the milk. Through
the use of genetic information carried by RNA molecules, ribosomes execute the
synthesis of proteins (Bionaz and Loor, 2011; Alberts et al., 2008). In contrast, the
proteasome is a complex containing proteases that serve to degrade unneeded or damaged
proteins tagged by ubiquitin (Alberts et al., 2008). Utilizing a microarray approach to
study gene expression in murine mammary glands during day 12 of pregnancy, Rudolph
and colleagues found that while milk protein gene expression increased throughout
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pregnancy, proteasomal gene expression correspondingly declined (Rudolph et al., 2003).
Rudolph and colleagues proposed this decrease in proteasomal expression is a functional
adaptation to conserve biosynthetic processes activated during lactation. Although the
current RNA sequencing experiment found pathways of the proteasome up-regulated in
MEC isolated from mice at day 10 of pregnancy compared to MEC isolated from virgin
mice, perhaps this phenomenon is explained by the timing-specific transition into
lactation initiated by P withdrawal in the presence of PRL and glucocorticoid (Anderson
et al., 2007). Specific to murine mammary glands, PRL rapidly spikes as P decreases just
prior to parturition (Neville et al., 2002). Thus, future efforts to better understand the
molecular mechanisms of protein synthesis, degradation, and their influence within
bovine MEC hold potential for capitalization on milk production in the dairy industry.
Still considering the virgin-to-pregnant developmental comparison, it is intriguing
to note that cellular components such as the lysosome were not found to be similarly upregulated within this developmental comparison, and yet pathways pertaining to the
lysosme and ribosome were. While lysosomes are known to be involved in involution of
the mammary gland, only recently have they been observed to be upregulated during
lactation (Zhou et al., 2014). With the enriched pathways of the lysosome in mind,
perhaps the mediators and inhibitors of the lysosome itself would be of clinical interest in
future applications specific to the lactational capacity of the mammary gland.
Furthermore, lysosomal proteins have been previously found to be activated during
lactation and involution, suggesting that their function and dysfunction might also
influence the prevalence of breast cancer (Boya, 2012).
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Of those genes detected as being differentially down-regulated from the virgin-topregnant developmental comparison, KEGG analysis identified the biological theme of
decreased cell-cell communication and interaction. Signaling and communicative
pathways such as the TNF, Ras, MAPK, Rap1, Jak-STAT, cytokine-cytokine receptor
interaction, focal adhesion, and ABC transporters were all depicted as being downregulated (Table 7). Specific to these pathways, GO analysis for cellular component
strongly identified the cell surface, cell membrane, and extracellular space as the
locations where gene products were down-regulated in pregnant MEC relative to virgin
MEC. GO analysis for molecular function and biological process likewise identified an
observed decrease in immune response, cell adhesion, receptor binding, cell migration,
and the transmembrane movement of substances (Table 6).
That a decrease in cellular communication was observed is surprising considering
several prior in vitro experiments on the development and differentiation of the mammary
gland. In their study of gap junctional communication in the CID-9 mammary cell line,
El-Sabban and colleagues demonstrated the importance of cell-cell communication in
mammary epithelial differentiation, where interactions with the ECM alone were unable
to induce a differentiated phenotype (El-Sabban, 2003). A similar dependence on
established cell-cell communication for optimal differentiation has also been described in
the cell lines of epidermal cells (Alford and Rannels, 2001), lung alveolar cells (Alford
and Rannels, 2001), and osteoblasts (Romanello et al., 2001). Studies within the
MC3T3-E1 cell line likewise have shown that intercellular communication is integral to
the development and differentiation of the mammary gland (McLachlan et al., 2007).
Considering the current experiment utilized uncultured primary cells, perhaps the
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observed decrease in cellular communicative and interactive GO and KEGG terms
highlights the idea that cellular communication may not be essential at all stages of MEC
development. Further analysis on additional interactive and signaling mechanisms such
as integrins and/or connexins is needed to determine if they compensate during this
observed down-regulated phenomenon.
In contrast, the observed decrease in immune response is in agreement with
analyses on both murine and bovine mammary gland development (Mowry et al., 2017;
Mallard et al., 1998). While the increased metabolic demands within MEC is thought to
partition energy resources that functionally enhance potential milk production, it does so
by reducing those demands of immune responsiveness (Mowry et al., 2017). Pregnancy
is typically characterized by an immune-tolerant microenvironment, and secretion of
extracellular vesicles with immunosuppressant activities is increased in the pregnant state
(Becker et al., 2016). Considering the immune response functions to provide a defense
against invading pathogenic organisms, understanding the impact and influence of its
down-regulation is therefore of economic relevance for future implications within the
dairy industry. Mastitis often manifests during lactation and early involution, following
the failure of macrophages to phagocytize the debris collected in the vasculature
enveloping the alveolar secretory units. Specific to the bovine mammary gland, the
prevalence of mastitis has numerous negative implications, including but not limited to
reduced milk yield, increased antibiotic use, and premature culling (Pai and Horseman,
2011). In a microarray study by Clarkson and colleagues, gene expression profiling on
murine mammary tissue found that the majority of those genes differentially detected
following involution were also differentially detected during pregnancy (Clarkson et al.,
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2003). Thus, the immune response observed during pregnancy is influential upon the
susceptibility to mastitis during lactation, and the mechanisms through which MEC
govern this biological process holds potential for selection strategies that best support
initial mammary gland development and subsequent milk production.
In summary, pregnancy is the developmental stage that enhances the lactational
capacity. Development of the mammary gland during pregnancy occurs in two distinct
phases—proliferation then differentiation. Taken together, these analyses identified
significant differences in the functions performed by those genes with down- and upregulated expression from the virgin-to-pregnant comparison of isolated MEC. Genes
involved in cell-cell communication and interaction showed a decrease in expression in
the pregnant state compared to that of the virgin. Yet for the same developmental
comparison genes involved in metabolism and proliferation showed an increase in
expression. This indicates that half-way through pregnancy, MEC are enhancing their
mitochondrial functioning for energy production in preparation for milk synthesis and
lactation, with differentiation and formation of the alveolus not yet occurring. The
economic implications of mammary gland development and subsequent milk
development would thus benefit from future studies restricted to those molecular systems
that enhance mitochondrial processes, amino acid availability and utilization, ribosomal
functioning, cellular communication, and the immune response within MEC.

Virgin vs. Post-Lactational Quiescent Comparison
Following the completion of lactation, involution is an essential process that
returns the mammary gland to its pre-pregnant state. The morphology of the post-
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involutional mammary gland is similar to that of the virgin mammary gland, marked by a
rudimentary ductal branching network (Pai and Horseman, 2011). Characteristic to
involution, the cellular quiescence following lactation is a physiological state distinct
from senescence, as the proliferative arrest is reversible in the former yet irreversible in
the latter. The mammary gland remains dormant until the hormonal cues of pregnancy
promote differentiation to reestablish the lactogenic alveoli in preparation for subsequent
pregnancies (Harmes and DiRenzo, 2009). Of those genes detected as being
differentially up-regulated from the virgin-to-post-involutional quiescent developmental
comparison, KEGG analysis strongly identified pathways of the ribosome as being
enriched, simply identified by those of the ribosome (Table 7).
Considering this specific ribosomal pathway, GO analysis for cellular component
expectedly identified the ribosome as the location where gene products were up-regulated
in quiescent MEC relative to virgin MEC. GO analysis for molecular function identified
structural constituent of the ribosome as the activity of gene products up-regulated in
quiescent MEC relative to virgin MEC. GO analysis for biological process likewise
identified translation, rRNA processing, ribosomal large unit assembly, and ribosomal
small unit assembly as biological entities up-regulated in post-involutional MEC relative
to virgin MEC (Table 6).
These GO and KEGG results strongly indicate an extra-ribosomal function of the
ribosome as a whole. Several hallmarks of cancer have been discussed in Chapter 1,
including a self-sufficiency in growth signals, insensitivity to anti-proliferative signals,
avoidance of apoptosis, sustained angiogenesis, and tissue invasion and metastasis
(Hanahan and Weinberg, 2000). As an example, cancerous cells are able to avoid
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apoptosis, aiding their survival and proliferation. Tumorigenesis has been associated
with alterations in the molecular mechanisms of the ribosome, where either the over- or
under-expression of specific ribosomal proteins can impart ribosomal instability, cause
nuclear stress, and ultimately have an effect on various oncogenes. For example, the
ribosomal proteins RPL5, RPL23, and RPS7 have been shown to bind to MDM2, thereby
blocking the degradation of p53 (Shenoy et al., 2012). As previously discussed in
Chapter 1, p53 translocates from the cytoplasm into the nucleus following
phosphorylation, stimulating the transcription of components for CDK inhibitors and
halting the progression through the cell cycle. While cancerous cells are able to avoid
apoptosis, increased expression of certain ribosomal proteins promote the extra-ribosomal
functions of DNA repair and cellular homeostasis (Warner and McIntosh, 2009). Perhaps
these post-involutional analyses exemplify the increased surveillance and monitoring
capabilities of the primiparous cells of the mammary gland.
Of those genes detected as being differentially down-regulated from the virgin-topost-involutional quiescent developmental comparison, KEGG analysis identified two
encompassing biological themes. First, there was decreased protease activity, marked by
the down-regulated pathways pertaining to focal adhesion. Second, various cancerous
pathways were likewise depicted as being down-regulated, as identified by those of
proteoglycans in cancer, pathways in cancer, Wnt signaling pathway, and mTOR
signaling pathway (Table 7).
Considering the pathways pertaining to protease activity, GO analysis for cellular
component identified the extracellular exosome and cell-cell adherens junction as the
locations where gene products were down-regulated in quiescent MEC relative to virgin
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MEC. GO analysis for molecular function identified protein binding and kinase activity
as the activities of gene products down-regulated in quiescent MEC relative to virgin
MEC. GO analysis for biological process likewise identified positive regulation of cell
migration and cell adhesion as biological entities down-regulated in post-involutional
MEC relative to virgin MEC. Considering those pathways pertaining to cancer, GO
analysis for cellular component identified the cytoplasm as the location where gene
products were down-regulated in quiescent MEC relative to virgin MEC. GO analysis
for molecular function identified Wnt-protein binding as the activity of gene products
down-regulated in quiescent MEC relative to virgin MEC. GO analysis for biological
process likewise identified Wnt signaling as the biological objectives that are downregulated in post-involutional MEC relative to virgin MEC (Table 6).
Through catabolic hydrolysis of peptide bonds, proteases enzymatically break
down proteins and peptides. Normally cells are tethered to the ECM and to other cells by
integrins and CAMs, respectively. However, when cancer cells alter these interactions,
they often exhibit an increased transcription of extracellular protease genes concomitant
with a decreased transcription of protease inhibitor genes (Alberts et al., 2008; Hanahan
and Weinberg, 2000). Proteases degrade the surrounding matrix, thereby facilitating the
invasion of cancerous cells into the stroma or blood supply. Invasive and metastatic
capabilities result from the up-regulation of protease genes and down-regulation of
protease inhibitors (Hanahan and Weinberg, 2000). Therefore, the decreased expression
of protease genes observed in this global transcriptomic analysis holds potential as a
factor influencing the association of parity and protection against breast cancer.
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Proteases provide cancer a means through which they are able to break through
the ECM and invade into other tissues. In in vitro studies, expression levels of proteaseactivated receptors (PAR) have previously been found to correlate with the degree of
invasiveness in established cancer cell lines. In their study of PAR2, Morris and
colleagues analyzed the signaling, migration, and invasion tendencies of these G-protein
coupled receptors within MDA-MB-231 and BT549 human breast cancer cell lines.
When cultured in NIH 3T3 fibroblast conditioned medium, depletion of PAR2 protein
significantly reduced MDA-MB-231 and BT549 cell migration and invasion, suggesting
PAR is a critical mediator of breast cancer tissue invasion and metastasis (Morris et at.,
2006). However, the mechanism through which PAR2 promotes breast cancer cell
migration and invasion is poorly understood, as whether PAR2 regulates effectors of
malignant progression in cancer cells, such as Ras- and Rho-GTPases, has not been
determined (Morris et at., 2006). Similarly, in their study on the activation of PAR1 in
MCF7 and MDA-MB-231 human breast cancer cell lines, Kamath and colleagues
determined that breast cancer cells express high levels of PAR1 (Kamath et al, 2001). In
vitro studies by Yang et al. likewise found that ectopic expression of PAR1 induced an
invasive phenotype representative of basal-like carcinoma that readily formed lesions in
the lungs of mice (Yang et al., 2015). Interestingly, both findings suggest therapeutics
targeted toward Gi/PI(3)kinase-dependent pathways expressed in breast cancers might
prove beneficial in inhibiting the progression of tissue invasion and metastasis (Kamath
et al., 2001; Yang et al, 2015). Simultaneously considering the decreased protease gene
expression observed in this current study, these findings collaboratively highlight a need
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for additional in vivo experiments centered on the specific signaling pathways through
which proteases influence the invasiveness of breast cancer.
The extracellular exosome was identified as a location where gene products were
down-regulated in quiescent MEC relative to virgin MEC. Functioning through
exocytosis, exosomes transfer various components such as bioactive molecules, proteins,
and lipids, thereby mediating communication between cells (Becker et al., 2016; Simons
and Raposo, 2009). While exosomes have been found to support the development and
involution of the mammary gland, their biological activities have likewise been observed
to contribute to patho-physiological processes, thereby mediating oncogenic signaling
between cancer cells (Hendrix and Hume, 2011). Exosomes have consequently been
proposed as viable biomarkers and therapeutic targets in both physiological and
pathological processes (Simons and Raposos, 2009).
Recent studies have indicated a role for angiogenic signaling promoted by
exosomes originating from hypoxic cancer cell. Sustained angiogenesis is an acquired
capability that supports the abnormal metabolic needs of cancerous cells. Under hypoxic
conditions, cancer cells secrete exosomes that modulate their local environment to
facilitate tumor angiogenesis and maintain communication to metastatic sites (Hendrix
and Hume, 2011; King et al, 2012). In their in vitro studies utilizing MCF7, SKBR3, and
MDA-MB 231 breast cancer cell lines cultured under either moderate (1% O2) or severe
(0.1% O2) hypoxia, King and colleagues isolated and quantitatively analyzed exosomes
utilizing immunoblotting and qPCR techniques. All three cell lines showed a significant
increase in the number of exosomes present in the hypoxic environment. Additionally,
exosomes were observed to be released extracellularly when treated with
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dimethyloxalylglycine (DMOG), a HIF hydrolase inhibitor, however transfection of cells
with HIF-1asiRNA prior to hypoxic exposure prevented the hypoxic-induced exosome
release (King et al., 2012). These findings provide evidence that hypoxia promotes the
release of exosomes by breast cancer cells, and that this response may be mediated by
HIF-1a. As cancer cells proliferate expression of HIF-1a is increased to promote the
transcription of pro-angiogenic factors for the purpose of vascular development. That the
extracellular exosome was found to be downregulated in the present global
transcriptomic analysis holds potential as yet another factor influencing the association of
parity and protection against breast cancer, however further investigations are needed to
explore exosome biogenesis, release, and the mechanisms through these events are
mediated (Becker et al., 2016; Hendrix and Hume, 2011).
The culmination of these ribosomal, proteasomal, and exosomal findings indicates
an overall decrease in those factors influencing the development of cancer. Excitingly,
this is supported by the observation that several pathways of cancer were likewise
depicted as being down-regulated from the virgin-to-post-involutional quiescent
developmental comparison.
Proteoglycans are glycosylated proteins that interact with growth factors, growth
factor receptors, and cytokines in the ECM to influence the extracellular environment and
govern cellular movement. Their effects have been observed in repair of the CNS,
wound healing, and cell motility. As with most cellular factors previously discussed, this
happens in both physiological and pathological states (Cattaruzza and Perris, 2005). For
example, activated stromal and tumor cells secrete effectors that promote the
reorganization of the ECM to facilitate tumor cell growth, migration, and invasion
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(Theocharis et al., 2010). Specific proteoglycans such as decorin and syndecan-1 have
previously been studied, and curiously influence different oncogenic environments. For
example, syndecans are known to interact with integrins, promoting cell adhesion and
migration. Syndican-1 expression by fibroblasts is thought to promote tumorigenesis by
regulating tumor cell adhesion, proliferation, and angiogenesis (Theocharis et al., 2010).
Conversely, low expression of decorin has prognostic significance in that it is associated
with lower survival rates among female humans diagnosed with certain types of breast
cancer (Troup et al., 2003) while administration of decorin can reduce breast cancer
tumor growth and metabolism (Theocharis et al., 2010). Proteoglycans thus hold
potential as mediators in pharmacological targets that modulate tumor progression.
Wnt signaling regulates numerous cellular processes such as cell fate and
proliferation and is strongly established as an oncogenic factor in the murine mammary
gland (Ayyanan et al., 2006; Howe and Brown, 2004; Klarmann et al., 2008). That
pathways, biological processes, and molecular functioning of Wnt signaling were
differentially down-regulated from the virgin-to-quiescent developmental comparison are
not surprising from a biological standpoint and are in agreement with studies indicating
either a genetically- or epigenetically-influenced disregulation of these controlling
mechanisms contribute to breast cancer development (Karlmann et al., 2008). Wnt
signaling is initiated by the interaction of a Wnt ligand and a Frizzled-related protein
receptor that subsequently leads to the stabilization of β-catenin, permitting β-catenin to
translocate into the nucleus and induce transcription. In the absence of Wnt signaling, the
downstream effects of β-catenin are kept in check and targeted for degradation via
phosphorylation (Ayyanan et al., 2006). As such, disregulation of the Wnt signaling
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pathway has drastic implications in cancer development (Ayyanan et al., 2006; Karlmann
et al., 2008). A wide range of cancers displays mutations in β-catenin, rendering them
resistant to phosphorylation, however the opposite is true in breast cancer. For example,
although β-catenin has been found to be upregulated in over forty percent of human
breast cancers, transgenic expression of stabilized β-catenin in murine mammary tissues
results in tumor development. (Ayyanan et al., 2006). Furthermore, the loss of Wnt
ligand antagonists lead to hyperactive Wnt signaling, thereby promoting tumorigenesis in
human mammary tissues (Howe and Brown, 2004). Regardless of all the studies
previously conducted concerning Wnt signaling and breast cancer development, much
remains to be learned regarding the tumor microenvironment and how paracrine factors
promote tumor propagation. Previous immunofluorescent studies concerning fibroblastsecreted exosomes suggest exosome-mediated Wnt signaling involvement in promoting
breast cancer cell motility and metastasis (Luga et al., 2012).
Similar to the observed Wnt signaling pathway results, the mTOR signaling
pathway was likewise differentially down-regulated from the virgin-to-quiescent
developmental comparison. Utilizing immunoblotting techniques on MCF7 and T47D
human breast carcinoma cell lines, Boulay and colleagues demonstrated cellular
proliferation was dependent on mTOR signaling (Boulay et al., 2018). Additionally,
phosphatase and tensin homolog (PTEN) has been proposed as a negative regulator of the
PI3K/mTOR/STAT3 signaling pathway. When NOD/SCID mice were inoculated with
MCF7 cells overexpressing PTEN, tumorigenicity was markedly decreased compared to
control mice (Zhou et al., 2007). Curious to note considering the up-regulated pathways
of the ribosome discussed above, when in the presence of mitogenic stimuli and sufficient
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nutritional requirements, mTOR relays a positive signal translational signal by activating
the 40S ribosomal protein S6 kinase (Boulay et al., 2018). Perhaps the parity-induced
increased stability of the ribosome contributes to extra-ribosomal functions such as
mTOR regulation, ultimately promoting cellular homeostasis and the suppression of
oncogenesis. The decrease in mTOR signaling observed in the current global
transcriptonic analysis is thus in agreement with studies indicating its regulation is
essential to tumor suppression.
Taken together, these analyses identified significant differences in the functions
performed by those genes with down- and up-regulated expression from the virgin-topregnant comparison and from the virgin-to-post-lactational quiescent comparison of
isolated MEC. Genes involved in several pathways influencing cell-cell communication
and interaction showed a decrease in expression in the pregnant state compared to the
virgin developmental state. Yet for the same developmental comparison genes involved
in metabolism and proliferation showed an increase in expression, each with unique
implications not only in milk production as it would relate to the dairy industry but also
in future breast cancer studies. Genes involved in several pathways leading to cancer
showed a decrease in expression in the quiescent state compared to that of the virgin
developmental state. Yet for the same developmental comparison genes involved in the
ribosome, its integrity, and its functioning showed an increase in expression. Recently,
individual ribosomal proteins have been highlighted as having extra-ribosomal functions
such as DNA repair, regulation of apoptosis, and autoregulation of ribosomal protein
synthesis while disorders resulting from impaired ribosome biogenesis and function have
been shown to be oncogenic and consequently detrimental to cellular homeostais (Shenoy
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et al., 2012; Warner and McIntosh, 2009). This indicates that perhaps the association of
parity and protection against breast cancer are related to the ribosome and perhaps the
association of risk for breast cancer is related to ribosomalpathies.
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CHAPTER 4 – Comparison of Key Regulator Genes Affecting Developmental Stages in
Mice to Factors Identified from the Parallel Proteomic Analysis
4.1 Introduction
The central dogma of biology states that DNA is encoded into mRNA for the
production of proteins, the expression of which defines each cell (Pepke et al., 2009).
RNA therefore influences the present and future activities of a cell and serves as the
intermediary regulator between genotype and phenotype (Marguerat and Bahler, 2010;
Mortazavi et al., 2008). Traditionally, mRNA concentrations have been used as proxies
for the corresponding protein concentrations and activities (Gunawardana and Niranjan,
2013). However, this relationship in expression is not exact. The Pearson correlation
coefficient from previous parallel transcriptomic and proteomic analyses range from 0.46
to 0.76, meaning approximately forty-six to seventy-six percent of the variation in protein
abundance can be explained by knowing the mRNA abundance (Hack 2004; Vogel and
Marcotte, 2012). Furthermore, while these correlation analyses have been studied in
yeast and plant samples, the relationship has not been considered extensively in
mammalian samples (Ghazalpour et al., 2011; Li et al., 2014).
Protein abundances are influenced primarily by four regulatory events: the rate at
which genes are transcribed, the rate at which RNA is degraded, the rate at which
proteins are translated, and the rate at which proteins are degraded. While the former two
affect RNA abundance, the latter two affect the difference between RNA and protein
abundance (Li et al., 2014). Synthesis of RNA itself is tightly controlled, yet through the
actions of modifiers such as microRNA and binding proteins, transcript abundance is
pliant and allows a cell to adapt rapidly to environmental or genetic changes (Vogel and
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Marcotte, 2012; Marguerat and Bahler, 2010). The stability of proteins following
translation depends on their biological role, where regulatory proteins that react to
various stimuli are synthesized and degraded rapidly in contrast to structural proteins that
are degraded less rapidly. However, considerable work remains to be accomplished for
better understanding the molecular kinetics of transcription and translation (Vogel and
Marcotte, 2012).
The regulation of gene expression is fundamental to the relationship between
genotype and phenotype. Unfortunately, system based approaches have traditionally
relied heavily on the interpretation of transcriptomic data for insight into cell physiology
and pathology (Ghazalpour et al., 2011). The varying methods through which the
transcriptome may be analyzed have been previously discussed. Various methods
likewise exist through which the proteome may be analyzed, including isotope-coded
affinity tag (ICAT), stable isotope labeling with amino acids in cell culture (SILAC),
large-scale western blotting, multi-dimensional protein identification technology
(MudPIT), and two-dimensional gel electrophoresis (2-DE) (Hack, 2004; Chandramouli
and Qian, 2009). Although labor-intensive and mechanical in nature, 2-DE remains the
primary method for separating proteins thanks in part to technical advances including the
availability of pre-cast polyacrylamide gels and improvements in pH gradient strips
(Hack, 2004). Specifically this method separates extracted proteins first by molecular
charge and then by size. Following protein separation and gel analysis, mass
spectrometry technologies such as mass-adsorption laser deionization time-of-flight
(MALDI-TOF) provide a method through which peptide sequences can be detected for
protein identification (Chandramouli and Qian, 2009). Interpretation of the spectra
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results thus generated is likewise dependent upon bioinformatics for the integration of
experimental data with software programs and databases to allow for the illustration of
the underlying molecular dynamics (Kitano, 2002).
In this experiment, results from the transcriptomic and proteomic global profiling
of isolated MEC at key developmental stages are explored. Significant to the “-omics”
experimental design was the use of the same sample source across all developmental
comparisons. Thus, for every isolated MEC sample being considered, RNA and protein
were extracted in parallel, with the subsequent differential analyses highlighting the
respective transcriptomic and proteomic molecular mechanisms influencing mammary
gland physiology and pathology. While this approach not only allowed for the
comparison of two differing means of analyzing the molecular phenotype, it is also a
novel joint approach unique to mammary gland development that has not yet been
previously reported.

4.2 Methods
4.2.1 Proteomic Analysis of Isolated Primary Virgin, Pregnant, and Post-Involutional
Quiescent Mammary Epithelial Cells
All procedures were performed as specified in Conly 2014 (see Appendix C).

4.2.2 Comparison of Proteomic Results to Identified Key Regulator Genes Affecting
Developmental Stages in Mice
For every differentially detected protein identified between the down- and upregulated virgin and pregnant protein sets and between the down- and up-regulated virgin
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and post-involutional quiescent protein sets by Conly 2014, the corresponding transcript
was assessed for detection and fold change as identified by the CLC Genomics
Workbench.

4.3 Results
Of the 31 protein spots differentially detected between the virgin and pregnant
samples, 28 were down-regulated while the remaining 3 were up-regulated (p < 0.02). Of
those proteins, 29 were detected as being expressed in the transcriptomic analysis (93.5%
similarity), but only 6 of those 29 were differentially expressed (19.6% similarity
detected proteins, 19.4% total proteins). Furthermore, differences existed in the direction
of fold change. For these protein-gene pairs that were dually differentially detected, 1
agreed in the direction of change (16.7% agreement), with the other 5 showing a fold
change in the opposite direction (83.3% disagreement). Of the 36 protein spots
differentially detected between the virgin and post-involutional quiescent samples, 31
were down-regulated while the remaining 5 were up-regulated (p < 0.02). Of those
proteins, 34 were detected as being expressed in the transcriptomic analysis (94.4%
similarity), but only 7 of those 34 were differentially expressed (20.6% similarity
detected proteins, 19.4% total proteins). Again, differences existed in the direction of
fold change. For these protein-gene pairs that were dually differentially detected, 1
agreed in the direction of change (14.3% similarity), with the other 6 showing a fold
change in the opposite direction (85.7% disagreement). The magnitude of change
detected by both the proteomic and transcriptomic analyses have been listed (Tables 7
and 8).
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Table 7: Fold Change Expression Values of Transcripts Corresponding to Differentially Detected
Proteins in the Pregnant State Compared to the Virgin State Originating from Proteomic Analysis of
Isolated MEC
Protein and RNA were extracted in parallel from all isolated murine MEC. For every previously identified
differentially detected down- and up-regulated protein and that protein’s detected fold change, the
magnitude of fold change was identified for every corresponding gene according to the CLC Genomics
Workbench. Detections of down-regulation from the virgin to the pregnant state are depicted in red,
detections of up-regulation from the virgin to the pregnant state are depicted in green. If the detection in
the transcriptomic analysis was not significant, those numbers were not color-coded, although the direction
is indicated by the presence or absence of a negative (-) symbol.

Gene Symbol
Acadl
Acads
Acat1
Aco2
Aco2

Protein Name
Long-chain specific acylCoA dehydrogenase,
mitochondrial precursor
Short-chain specific acylCoA dehydrogenase
Acetyl-CoA transferase,
mitochondrial precursor
Aconitate hydratase,
mitochondrial precursor
Aconitate hydratase,
mitochondrial precursor

Ensembl Gene ID

Proteomic
Fold
Change

CLC Genomics
Workbench
(p-value)

ENSMUSG00000026003

1.65

1.57
(0.033)

ENSMUSG00000029545

-0.75

ENSMUSG00000032047

-0.71

ENSMUSG00000022477

-0.66

ENSMUSG00000022477

-0.56

1.77
(0.112)
1.68
(0.110)
1.06
(0.453)
1.06
(0.456)
-1.04
(0.775)
N/A
N/A

Afp

Alpha-fetoprotein, partial

ENSMUSG00000054932

-0.58

Alb
Alb

Serum albumin
Serum albumin
Fructose-bisphophate
aldolase A isoform
precursor

ENSMUSG00000029368
ENSMUSG00000029368

-0.53
-0.52

ENSMUSG00000030695

-0.68

1.09
(0.240)

Catalase

ENSMUSG00000027187

-0.47

1.20
(0.457)

ENSMUSG00000032314

-0.46

1.38
(0.047)

ENSMUSG00000057666

-0.64

ENSMUSG00000015656

3.74

ENSMUSG00000091971

-0.40

Aldoa
Cat
Etfa
Gapdh
Hspa8
Hspa1a

Electron transfer
flavoprotein subunit alpha,
mitochondrial
Glyceraldehydes-3phosphate dehydrogenase
Heat shock protein 70
cognate
Heat shock protein 1A
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-1.24
(0.339)
-1.23
(0.244)
-1.34
(0.440)

Ighvdj
Krt1
Krt16
Krt19
Lasp1
Lmna

Immunoglobulin heavy
chain variable region
Keratin, type II
cytoskeletal 1
Keratin, type I cytoskeletal
16
Keratin, type I cytoskeletal
19
LIM and SH3 domain
protein 1
Prelamin-A/C isoform A
precursor

ENSMUSG00000096767

-0.73

ENSMUSG00000046834

-0.35

ENSMUSG00000053797

-0.59

ENSMUSG00000020911

1.39

ENSMUSG00000038366

-0.63

ENSMUSG00000028063

-0.49

Lmnb1

Lamin-B1

ENSMUSG00000024590

-0.69

Mdh2

Malate dehydrogenase

ENSMUSG00000019179

-0.55

ENSMUSG00000055044

-0.56

ENSMUSG00000066366

-0.53

ENSMUSG00000066366

-0.50

ENSMUSG00000066366

-0.41

Pdlim1
SERPINA1
SERPINA1
SERPINA1

PDZ and LIM domain
protein 1
Alpha-1-antiproteinase
precursor
Alpha-1-antiproteinase
precursor
Alpha-1-antiproteinase
precursor

Tf

Serotransferrin precursor

ENSMUSG00000032554

-0.46

Tkt

Transketolase

ENSMUSG00000021957

-0.79

ENSMUSG00000005981

-0.56

ENSMUSG00000073838

-0.72

ENSMUSG00000021771

-0.64

Trap1
Tufm
Vdac2

Heat shock protein 75 kDa,
mitochondrial
Elongation factor Tu,
mitochondrial isoform 2
Voltage-dependent anion
channel 2
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2.76
(0.288)
-5.64
(0.0051)
1.43
(0.281)
1.41
(0.245)
1.33
(0.327)
-1.06
(0.193)
1.24
(0.067)
1.21
(0.036)
-1.16
(0.472)
-8.76
(0.103)
-8.76
(0.103)
-8.76
(0.103)
1.16
(0.646)
0.63
(0.004)
1.24
(0.104)
0.16
(0.039)
1.48
(0.006)

Table 8: Fold Change Expression Values of Transcripts Corresponding to Differentially Detected
Proteins in the Post-Involutional Quiescent State Compared to the Virgin State Originating from
Proteomic Analysis of Isolated MEC
Protein and RNA were extracted in parallel from all isolated murine MEC. For every previously identified
differentially detected down- and up-regulated protein and that protein’s detected fold change, the
magnitude of fold change was identified for every corresponding gene according to the CLC Genomics
Workbench. Detections of down-regulation from the virgin to the pregnant state are depicted in red,
detections of up-regulation from the virgin to the pregnant state are depicted in green. If the detection in
the transcriptomic analysis was not significant, those numbers were not color-coded, although the direction
is indicated by the presence or absence of a negative (-) symbol.

Gene Symbol
Acads
Aco2

Protein Name
Short-chain specific acylCoA dehydrogenase
Aconitate hydratase,
mitochondrial precursor

Ensembl Gene ID

Proteomic
Fold
Change

CLC Genomics
Workbench
(p-value)

ENSMUSG00000029545

-0.63

N/A

ENSMUSG00000022477

-0.61

Actb

Actin, cytoplasmic 1

ENSMUSG00000029580

2.34

Actb

Actin, cytoplasmic 1

ENSMUSG00000029580

1.47

Afp

Alpha-fetoprotein, partial

ENSMUSG00000054932

-0.60

Alb

Serum albumin
Aldehyde dehydrogenase,
mitochondrial precursor
ATP synthase subunit beta,
mitochondrial precursor
Cell division control
protein homolog 42
Dihydrolipoamide
dehydrogenase precursor

ENSMUSG00000029368

-0.60

ENSMUSG00000029455

-0.48

ENSMUSG00000025393

-0.55

ENSMUSG00000006699

-0.36

ENSMUSG00000020664

-0.46

Elongation factor 1-gamma

ENSMUSG00000071644

-0.42

ENSMUSG00000032314

1.12

ENSMUSG00000026526

-0.81

ENSMUSG00000007850

-0.57

ENSMUSG00000059005

-0.55

Aldh2
Atp5b
CDC42
DLD
Eef1g
Etfa
Fh
Hnrnph1
Hnrnpa3

Electron transfer
flavoprotein subunit alpha,
mitochondrial
Fumarate hydratase,
mitochondrial precursor
Heterogeneous nuclear
ribonuclearprotein H
Heterogeneous nuclear
ribonuclearprotein A3
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1.06
(0.456)
1.19
(0.415)
1.19
(0.415)
-1.04
(0.775)
N/A
-1.19
(0.116)
1.07
(0.291)
1.04
(0.212)
1.18
(0.119)
1.18
(0.016)
1.38
(0.047)
1.05
(0.516)
1.00
(0.899)
-1.09
(0.276)

Hsp90ab1

Heat shock protein 84

ENSMUSG00000023944

-0.48

Hsp90b1

Endoplasmin

ENSMUSG00000020048

-0.42

ENSMUSG00000025980

-0.60

ENSMUSG00000015656

3.93

ENSMUSG00000096767

-0.60

ENSMUSG00000007670

-0.65

ENSMUSG00000046834

-0.59

ENSMUSG00000053797

-0.51

ENSMUSG00000020911

1.87

ENSMUSG00000028063

-0.43

ENSMUSG00000055044

-0.55

ENSMUSG00000021577

-0.34

ENSMUSG00000066366

-0.72

ENSMUSG00000066366

-0.40

ENSMUSG00000066366

-0.33

Hspd1
Hspa8
Ighvdj
Khsrp
Krt1
Krt16
Krt19
Lmna
Pdlim1
Sdha
SERPINA1
SERPINA1
SERPINA1

60 kDa heat shock protein,
mitochondrial
Heat shock protein 70
cognate
Immunoglobulin heavy
chain variable region
Far upstream elementbinding protein 2
Keratin, type II
cytoskeletal 1
Keratin, type I cytoskeletal
16
Keratin, type I cytoskeletal
19
Prelamin-A/C isoform A
precursor
PDZ and LIM domain
protein 1
Succinate dehydrogenase
flavoprotein subunit
Alpha-1-antiproteinase
precursor
Alpha-1-antiproteinase
precursor
Alpha-1-antiproteinase
precursor

Tf

Serotransferrin precursor

ENSMUSG00000032554

-0.50

Tf

Serotransferrin precursor

ENSMUSG00000032554

-0.47

Tf

Serotransferrin precursor

ENSMUSG00000032554

-0.44

Tkt

Transketolase

ENSMUSG00000021957

-0.66

ENSMUSG00000073838

-0.45

ENSMUSG00000021771

-0.68

Tufm
Vdac2

Elongation factor Tu,
mitochondrial isoform 2
Voltage-dependent anion
channel 2

-1.01
(0.774)
1.12
(0.015)
1.33
(0.039)
-1.23
(0.244)
2.76
(0.288)
-1.01
(0.815)
-5.64
(0.051)
1.43
(0.281)
1.41
(0.245)
-1.06
(0.193)
-1.16
(0.472)
1.21
(0.257)
-8.76
(0.103)
-8.76
(0.103)
-8.76
(0.103)
1.16
(0.646)
1.16
(0.646)
1.16
(0.646)
1.64
(0.001)
1.19
(0.007)
1.48
(0.006)

4.4 Discussion
System-level research and advances in “-omic” technologies have enabled the
analyses of thousands of biomolecules simultaneously, providing a unique approach to
better understanding the biology of the organism of interest (Klopfleisch and Gruber,
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2012). Such global approaches are aimed at comprehensively illustrating the complex
molecular mechanisms underlying cell physiology and pathology. Traditionally,
transcriptomic results and analyses have been used as proxies for the corresponding
interpretation into protein concentrations and activities (Gunawardana and Niranjan,
2013). However, not only is this relationship in expression inexact, but it also has been
limited primarily to yeast and plant samples (Ghazalpour et al., 2011; Li et al., 2014).
The Peterson Lab’s comparative analyses of developmental stages in isolated
MEC have generated a relatively large transcriptomic data set and a relatively small
proteomic data set. Both data sets identify the names of either genes or proteins that are
differentially expressed between key developmental stages, the magnitude in fold change
of that differential expression, and the corresponding statistical significance. Unique to
this experiment, the analyses of the transcriptome and proteome were performed in
parallel, using the same sample source. This novel joint approach has allowed for an
exploration in the relationship of the governing transcriptomic and proteomic
mechanisms within isolated murine MEC, where the corresponding gene expression
profile was assessed for each previously identified differentially expressed protein.
As previously discussed, the transcriptomic analysis of mammary gland
development identified specific molecular mechanisms regulating cell metabolism,
communication, pathways of cancer, and ribosomal function. Although similar
inferences were made from the proteomic analysis between the nulliparous and
primiparous states, a greater abundance of proteins was detected in the virgin MEC
compared to both other developmental stages investigated. Specifically, the
identification of those proteins expressed differentially suggests a greater level of
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molecular activity in MEC isolated from the virgin mammary gland (Conly, 2014).
While the transciptomic and proteomic analyses were conducted in parallel from the
same sample course, it is interesting that distinct abundances of proteins yet somewhat
similar abundances of genes were detected as being differentially up- and down-regulated
across the developmental stages being compared.
There are several factors and variables to consider when comparing
transcriptomic and proteomic data. First, although a small proportion of proteins were
unable to be compared to their corresponding transcripts, this does not mean the
transcripts were absent within the isolated MEC. Rather, the differential analysis
performed by the software applications was unable to detect a difference in expression
between the two developmental states being considered. Second, although transcriptomic
technologies produce a greater amount high-throughput data compared to the limitations
in depth and coverage of proteomic technologies, each provides a necessary and unique
perspective for analyzing the molecular phenotype (Nagalakshmi, et al., 2010; Hegde et
al., 2003). Specific to the 2-DE methods utilized for the proteomic analysis, while the
data sets thus generated are not complete lists of all differential protein products
influencing MEC physiology and pathology, they nevertheless highlight those events
occurring and provide a framework for further exploration and validation (Conly, 2014).
Unfortunately, although 2-DE is extensively used for qualitative proteomic experiments,
the analysis of hydrophobic proteins remains a challenge unique to this approach due to
their poor solubility in aqueous buffers (Chandramouli and Qian, 2009). Third,
biological events and practical aspects may be accounted for in any observed differences
in detected abundances. For example, the diverse chemical nature of proteins compared
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to RNA is important to note, where global analyses are complicated by the various ways
the twenty different amino acids versus only the four nucleotide bases may be combined
(Hegde et al., 2003). Likewise, post-transcriptional and post-translational modifications
such as alternative splicing, polyadenylation, RNA degredation, allosteric protein
interactions, phosphorylation, glycosylation, and proteolysis affect transcript and protein
abundance, stability, and turnover (Vogel and Marcotte, 2012; Marguerat and Bahler,
2010). Fourth, many transcripts could have encoded for either relatively large, small, or
highly insoluble proteins that are difficult to detect and analyze through proteomic
technologies. For example, the transcriptomic analysis differentially detected an upregulation in transcripts corresponding to the whey acidic protein (Wap) gene in the
virgin-to-pregnant comparison (fold change = 129.14, p-value = 0.02); an up-regulation
in transcripts corresponding to the immunoglobulin kappa chain variable 8-30 (Igkv8-30)
gene in the virgin-to-post-involutional quiescent comparison (fold change = 96.34, pvalue = 0.01); and a down-regulation in transcripts corresponding to the fibrillin (Fnb2)
gene in the virgin-to-post-involutional quiescent comparison (fold change = -20.24, pvalue = 0.04); however none of these proteins were detected in the corresponding
proteomic analyses. That the proteins for which the former two genes encode are
relatively small at 14.423 kDa and 14.529 kDa, respectively, and that the protein for
which the latter gene encodes is relatively large at 313.818 kDa might explain the lack of
detection within the 2-DE analysis. Additionally, the RNA-seq technology utilized
sequenced single-ended reads as opposed sequencing reads in pairs. While paired-end
RNA-seq can help detect alignment errors and improve sequencing sensitivity and
specificity, such an experimental approach is necessary only when isoform annotation
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and exploration of the genetic architecture are the primary goals (Li and Homer, 2010).
As these were not the objectives of the previous comparative transcriptomic analyses
discussed, the approach did not consider isoform specific expression. Here, the inability
to measure isoform expression may be impacting the correlation between abundance
results for certain peptides that represent specific isoforms, however this cannot be
definitively stated (Ghazalpour et al., 2011). With these considerations in mind, the
observed lack of correlation between protein and transcript abundance in relation to those
of isolated virgin MEC can be explained by the technical differences in the methods
utilized and the various biological events and practical aspects that influence RNA
stability and the potential for protein degradation.
Of the 6 protein-gene pairs that were dually differentially detected in the virginto-pregnant developmental comparison, insights into the biological mechanisms of MEC
can be found by considering the functions of those identified proteins. For example,
transketolase (TKT) is a pentose-phosphate enzyme whose overexpression leads to
increased production of glyceraldehyde-3-phosphate for augmented fermentation of
glucose to lactate. In the histological analysis of breast cancer samples for transkelotaselike-1 (TKTL1), a mutated transkelotase enzyme, Foldi and colleagues demonstrated
TKTL1 is overexpressed in tumor cells yet treatment with specific transkelotase
inhibitors led to a reduction in tumor cell proliferation, indicating this enzyme holds
potential as a targeted biomarker for tumor growth maintenance (Foldi et al., 2006).
Another metabolic protein-gene pair identified in the present study is malate
dehydrogenase (MDH2), an enzyme that catalyzes the oxidation of malate to oxaloacetate
for the generation of NADPH. Both TKT and MDH2 were found to be down-regulated
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in the proteomic analysis of MEC in the pregnant state yet up-regulated in that of the
transcriptomic analysis. In a unique analysis of MALDI mass spectrometry of proteins
excised from gel spots of liver and mammary samples collected from lactating Friesian
cows, Rawson and colleagues found an overall greater abundance of both TKT and
MDH2 in the liver tissue compared to the mammary tissue. Findings from this proteomic
analysis supported the hypothesis that gluconeogenesis and β-oxidative pathways should
predominate in the liver during lactation while fat synthesis should predominate in the
mammary gland (Rawson et al., 2012). Although this was not a developmental
comparison on isolated MEC, and although drastic differences do exist in the regulatory
mechanisms between bovine and murine mammary glands, the proteomic findings by
Rawson and colleagues do emphasize the consideration of metabolic outputs of hepatic
and mammary tissues.
Voltage-dependent anion channel 2 (VDAC2) was likewise another protein-gene
pair identified in the present study. With the exception of a few membrane-permeable
lipophilic compounds, hydrophilic metabolites and respiratory substrates such as ATP,
ADP, and inorganic phosphate that enter and exit the mitochondria must pass through the
outer mitochondrial membrane through a VDAC. In addition to ATP generation during
oxidative phosphorylation, VDAC2 is significant in enhancing glycolysis for the
synthesis of lipids, proteins, and nucleotides (Maldonado et al., 2013). Recently, VDAC2
has also been shown to have inhibitory effects upon the Bak-mediated apoptotic response
as Bak is typically inactive when bound to VDAC2 and localized in the outer
mitochondrial membrane. When no longer sequestered to VDAC2, Bak is able to carry
out its pro-apoptotic functions, suggesting that in addition to its metabolic functions
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VDAC2 also plays a role in the regulation of controlled cell death and may serve as a
target for drug discovery (Chandra et al., 2005).
Still pertaining to metabolism, the electron transfer flavorprotein subunit alpha
(ETFA), together with the beta subunit, is localized within the mitochondrial matrix and
serves as an obligatory electron acceptor during fatty acid β-oxidation. This protein is
thought to be dependent upon GH signaling, as prior studies in GHR knockout mice
(GHR-/-) showed a notable reduction in ETFA content, granted these studies were
focused on the proteomic activity influencing murine lung development (Beyea et al.,
2006).
Long-chain specific acyl-CoA dehydrogenase (ACADL) was the only proteingene dually differentially detected in the virgin-to-pregnant developmental comparison
that agreed in the direction of fold change. Long-chain acyl-CoA esters not only serve as
important intermediates in lipid biosynthesis and fatty acid degradation but are also
known to regulate metabolism and gene expression (Faergeman and Knudsen, 1997).
Accordingly, the ACADL enzyme plays a pivotal role in lipogenesis within the
mammary gland. Through mitochondrial fatty acid β-oxidation and the degradation of
fatty acids of different chain lengths, each cycle of β-oxidation by ACADL generates a
two-carbon-chain shortened acyl-CoA and acetyl-CoA (Hunt and Alexson, 2002). These
newly formed fatty acid chains are esterified to a glycerol-3-phosphate backbone by the
actions of glycerol-3-phosphate acyl transferase and diacylglycerol acyltransferase
enzymes located on the endoplasmic reticulum, thereby completing the synthesis of
triacylglycerol (TAG) (Bernard et al., 2008). During lactation, individual TAG
molecules combine and incorporate themselves into cytoplasmic lipid droplets that are
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ultimately secreted in a membrane-enveloped lipid particle known as the milk fat globule
(MFG) (Neville and Picciano, 1997). Interestingly, studies on ACADL knockout mice
(ACADL-/-) have shown that decreased mitochondrial fatty acid oxidation results in an
increased content of intracellular diacylglycerol, the activation of protein kinase C
(PKC), and consequently decreased insulin signaling and action within hepatic and
skeletal muscle tissues (Zhang et al., 2007).
Taken together, the differences in the transcriptomic and proteomic expression
found in the pregnant state relative to the virgin state highlight a hormonal phenomenon
influencing the metabolic regulation of MEC. Analyses on murine mammary tissue
utilizing electron microscopy have not only shown that during pregnancy there is a
notable increase in the number of mitochondria per secretory cell but also an increase in
the activities of numerous mitochondrial enzymes, suggesting that the mitochondrial
activity within MEC is correlated to milk production (Hadsell et al., 2010). These
findings have similarly been noted in humans and dairy cows (Laubenthal et al., 2016).
The increased mitochondrial processes observed in the transcriptomic analyses of isolated
MEC in the pregnant state relative to the virgin were therefore to be expected and suggest
that half-way through pregnancy, MEC are enhancing their mitochondrial functioning for
energy production in preparation for milk synthesis and lactation. Yet curiously, the
overall trend noted from the proteomic analyses of MEC isolated in parallel was a
decrease in metabolic activity in the pregnant state of the cell. All proteins involved in
metabolic processes were downregulated in the pregnant state compared with the virgin
state, suggesting less energy generation is occurring in the pregnant state than the virgin
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state and perhaps that the differentiated state of the cell is more energy efficient (Conly,
2014).
Similarly, of the 7 protein-gene pairs that were dually differentially detected in
the virgin-to-post-involutional quiescent developmental comparison, biological
significance within MEC can be found by considering those functions of the identified
proteins. VDAC2, TKT, ETFA, and TUFM, which were all dully differentially detected
in the prior developmental comparison, were again dully detected in the primiparous
developmental comparison. Again, only one protein-gene pair dually differentially
detected in agreed in the direction of fold change, this time ETFA. Unique to the postinvolutional developmental comparison are 60 kDa heat shock protein (HSPD1),
elongation factor 1-gamma (EEF1G), and enoplasmin (HSP90B1).
HSPD1 is a specific heat shock protein weighing 60 kDa. Heat shock proteins are
known to be involved in protein synthesis and folding through their contributions to
protein synthesis, secretion, trafficking, degradation, and regulation of transcription
factors. By preventing the formation of nonspecific protein aggregates, they maintain
proteostasis and have come to be known as “protein chaperones” that enhance protein
stability. Conversely, heat shock proteins are characteristically over-expressed in cancer.
By preventing the translocation of Bax to induce apoptosis, HSPD1 also has the potential
to promote cell survival can detrimentally contribute to tumor cell proliferation, invasion,
differentiation, and metastasis (Lianos et al., 2015; Swindell et al., 2009). Specifically,
by recognizing various exposed hydrophobic amino acid side-chains HSPD1 assists in
the transport and folding of mitochondrial proteins through ATP-regulated cycles of
binding and hydrolysis (Hartl and Hayer-Hartyl, 2009). HSPD1 expression has been
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found to be elevated in breast cancer tissues, and thus holds potential as a molecular
marker of cancer and in drug targeting (Lianos et al., 2015).
Another heat shock protein, SHP90B1, functions in a similar manner as HSPD1,
except it is located in the endoplasmic reticulum (ER). Under normal circumstances this
endoplasmic chaperone not only assists in protein folding but also targets misfolded
proteins for ER-associated degradation. In cancerous cells, HSP90B1 expression is
upregulated in an effort to combat the accumulation of misfolded and damaged proteins
that accumulate in the lumen of the ER (Kumar et al., 2018). HSP90B1 has recently been
found to be a chaperone for the group of pathogenic receptors known as Toll-like
receptors (TLR’s), implying HSP90B1 plays a critical role in the immune response
against infection (Liu et al., 2010).
The three steps of protein translation—initiation, elongation, and termination—
are mediated by several factors. The cycles of elongation repeat a number of times that
corresponds to the number of amino acids comprising the protein of interested
(Kavaliauskas et al., 2012). Amino acids destined for protein synthesis are coupled to
their conjugate tRNA and selected according to the correct base pairing match between
the codon exposed in the A site on the small ribosomal subunit and the anticodon of the
incoming tRNA. During elongation, the amino-bound tRNA is delivered to the A site of
the ribosome, GTP hydrolysis is activated, and a peptide bond is formed (Alberts et al.,
2008). Specific to this process is elongation factor 1g (EEF1g), which functions in the
guanine nucleotide exchange following the delivery of the aminoacyl-tRNA (AlMaghrebi et al., 2005). Prior in vitro studies have reported altered and upregulated
expression of EEF1g in T47D (Al-Maghrebi et al., 2005), MDA-MA-231 (Al-Maghrebi
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et al., 2005), and MCF-7 cancer cell lines (Joseph et al., 2004). Distinct from EEF1g is
TUFM, the elongation factor that functions in the selection of the correct amino acid to
be incorporated into the growing peptide chain (Kavaliauskas et al., 2012). TUFM is
additionally understood to inhibit serine proteases, presumably allowing for increased
protein degradation and decreased protein production (Conly, 2014).
Taken together, the differences in the transcriptomic and proteomic expression
found in the post-involutional quiescent state relative to the virgin state highlight a
hormonal phenomenon influencing the translational regulation of MEC. In the global
transcriptomic analysis, it was surprising to observe increased expression in those genes
pertaining to the ribosome, its integrity, and its functioning. These findings suggest that
perhaps the increase in ribosomal integrity may be associated with the parity-induced
protection against breast cancer. Yet curiously, the overall trend noted from the
proteomic analyses of MEC isolated in parallel was a decrease in RNA processing in the
post-lactational quiescent state of the cell. All proteins involved in transcriptional
regulatory processes were downregulated in the quiescent state compared with the virgin
state, suggesting a decrease in production of transcripts and proteins in the primiparous
MEC relative to virgin MEC (Conly, 2014)
A comparative analysis performed in parallel of the transcriptome and proteome
has allowed for an exploration in the relationship of the governing mechanisms within
isolated murine MEC of developmental stages. Although a Pearson correlation
coefficient could not be calculated from the dual analysis, confidence does exists in
describing those results obtained from these two differing means of analyzing the
molecular phenotype. Results generated from this analysis included a relatively large
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transcriptomic data set and a relatively small proteomic data set, yet upregulation in
mRNA did not necessarily reflect the expression pattern of the corresponding protein.
This lack of correlation between protein and transcript abundance in relation to those of
isolated virgin MEC was surprising. Technical differences in the methods utilized and
the various biological events influencing RNA stability and the potential for protein
degradation were previously listed as possible considerations to explain this
phenomenon. However, the data further indicate a unique mathematical phenomenon
occurring within MEC.
Of the 31 protein spots differentially detected between the virgin and pregnant
samples, 6 were detected as being differentially expressed in the transcriptomic analysis
(19.4% total proteins). Of the 36 protein spots differentially detected between the virgin
and post-involutional quiescent samples, 7 were detected as being differentially
expressed in the transcriptomic analysis (19.4% total proteins). That the same percentage
of dually detected protein-gene pairs was identified for both developmental comparisons
was fascinating and warranted further investigation.
There are numerous regulatory events occurring after mRNA translation that
influence protein abundance. mRNA is less stable than protein, and accordingly suggest
a marked decrease in protein concentration could be explained by preparations for
cellular division (Vogel and Marcotte, 2012). This would support the observed
differences in the virgin-to-pregnant developmental comparison, where MEC are
supposedly devoted to growth and proliferation, but not the virgin-to-post-translational
developmental comparison. A study examining the comparisons between these stages of
development in both mammary and hepatic samples would be useful in categorizing these
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observed trends of transcript and protein expression profiles in MEC. The kinetics of
transcription and translation also deserve consideration, as mRNAs are produced at a
much slower rate than proteins, approximately two copies of mRNA per hour versus
multiple corresponding proteins per hour, respectively, in mammalian cells (Vogel and
Marcotte, 2012). This might support the observed differences in both developmental
comparisons, where hormonal influences have encouraged transcriptional factors to
promote the generation of specific transcripts, yet the translation of which is strictly
monitored. Perhaps the 19.4% protein expression observed in this study implies even
with sufficient transcript abundance approximately only twenty percent of genes are
actively expressed at a given time. Indeed, it has been previously documented that
variations in mRNA and protein abundances are often uncorrelated and a specifically
protein expression is thought to be buffered with respect to the variation introduced
transcriomically (Battle et al, 2015).
In conclusion, from the transcriptomic and proteomic profiles differentially
detected the comparative analyses of developmental stages in isolated MEC have
identified several molecular mechanisms influencing murine mammary gland physiology
and pathology. Yet by no means do these investigations provide the complete story to the
molecular happenings that can be described. They do, however, uniquely contribute to
the global understanding of the biological systems influencing mammary gland
development. Through this novel join approach, the identification of transcriptomic and
proteomic effectors in cell metabolism, communication, pathways in cancer, and
ribosomal function may guide further analyses related to enhanced lactational capacity
and breast cancer development.
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APPENDIX A – CLC Genomics Workbench Sequencing QC Reports
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APPENDIX C-- Methods for the Proteomic Analysis of Isolated Virgin, Pregnant, and
Primiparous Quiescent Mammary Epithelial Cells

Protein Extraction
Three plates of cells were pooled for each protein extraction sample leading to 3
samples per treatment (n=3). Media was aspirated from plates and cells were transferred
to microcentrifuge tubes and rinsed with PBS. Cells were then lysed by sonication in
homogenization buffer (7 M urea, 2 M thiourea, 40 mM tris base, 1% ASB-14, 40 mM
DTT, 0.5% ampholyte IPG, 0.001% bromophenol blue). Lysate was separated by
centrifugation for 30 minutes at 10,400 x g and 4°C and supernatant containing isolated
soluble proteins was transferred to a new tube.
Protein was precipitated with 10% trichloroacetic acid in acetone overnight at 20°C. Protein was rinsed with 100% acetone and allowed to dry. Protein was solubilized
overnight at 4°C in rehydration buffer containing 7 M urea, 2 M thiourea, 2% CHAPS,
2% nonidet P-40, 100 mM DTE, 0.5% ampholyte IPG, and 0.002% bromophenol blue.
After centrifugation for 15 min at max speed and 4°C, supernatant containing solubilized
protein was transferred to a clean tube and stored at -80°C.
Protein was quantified using the 2-D Quant Kit (GE Healthcare Life Sciences, Pittsburgh,
PA).

Two-dimensional gel electrophoresis (2DGE)
All equipment and materials used for 2DGE were purchased from Bio-Rad
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(Hercules, CA) unless otherwise stated. All buffer reagents were purchased from SigmaAldrich (St. Louis, MO) unless otherwise stated.
Immobilized pH gradient strips (11 cm, pH 3 -10) were actively rehydrated with
the rehydration buffer containing the protein samples for 12 hours at 50 V. Isoelectric
focusing (IEF) for the first dimension of separation was then performed at ~8,000 V and
20°C for 35,000 Volt hours. Active rehydration and IEF were performed using the
Protean IEF Cell. Strips were stored at -80°C until subjected to the second dimension.
For the second dimension, IPG strips containing protein were incubated with
equilibration buffer (375 mM tris-HCl (pH 8.8), 6 M urea, 30% glycerol, 2% SDS,
0.002% bromophenol blue) containing 10 mg/ml DTT on a rotator for 15 min at room
temperature followed by incubation with equilibration buffer containing 25 mg/ml
iodoacetamide for 15 min. Proteins were then separated by molecular mass using 11 cm
10% polyacrylamide Criterion tris-HCl gels using the Criterion Dodeca Cell at 200 V,
allowing all gels to be run simultaneously. Samples were run in duplicate and proteins in
all gels were stained overnight with colloidal Coomassie Blue G-250 and de-stained with
Type I DI water.

Gel analysis, spot picking and trypsin digestion
Stained gels were scanned using an Epson 1280 transparency scanner (Epson,
Long Beach, CA, USA). Scanned gel images were processed and analyzed by Delta 2D
(version 3.6, Decodon, Greifswald, Germany). Spots boundaries were defined and gels
were overlaid and fitted to align corresponding spots across gels. Differentially expressed
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protein spots were identified using a t-test performed according to a null distribution that
was generated with 1000 permutations in order to account for unequal variance and nonnormal distribution of data.
Protein spots that differed in abundance due to treatment were excised using a
manual 1.5 mm tissue puncher (Beecher Instruments, Prairie, WI) and stored at -80°C in
0.5 ml microcentrifuge tubes until further processing. Gel plugs containing individual
protein spots were destained twice by incubation for 30 min at room temperature on a
shaker with destaining buffer (25 mM ammonium bicarbonate in 50% acetonitrile),
dehydrated with 100% acetonitrile, and digested overnight with trypsin solution (11 μg/μl
MS-grade porcine trypsin gold (Promega, Madison, WI) in 40mM ammonium
bicarbonate/10% acetonitrile) at 37°C. Digested proteins were eluted with analyte
solution (0.1% trifluoroacetic acid (TFA)/acetonitrile 2:1) for 30 min on a shaker at room
temperature, repeated twice. Samples were concentrated using a SpeedVac (Thermo
Fisher Scientific, Waltham, MA) at 45°C, resuspended in 6 μl of matrix solution (0.2
mg/ml α-cyano-4-hydroxycinnamic acid in acetonitrile) and plated on an Anchorchip
target plate (Bruker Daltonics Inc., Billerica, MA). Plated protein spots were washed with
0.1% TFA and recrystallized with acetone/ethanol/0.1% TFA (6:3:1).

Mass spectrometry and protein identification
Peptide mass fingerprints (PMFs) were obtained using a matrix-assisted laser
desorption ionization tandem time-of-flight (MALDI TOF/TOF) mass spectrometer
(Ultraflex II; Bruker Daltonics Inc., Billerica, MA). Trypsin was used for internal mass
calibration. PMFs were analyzed using MASCOT server launched from BioTools
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software (Bruker Daltonics, Billerica, MA) against the NCBI database. PMF were further
analyzed using MS/MS spectra using five to ten of the largest peaks per sample
(excluding keratin and trypsin). Spectra were internally calibrated and processed using
FlexAnalysis software (Bruker Daltonics, Billerica, MA). PMF and MS/MS spectra were
combined and queried as described for PMF spectra analysis using the MS/MS spectra.
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